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Abstract 
In 2014, breast cancer was the second leading cause of death among Canadian women, 
with women over age 50 years making up 82% of the identified cases. To address this 
issue, the Ontario Breast Screening Program developed a media campaign that promoted 
the benefits of mammogram screening, but not the associated risks (i.e., false-positive, 
false-negative, radiation exposure, and overdiagnosis). This study was designed to 
determine whether there was a statistically significant relationship between knowledge of 
overdiagnosis and participation in mammogram screening. This cross-sectional, 
correlational study used schema theory supported by the effective health communication 
model. Forty-one women were invited to listen to a brief presentation on the benefits and 
risks of screening mammograms and then completed a modified Champion Health Belief 
Model Scale survey. Two sample t tests and logistic regression analyses of the survey 
scores showed that the data did not support any correlations with education and 
screening, but did indicate a correlation between overdiagnosis and participation. The 
less a participant felt that overdiagnosis was a negative consequence, the more likely they 
were to participate in breast screening. Survey participants also stated that promotions of 
mammograms should present balanced information about the benefits and risks of 
screening. The positive social change and policy implications of this study include 
providing women aged 50–69 years more information on overdiagnosis in mammograms 
so they are more informed participants in the decision-making process, and educating 
Ontario government policymakers with information about the barriers that women aged 
50–69 years face in getting balanced information on mammography programs.  
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Chapter 1: Introduction to the Study 
Introduction 
Breast cancer has no cure and is the most common form of cancer among 
Canadian women. In Canada, in their lifetime, an estimated one in nine will have 
developed the disease by the age of 90 years; one in 30 will die (Canadian Breast Cancer 
Foundation [CBCF], 2014b, Key statistics section, para. 1–3). The Government of 
Ontario and several public health organizations have dedicated significant research and 
financial resources to establishing more effective ways of addressing breast cancer. One 
of the key ways to address breast cancer has been through the promotion of early 
detection via screening mammography. However, despite the increased focus and media 
campaigns promoting mainly the benefits (and not the associated risks) of screening 
programs, the rate of participation estimated in the Province of Ontario has not reached 
the hoped-for target participation level of 70%–73%, which was set by Cancer Care 
Ontario (CCO)’s Ontario Breast Screening Program (OBSP) (Breast Cancer Society of 
Canada [BCSC], 2014a; CBCF, 2014b; Office of the Auditor General of Ontario, 2012). 
The reasons for this lower-than-expected rate of participation have been attributed to a 
variety of barriers identified in several different studies. Some of the identified barriers to 
screening participation include embarrassment, fear of pain, underlying health, lack of 
access to services, language barriers, lack of knowledge, cultural beliefs, and the 
unhelpful attitudes of health professionals (Vigod, 2011; Welch, 2004). Of these 
identified barriers many studies have concentrated on how fear of pain, embarrassment, 
and lack of access to services have impacted breast screening participation rates.  
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Other studies addressing breast screening have focused on considerations of the 
associated risks of screening mammography. Studies conducted by Baines (2005), 
Brouwers et al. (2011), Elmore and Fletcher (2012), and Nelson and Hagedorn (2011) 
have looked at issues of (a) false-positive, (b) false-negative, (c) radiation exposure 
associated with screening, and (iv) overdiagnosis. However, Bleyer and Welch (2012), de 
Gelder et al. (2011), Duffy et al. (2010b), Elmore and Fletcher (2012), Hellquist, Duffy, 
Nyström, and Jonsson (2012), Jørgensen and Gøtzsche (2009), Kopans, Smith, and Duffy 
(2011), McPherson (2010), Welch and Black (2010), and Welch, Schwartz, and 
Woloshin (2011) focused their respective studies on overdiagnosis in breast screening. 
These above-mentioned studies and others contribute to existing literature about breast 
cancer screening, and established context for the specific aspect of mammography 
screening that was examined in this study.  
This study addressed a gap in current literature relating to breast cancer 
overdiagnosis in Ontario, Canada. Welch et al. (2011) defined overdiagnosis as occurring 
“when individuals are diagnosed with conditions that will never cause symptoms or 
death” (p. xiv). Welch et al. further indicated the need for more research that definitively 
looks at how breast screening programs are impacted by a lack of knowledge of 
overdiagnosis and by mass media. From the perspective of mass media/ media 
communications, Favaro (2012) noted that current health communications continue to 
present unbalanced information about screening. Hersch et al. (2013) emphasized that 
“great care is needed in communicating this [new] information [about overdiagnosis] as it 
may influence screening and treatment decisions in unintended ways” (p. 10); Based on 
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breast cancer statistics in Ontario, Canada and the comments and recommendations from 
Bleyer and Welch (2012), Favaro (2012), Hersch et al. (2013), Welch and Black (2010), 
Welch et al. (2011), among others, this research placed emphasis on examining whether 
knowing about overdiganosis related to breast cancer screening decision-making. 
Within the context of Canada, a study by Coldman and Phillips (2013) examined 
the Province of British Columbia (BC), and estimated the rate of overdiagnosis for breast 
cancer in women over the age of 60 years at 5.4% for invasive diseases and 17.3% for 
both invasive diseases and ductal carcinoma in situ (p. E492). However, the literature 
review for this study did not identify any Ontario-specific data outlining the rate of 
overdiagnosis in the province. Additionally, no prior studies were found that examined 
the relationship between documented levels of screening participation and a knowledge 
of overdiagnosis. To my knowledge, this study was designed as the first that examined 
this topic in Ontario. It is also the first of its kind to combine schema theory with the 
effective health communication model to create a new approach for presenting 
information about breast cancer screening programs and the associated risk of 
overdiagnosis.  
This study was designed to promote positive social change by making future 
screening participants better-equipped to make informed decisions about participating in 
screening programs. It specifically responds to the lack of Ontario-specific data on the 
correlation between overdiagnosis and screening participation. It also facilitates greater 
understating of how a combined understanding of schema theory and the effective health 
communication model helps in efficient delivery of information about overdiagnosis. It 
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will inform screening participants by providing access to comprehensive information on 
both the benefits and risks of screening mammography. Another predicted positive social 
change implication is that policy-makers and public health care providers will be able to 
improve the screening process by creating more comprehensive patient screening. It 
promotes improvements in screening processes by identifying the best practice strategic 
tools to track, assess, and enhance the quality and quantity of screening service delivered. 
In addition, this study lays the groundwork for a critical assessment and consideration of 
whether the current aggressive (Favaro, 2012, para. 10) and unbalanced promotion of 
breast cancer screening, as being predominantly beneficial, has a relationship to the 
reported increase in the rates of screening mammography participation. With a more 
accurate overview of the rates of screening participation, the Government of Ontario will 
be better able to establish policies that can address how information is presented about 
breast screening programs. 
The primary research question therefore asked: Is there a relationship between 
knowledge of overdiagnosis and the decision to participate in breast cancer screening 
among women aged 50–69 years? The working hypothesis tested by the study was that 
the more knowledge a woman has regarding the screening process, the more likely she is 
to participate in breast cancer screening. To answer the research questions and 
hypotheses, primary data were collected from a sample of 41 female participants (focus 
group/cohort, n = 41) who collectively listened to a brief presentation on breast cancer 
screening and its various implications, and then were administered a 45-item survey 
instrument. The first section of the survey instrument consisted of seven closed-ended 
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ordered-category items intended to gather preliminary background (contextual) 
information. This background information served the purpose of identifying/establishing 
relevant context for the interpretation of the primary data collected. The final section of 
the survey instrument had 38-items that were 5-point closed-ended Likert-format 
questions. This section incorporated three of the eight Champion Health Belief Model 
Scales (CHBMS) developed by Champion (1999), and two new scales created 
specifically for this study. Each question required responses that ranged from strongly 
disagree to strongly agree.  
The three Champion scales measured each participant’s knowledge of breast 
cancer screening, its associated benefits and risks, and considerations of what motivates 
health-related decision-making. The supplementary scales addressed each participant’s 
knowledge of overdiagnosis and their respective opinions on how information related to 
breast cancer screening was presented. The complete survey instrument had five major 
scales that respectively addressed: 
 health motivation, consisting of a preexisting seven-item scale and a one-item 
scale created for this study (eight items total) 
 benefits–mammogram, consisting of a six-item scale, 
 barriers–mammogram, consisting of a five-item scale from the final revised 
health belief model (HBM) scale and six of Champion’s confirmatory factor 
loading for scale items (eleven items total) 
 knowledge of overdiagnosis, consisting of a five-item scale, and 
 information presentation, consisting of an eight-item scale.  
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The survey instrument is detailed in Appendix A. 
Champion (1999) established the reliability of each individual scale on the eight-
scale Health Belief Model (HBM) survey (see Appendix B). This enables other 
researchers to selectively eliminate scales in the HBM survey once it is established that 
the removed scales are not relevant to the study being undertaken, as was the case with 
this study. Each included scale was evaluated and deemed relevant because they directly 
addressed considerations of perceived positive and negative implications of breast cancer 
screening. Those scales also facilitated an assessment of the motivating factors in health-
related decision-making. For those selected scales, adequate reliability was maintained. 
The remaining sections for this chapter discuss the study’s background, problem 
statement, theoretical framework, purpose of the study, research question, research 
method, nature of the study, and definition of terms. It also details the assumptions made, 
the limitations, scope, and delimitations of the study. The significance of the study is 
discussed and summary statements are given. Overall, this chapter offers specific details 
about key concepts related to breast cancer. As well, it provides a brief summary of 
breast cancer and screening mammography in the context of Ontario, Canada. The 
chapter further presents an overview of relevant information pertaining to how this 
research was structured and conducted. 
Background 
At the time of the study, breast cancer was the second-highest cause of death 
among women in Canada. In 2014, it was projected that almost 24,400 women would to 
be diagnosed with the breast cancer and that roughly 5,000 members of the diagnosed 
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population would die from the disease. This represents an estimated 14 deaths out of 
every 67 Canadian women diagnosed each day. The estimated cases of breast cancer 
among Canadian men were noted to be 60 deaths from an estimated 210 diagnosed 
(BCSC, 2014a; CBCF, 2014b; CCO, 2014a; Canadian Cancer Society [CCS], 2014c). To 
deal with this issue of breast cancer, screening mammography programs were introduced 
in the 1988 by the Government of Canada (Canada. Parliament, 2013). The identified 
improvements in the rate of survival and the rate of mortality (measured in five-year 
increments) have indicated that screening and early detection programs are somewhat 
effective in identifying cancers at earlier stages (CBCF, 2014a). Early detection enables 
the use of less invasive treatment options; however, this detection has also raised the 
recorded incidence rate of breast cancer in Canada since the 1980s. 
Several studies have noted a variety of risks associated with screening 
mammographies (Brouwers et al., 2011; Coldman & Phillips, 2013; Elmore & Fletcher, 
2012). These risks include false-positive, false-negative, radiation exposure, and 
overdiagnosis. This study focuses on the risk of overdiagnosis. The issue of 
overdiagnosis is not a new concept in relation to cancer. As noted by Welch et al. (2011) 
overdiagnosis gained popularity in the context of prostate cancer screening in men aged 
50 years and older. In more recent years it has been the focus of many studies (e.g. 
Bellenir, 2009; Brouwers et al., 2011; de Gelder et al., 2011; Duffy & Parmar, 2013) that 
address the issue of breast cancer and screening mammography participation.  
Several other studies on breast cancer screening programs have evaluated how 
risk factors increase the potential for breast cancer. Previously examined risk factors 
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include personal history, smoking habits, family history, ancestry, obesity 
postmenopause, and lack of physical activity. Many recent studies have also compared 
breast cancer risk factors and the observed incidence rate of breast cancer (CBCF, 
2014a). Others have chosen to address breast cancer screening, not in relation to the rate 
of incidence, but rather with a focus on the issue of overdiagnosis (Bellenir, 2009; 
Brouwers et al., 2011; de Gelder et al., 2011; Duffy & Parmar, 2013; Giordano, Webster, 
Segan, & Austoker, 2006; Gøtzsche, Hartling, Nielsen, Brodersen, & Jørgensen, 2009; 
Hersch et al., 2013; Jørgensen & Gøtzsche, 2009; McPherson, 2010; Welch et al., 2011). 
More recently, Bleyer and Welch (2012) found that in the United States of America 
(U.S.) one in three women with breast cancer had been overdiagnosed. Elmore and 
Fletcher (2012), Nelson and Hagedorn (2011), and Welch and Black (2010) separately 
claimed that there is a lack of knowledge about how screening participation levels are 
impacted when emphasis is placed on overdiagnosis as a consequence of breast 
screening. Many of the above-mentioned studies focused on overdiagnosis used 
randomized clinical trials (RCT) and/or lead-time approach research design to examine 
the rate of overdiagnosis in a given population.  
There is very limited information or research conducted on the issue of breast 
cancer overdiagnosis in the specific geographic context of Ontario. As a result, the 
impact of this overdiagnosis on the current rate of participation is unknown. However, 
prior to any examination of a cause and effect relationship between the two study 
variables, knowledge of overdiagnosis and the decision to participate in breast cancer 
screening, it was vital that this research first determine the existence of a relationship 
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between the variables within the context of Ontario. Post data collection, if the study’s 
findings indicate that a relationship exists between the study variables further 
examination of the cause-effect relationship is merited.  
Problem Statement 
The Office of the Auditor General of Ontario’s (2012) annual report stated that 
“[breast cancer] screening programs are effective if they reach a sizeable percentage of 
the target population” (p. 50). A three-year participation target range of 90% to 95% was 
set in 2003. However, after further assessment, the same office decided to reach this goal 
via incremental screening mammogram target increases from 66% in 2009 to 73% in 
2013/2014 (Office of the Auditor General of Ontario, 2012, p. 50). This participation 
target range was then further narrowed to focus on females aged 50 years and older, as 
current statistics (on the incidence of breast cancer, rate of mortality, and rate of survival 
for Canadian women) identified this age group as requiring particular emphasis. The 
CBCF (2014b) specifically noted that 82% of the identified cases of breast cancers in the 
country are found in Canadian females over age 50 years.  
The CCO (2014a) also noted that there was no family history of breast cancer for 
a majority of women identified with the disease, and since there is currently no way to 
stop breast cancer, if the disease is found earlier the chances for a cure increases. In 
Ontario, for 2014, about 9,500 women were predicted to develop breast cancer, with 
almost 1,950 predicted to die from the disease (see Table 1; CBCF, 2014b; CCO, 2014a; 
CCS, Statistics Canada, Public Health Agency of Canada, & Provincial/Territorial 
Cancer Registries, 2014). According to the CCO (2011b), CCS (2014b) and the Canadian 
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Task Force on Preventive Health Care [CTFPHC] (2014), out of every roughly 1,000 
women screened aged 50–69 years, 36 (3.60%) would have an unnecessary breast biopsy, 
and approximately 283 (28.30%) would have a false positive mammography. CTFPHC 
(2014) indicated that, for each identified case of false positive, the effects on these 
(overdiagnosed) screened women were “unnecessary anxiety and follow-up testing” 
(CTFPHC, 2014, “To save one life,” p. 1). For every 1,000 women screened, CTFPHC 
also noted that 5 will undergo unnecessary surgery for breast cancer (“For every 1000 
women,” p. 1). However, despite (a) the approximately $92 million Canadian dollars 
spent on screening programs during the 2011/2012 fiscal year (Office of the Auditor 
General of Ontario, 2012, p. 14), and (b) the robust health care media communication 
campaign promoting the CCO’s Ontario Breast Screening Program [OBSP]—rationalized 
by the statement breast “cancer screening saves lives” (Ontario Ministry of Health and 
Long-Term Care [MHLTC], 2014, para. 1)—the information presented by such 
organizations as CCO, CCS, CBCF and CBCS have not adequately offered a balanced 
perspective that outlines the benefits as well as any associated risks of screening 
mammography.  
This study was designed to determine the correlation between the variables, 
knowledge of overdiagnosis and the decision to participate in breast cancer screening 
among women aged 50–69 years. The findings are expected to inform the Government of 
Ontario in creating more balanced health communication strategies and campaign content 
for the province’s breast screening program. This cross-sectional, correlational 
(nonexperimental, quantitative) study sought to address the following research question: 
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Is there a relationship between knowledge of overdiagnosis and the decision to participate 
in breast cancer screening among women aged 50–69 years?  
Theoretical Framework 
The theoretical framework for this study was based on schema theory and the 
effective health communication model. Grounded in Bandura’s (1977) social cognitive 
theory, schema theory argues that the human mind is organized by a series of schemas 
that classify and interpret information to create a general picture of how that individual 
understands specific topics. This picture created is a cognitive construct and a 
consequence of that individual’s use of all the information present and the associations 
from that present information. According to schema theory, persons use schemata 
(scripts) to group current information/knowledge and provide a framework for future 
understanding (Erasmus, Boshoff, & Rousseau, 2002). According to Rumelhart (as cited 
in Sabella 1999):  
Schemas are the fundamental elements upon which information processing 
depends. Schema[s] are employed in the process of interpreting sensory data . . .in 
retrieving information from memory, in organizing actions, in determining 
goals . . .in allocating resources, and generally in guiding the flow of processing 
in the system. (p. 8) 
Rumelhart further described a schema as a data structure where general ideas are retained 
in memory. In other words, schemas represent knowledge about “objects, situations, 
event, sequences of events, actions, and sequences of actions” (as cited in Sabella, 1999, 
p. 8). The process of an individual’s schema is illustrated in Figure 1. 
12 
 
 
 
 
Figure 1. A diagram depicting the integral learning cycle. Each quadrant within the circle 
represents the four stages of learning. Starting anticlockwise each stage/quadrant 
addresses in sequential order: What is happening? What does it mean? What have we 
learned? What do we do? Adapted from “The integral learning cycle and the map,” by C 
Dierkes, 2009, May 23, [Web log post] Retrieved from 
http://indistinctunion.wordpress.com/category/integral/. Copyright 2009 by Chris 
Dierkes. 
 
Schema theory was used in the following studies: Anderson and Pichert (1978), 
Brewer and Treyens (1981), Gara et al. (1993), Georgeon and Ritter (2012), Markus 
(1977), Nishida (1999), and Onorato and Turner (2004). Each study addressed issues of 
knowledge and the interpretation of knowledge in relation to cultural learning, social 
learning, behavioral learning, and experiential learning (see Figure 1). Although not 
specifically related to this study’s focus on knowledge of overdiagnosis, the information 
presented in each research nevertheless offered relevant insights (about how 
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information/knowledge is processed and applied on an individual level) that are 
applicable to this study. 
For this study, Giordano et al.’s (2006) effective health communication model 
was used to support schema theory. According Giordano et al., for effective 
communication, “health professionals must provide individuals with such information 
that will allow them to ‘knowledgeably’ decide whether or not to undergo an 
intervention, taking into consideration available alternatives, potential risks and 
foreseeable outcomes” (p. 382). More specifically, Giordano et al. indicated that 
“appropriate information in suitable formats should be available and accessible to all 
women who would benefit from breast screening” (p. 384). Giordano et al. further 
mentioned that: 
Women obtain breast cancer information from a variety of sources, among which 
health professionals are one of the obvious. The health professionals play a 
central role in the provision of information. . . .[Therefore] it is important that 
these people [health professionals] acquire comprehensive knowledge needed to 
inform women about the pros and cons of screening. (p. 384) 
This problem of effective communication in health-related matters (as noted by Giordano 
et al. 2006) was also addressed by researchers Glanz, Rimer, and Viswanath (2008), 
Kreuter and Wray (2003), Politi, Han, and Col (2007), and Stewart (1995). Although all 
these above-mentioned studies did not directly address health issues related to breast 
cancer, they each demonstrated the significance of considerations such as “physician-
patient communication mak[ing] a significant difference to patient health outcomes” 
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(Stewart, 1995, p. 1429). Politi et al., (2007) specifically noted that care was needed in 
communicating uncertainties of the harms and benefits of medical interventions (similar 
to the medical intervention of screening mammography that is addressed in this study). 
Within the context of screening mammograms, this study’s focus was on 
understanding the correlation between knowledge of overdiagnosis and decisions about 
screening participation. As the issue of “overdiagnosis will be new and counterintuitive 
for many people and may influence screening and treatment decisions in unintended 
ways, [it underscores] the need for careful communication” (Hersch et al., 2013, p. 1). 
Therefore, it was relevant for this study that schema theory be used in conjunction with 
Giordano et al.’s (2006) effective health communication model. Both acted as a guide to 
understanding not only how individuals interpreted and understood new information in 
the context of their reality, but also to the consideration that care should be taken in how 
this new information was presented. With an understanding of both schema theory and 
the effective health communication model the Government of Ontario, public health 
policy makers, and other health care providers will be better-equipped to establish 
screening information guidelines. This can then facilitate a balanced (benefits and risks, 
including overdiagnosis) approach to how information is presented about screening 
mammography. This, by extension, also allows participants to make more informed 
decisions on whether or not to participate in screening. It may also possibly limit negative 
impacts to screening participation levels.  
Further details about schema theory and the effective health communication 
model are outlined in Chapter 2. This outlined information helped to establish and 
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contextualize the topic being investigated. Both schema theory and the effective health 
communication model allowed for an understanding of how theoretical suggestions can 
offer strategies for real-life social (societal) application. Furthermore, this information 
will enable readers of this study to learn the connections among (a) notions of cognitive 
learning (understanding); (b) environmental (social) factors that influence such learning; 
(c) the development of appropriate solutions (for this public policy-related research 
question); and (d) implementation methods for those identified solutions. 
Purpose of the Study 
The objective/purpose of this quantitative study was to determine if there is a 
relationship (correlation) between knowledge of overdiagnosis (independent variable) 
and the decision to participate in breast cancer screening (dependent variable) among 
women aged 50–69 years. This information can be used (by the Government of Ontario, 
public health policy administrators, public health care providers, people who are at risk of 
developing breast cancer, individuals deciding whether or not to participate in breast 
screening programs, and others) to understand the potential consequences of 
overdiagnosis in screening mammography. 
Research Question 
This research sought to investigate among women aged 50–69 years if there exists 
a relationship between knowledge of overdiagnosis and decisions about participating in 
screening mammography. The primary research question asked: Is there a relationship 
between knowledge of overdiagnosis and the decision to participate in breast cancer 
screening among women aged 50–69 years? Secondary research questions examined 
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whether relationships exist between thoughts and attitudes on subsections of the survey 
(such as mammogram barriers) and decision to participate in breast cancer screening. To 
answer the research question, this study used a cross-sectional, correlational 
(nonexperimental, quantitative) survey research design (Black, 2012; Salkind, 2010). The 
nonexperimental approach was selected because this study used existing records 
(secondary data) to establish the relevance of conducting this exploratory research (as is 
outlined throughout this study). However, a Likert-format survey instrument 
(questionnaires) distributed to a specified group/cohort (within the target population) was 
ultimately used as the means of determining how the independent variable correlated with 
the dependent variable.  
In this study, the independent variable being examined could not be manipulated, 
but rather was explored to determine the nature of the relationship between the variables 
investigated. Knowledge of overdiagnosis was examined in relation to decision-making 
about whether to participate in screening mammography. Logistic regression was used to 
explore whether a correlation exists between knowledge of overdiagnosis and screening 
decision-making. This method of analysis was appropriate because this type of regression 
analysis is used for predicting a categorical dependent variable—specifically for 
questions where the dependent variable is binary; that is, the number of available 
categories is two—based on one or more continuous, independent variables (Black, 
2012).  
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Research Method 
Knowledge of overdiagnosis among women aged 50–69 years was assessed with 
the use of a modified CHBMS (Likert-format) survey. It was also assessed by calculating 
a total score for this survey, wherein a higher score is indicative of women’s thoughts and 
attitudes being more positive towards breast cancer screening. The study’s sample 
consisted of 41 women aged 50–69 years, who live in the Greater Toronto Area (GTA) in 
the Province of Ontario, and who can read and write in English. Because current 
literature did not outline the number of women living in the GTA who were between the 
ages of 50 to 69 years, the nonprobability strategy was used to determine sample size. As 
well, there was no single list in the GTA that contained the names or contact information 
for the sample population. Therefore, finding the accessible population required to have 
the sample size be generalizable to the target population, was a major challenge. I gained 
all the necessary preliminary approvals from the Institutional Review Board (IRB) of 
Walden University prior to commencing the survey and data gathering stage. This was 
done to ensure that all ethical considerations were appropriately addressed. The study’s 
community partner Tropicana Community Services (TCS) was required to provide a 
signed letter of cooperation for the data collection process (see Appendix C). Informed 
consent was implied (see Appendix D) by each participant who returned a completed 
survey form to me.  
The final modified CHBMS (Likert-format) survey used in the study was 
relatively straight forward to determine as the remaining five scales not selected focused 
on concerns of (a) susceptibility to breast cancer, (b) perceived seriousness of life style 
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implications given a positive diagnosed of breast cancer, (c) the benefits of breast self- 
examinations (BSE), (d) the barriers BSE, and (e) the levels of confidence to conducting 
BSE. Although all the above are important in the context of understanding an individual’s 
overall knowledge and perception of breast cancer screening, those particular scale items 
were not directly pertinent to this study. Additionally, although the use of the complete 
CHBMS would have produced smaller intervals of confidence, the feasibility of getting 
41 participants to spend the time required to complete a 53 scale item survey 
supplemented with another 28-items—that included questions related to their 
background, knowledge of overdiagnosis, and perceptions of how information on breast 
cancer screening is presented—could have caused participants to lose interest and/or 
focus.  
As outlined by TCS (2014) a wide variety of programs and services are 
administered “to provide (GTA) community members with opportunities and alternatives 
that lead to success and positive life choices” (TCS, 2014, What we do section, para. 1). 
For these reasons and others I strongly believed a partnership with TCS enhanced the 
chances of creating and executing on a quality and ethically sound study. With the 
assistance of TCS, women in the organization’s network were contacted via email, the 
organization’s community notice boards, and telephoned to request their participation in 
the study’s survey. Prior to the collection of data, a pilot study was conducted to verify 
the validity and reliability of the entire survey instrument. More specifically, the pilot test 
was used to confirm the validity and reliability of the two supplementary scales I created. 
However, Cronbach’s alpha (α) was not calculated given the small number of pilot test 
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participants (five), but face validity of the survey instrument was confirmed as pilot 
participants felt the survey covered the concepts it purported to measure.  
A similar recruiting and sampling process was used for the pilot test and the 
actual study survey. In practical terms, this meant that the pilot study included (a) the 
same letter of invitation; (b) a reminder email outlining the date, time, location, and thank 
you gifting post survey completion; (c) the same presentation—I presented during the 
actual survey—about breast cancer screening and its associated benefits and risks, 
including overdiagnosis; (d) an opportunity for pilot participants to seek clarification, if 
needed, prior to completing the survey; and (e) distribution of the group administered 
survey. A copy of the survey instrument that was pilot tested and the informed consent 
form can be seen in Appendix A and D. Unlike the actual study, the pilot study was (a) 
not conducted at the TCS facilities, but rather a different location that much like the TCS’ 
facility was at no cost to me and easily accessible for the pilot participants; and (b) 
conducted on a smaller scale because fewer participants are generally needed for pilot 
studies. Five participants were used for the pilot test and no revisions were required based 
on pilot participant feedback. The information collected from these five participants’ 
surveys was not included in the actual study. 
Nature of the Study 
As mentioned by Geddes (1990), until the research findings indicate the existence 
of a correlation, one will not be assumed (p. 133). Therefore, because there was no 
specific research in Ontario indicating the existence of a relationship between the 
dependent and independent variables, the nature of this research was an exploratory 
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study. This cross-sectional, correlational (nonexperimental, quantitative) study sought to 
determine the relationship between two quantitatively represented variables based on data 
collected using a group administered, close-ended Likert-format survey questionnaire 
(nonexperimental), among a specified group (cohort–women 50–69 years) (Black, 2012; 
Creswell, 2009; Frankfort-Nachmias & Nachmias, 2008). Because this study was 
examining the relationship (correlation) between two quantitatively represented variables, 
the research method and design were appropriate for the research problem. As indicated 
by Black (2012), correlational research refers to quantitative approaches that investigate 
relationships as pairs of variables to see how they vary in relation to each other. This type 
of research does not offer answers to establish causality (cause-effect), but does provide 
“a rationale for more structured experimental or quasi-experimental studies when 
population parameters are known” (p.46), as was the case for this study. 
As an exploratory study the results of this research (independent of additional 
studies using larger sample sizes) has limited usefulness for decision-making by 
themselves. However, the results of exploratory studies can provide significant insight 
into a given situation. As well, such studies (like this one) aid in gathering preliminary 
information that can be used to assist in the definition of problems and the positing of 
hypotheses (p.51). For Vogt (2007) the levels of measurement for the study’s dependent 
variable, decision to participate in breast cancer screening, were nominal (categorical) 
because it had two or more categories without having an intrinsic order. It was also 
dichotomous (binary) because the variable had only two categories or levels: participate 
or not participate. Vogt (2007) noted that nominal variables “must be exhaustive (not 
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leaving anything out) and mutually exclusive (each person or things is only categorized 
in one way)” (p. 9). The study’s independent variable, knowledge of overdiagnosis, was 
an interval level of measurement. It was classified as an interval level variable because 
there is an increasing score (by units of 1) and a higher score represents women’s 
thoughts and attitudes towards breast cancer screening being more positive (p. 10). The 
study’s target population was limited to women living in Ontario’s GTA, particularly 
those who understand (read and write in) English.  
One benefit of this research method and research design—cross-sectional, 
correlational survey (nonexperimental, quantitative) that included the use of a survey 
instrument given to a focus group/cohort of female participants—was that a smaller 
sample population was used based on time and cost constraints. On the other hand, this 
resulted in a lower probability for more comprehensive generalizations that were 
reflective of the general Ontario population from which the sample was derived. With a 
lower probability for comprehensive generalizations, the external validity of the study’s 
findings therefore decreased. However, other value adds to this research method and 
design were that it facilitated the generation of hypotheses tested post the collection of 
data, and the testing and reaffirmation of any existing theories about the phenomenon 
examined. Other benefits to this research method and design were that because of the 
numerical nature of the data collected, there was a greater opportunity for limited-scope 
predictions from the information gathered.  
Additionally, because this research was examining a correlation relationship, it 
enabled the establishment of control variables/parameters to better determine what that 
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correlation was. Consequently, this increased the study’s internal validity through the 
reduction of confounding factors. This research design and method also provided 
enhanced reliability and validity of the results because the data were largely based on 
first-hand collected and verified quality data (Lapan & Quartaroli, 2009, p. 60). The 
research design was ideal for this study as it facilitated the discovery of functional 
correlations or causal relationships among variables. It was also advantageous because 
subjects could not be randomly assigned to the level of independent variable—rather, 
they assigned themselves. As such, this research was better able to focus on the noted 
effect/phenomenon and, through this, attempted to determine what caused the observed 
effect (as is the case of this research) (Christensen, 2010). 
In discussions of research design strategies Patton (2002) noted that there are 
critical trade-offs due to limitations of time, resource, and the human ability to 
understand complex social realities. Hence, “there are no perfect research designs” (p. 
223). As the above notion relates to this research, considerations of time constraints, 
finance, research generalizability, validity and reliability were used to determine what 
would be the optimal sampling strategy. To this end, purposive sampling (nonprobability 
sampling, rather than probability sampling) was the more practical and appropriate 
choice. Patton (2002) also stated that in purposeful (purposive) sampling “cases for study 
are selected because they are information rich and illuminative, that is, they offer useful 
manifestations of the phenomenon of interest; Sampling is . . .aimed at insight . . .not 
empirical generalizations” (pp. 40; 243). Of the various nonprobability sampling options, 
purposive sampling was implemented as it offered the opportunity to focus on the target 
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population even though it was not possible to statistically specify this population—as 
they were not known, and access was difficult.  
Probability sampling—stratified random sampling—was initially considered for 
this research to ensure participants would be randomly selected but targeted to the group 
of interest, thereby increasing the external reliability. However, as the study was aimed at 
exploring the phenomenon being investigated (and not focused on making 
generalization), use of nonprobability purposeful sampling better facilitated the selection 
of participants—from the list of women contacted by TCS—for this research. This 
approach allowed the study’s specified interest group (all GTA Ontario women aged 50–
69 years who are eligible for screening mammography—participants and nonparticipants) 
a higher probability of being selected (Patton, 2002; Salkind, 2010). Using Cronbach’s 
alpha statistics, the data collected were then assessed for consistency. This then permitted 
the creation of a total survey score (sum of individual questions) to serve as a single 
measure representing a women’s thoughts and attitudes towards breast cancer screening.  
Two sample 2-sided t tests were used to compare the mean total survey scores 
between those who had participated in breast cancer screening and those who did not. 
Survey scores on subsections (such as mammogram barriers) were similarly compared 
between the two groups. Using a logistic regression model, the relationship between the 
outcome (breast cancer screening) and total survey score was assessed. This logistic 
regression model adjusted for the respondents’ education level completed. Results were 
displayed as odds rations with their associated 95% confidence intervals. Similar logistic 
regression models were conducted on the total scores for survey subsections.  
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Given the unique nature of the population, it was uncertain how many females fell 
into the study criteria inclusion category. Thus, power analysis could not be used to 
determine sample size. The basis of sample size for this study was as a result of 
recommendations found in the research of Baumgartner, Strong, and Hensley (2002) who 
recommended between 8–12 participants and Johnson and Christensen (2004) who 
contended a group of 6–12 participants was appropriate. Because presentations at TCS 
generally had 40–60 participants, I opted to incorporate a sample of 41 participants. 
Using the Statistical Package of the Social Sciences (SPSS software), I analyzed and 
checked for missing data. 
The intent of this study’s finding is to assist Ontario public health care policy 
makers’ understand that (a) a balanced presentation of information about screening 
mammograms (benefits and risks) will facilitate potential participants to make more 
informed decisions about getting screened; and (b) this balanced presentation of 
information and the subsequent informed decisions made, will not have adverse/negative 
consequences to the currently documented rate of participation for screening 
mammography. Ultimately, the cross-sectional, correlational (quantitative, 
nonexperimental) survey research design was beneficial as it served the main research 
purpose. The research purpose was to enable the initial identification of possible 
associations that need further investigation. The research design also allowed for 
predication from one variable to the next. The detailed discussions concerning 
methodologies are discussed in Chapter 3. 
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Definition of Terms 
The relevant concepts related to breast cancer screening and its associated risks 
which will be encountered throughout this study are as follows: 
Benign: “Not cancerous. Benign tumors may grow larger but do not spread to 
other parts of the body. Also called nonmalignant” (National Cancer Institute [NCI], 
2014b, Benign section, para. 1). 
Biopsy: “The removal of cells or tissues for examination by a pathologist” (NCI, 
2014b, Biopsy section, para. 1). 
Breast density: Relates to “the relative amount of different tissues present in the 
breast” (NCI, 2014a, Breast density section, para. 1). 
Breast cancer: Cancer originating in the breast, whether (a) in the line of a breast 
duct (ductal carcinoma) or (b) in a lobule of the breast (lobular carcinoma) (NCI, 2014e).  
Breast lobe: “A section of the breast that contains the lobules (the glands that 
make milk)” (NCI, 2014b, Breast lobe section, para. 1). 
Cancer: A disease caused by changes in normal cells that grow uncontrollably 
and therefore causes a lump (tumor) to form (NCI, 2014b). 
Diagnostic mammogram: “X-ray of the breasts used to check for breast cancer 
after a lump or other sign or symptom of breast cancer has been found” (NCI, 2014a, 
Diagnostic mammogram section, para. 1). 
Duct: “In medicine, a tube or vessel of the body through which fluid 
pass” (NCI, 2014b, Duct section, para. 1). 
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Effective health communication: The strategic dissemination and critical 
evaluation of—honest, adequate, evidence-based, accessible, unbiased, respectful, 
relevant, accurate, and understandable—health information that is communicated to and 
from intended audiences. In effective health communication, adequate consideration must 
therefore be given to each individual’s specific needs, and differences in values and 
beliefs (Giordano et al., 2006). 
False-negative: “A test result that indicates that a person does not have a specific 
disease or condition when the person actually does have the disease or condition” (NCI, 
2014b, False-negative test result section, para. 1). 
False-positive: “A test result that indicates that a person has a specific disease or 
condition when the person actually does not have the disease or condition” (NCI, 2014b, 
False-positive test result section, para. 1).  
Knowledge: “The fact or condition of knowing something with familiarity gained 
through experience or association; Acquaintance with or understanding of a science, art, 
or technique; The fact or condition of being aware of something” (Merriam-Webster’s 
Online Dictionary, 2014a, para. 2–3). 
Knowledge of overdiagnosis: Refers to indicators that an individual is familiar 
with (has an association/experience/acquaintance with) or understanding that, by 
participating in screening mammography, there is the possibility that a nonprogressive 
cancer and/or slow-growing cancer that is identified correctly would never cause 
symptoms or death during the lifetime of that diagnosed patient. Using a modified 
27 
 
 
version of the CHBMS augmented by two research-specific survey scales, this concept of 
knowledge of overdiagnosis was evaluated (Champion, 1993; 1999). 
Lead-time approach: Research that involves a calculation of “the percentage of 
overdiagnosis by comparing incidence in the current screening group with incidence 
among women…[x] years older in the historical screening group, accounting for average 
lead-time” (Kalager, Adami, Bretthauer, & Tamimi, 2012, p.491). 
Lifetime risk: “A measure of the risk that a certain event will happen during a 
person’s lifetime; The likelihood that a person . . .free of a certain type of cancer will 
develop or die from that type of cancer during his or her lifetime” (NCI, 2014b, Lifetime 
risk section, para. 1). 
Lobe: “A portion of an organ, such as the liver, lung, breast, thyroid, or brain” 
(NCI, 2014b, Lobe section, para. 1). 
Malignant: “Cancerous. Malignant cells can invade and destroy nearby tissue and 
spread to other parts of the body” (NCI, 2014b, Malignant section, para. 1). 
Magnetic resonance imaging (MRI): “A strong magnet linked to a 
computer…used to make detailed pictures of [the] chest, abdomen, or brain. An MRI can 
show [if a] cancer has spread to these [above-mentioned] areas” (U.S. Department of 
Health and Human Services, National Cancer Institute, 2012, p. 6).  
Mammography: “The use of film or a computer to create a picture [x-ray] of the 
breast” (NCI, 2014b, Mammography section, para. 1).  
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Metastasis: The spread of the cancer, as related to time of discovery, diagnosis, 
progress, and treatment, with some cancers metastasizing at a slower rate than others 
(NCI, 2014b). 
Mortality: The number of deaths caused by cancer over a specific timeframe 
(NCI, 2014b). 
Overdiagnosis: Cancers that may never cause any symptoms or decreased life 
expectancy or quality of life. In other words, it is the identification of a nonprogressive 
cancer and/or slow-growing cancer that is identified correctly, but “the disease would 
never cause symptoms or death during the lifetime [of the diagnosed patient]” (Welch et 
al., 2011, p. xiv-xv). 
Participate: “To take part in or experience something along with others” 
(Merriam-Webster’s Online Dictionary, 2014b, Partake section, para. 1). 
Prognosis: “The likely outcome or course of a disease. The chance of recovery or 
recurrence” (NCI, 2013a, Prognosis section, para. 1). 
Randomized clinical trials (RCT): “A study in which the participants are assigned 
by chance to separate groups that compare different treatments; neither the researchers 
nor the participants can choose which group. Using chance to assign people to groups 
means that the groups will be similar and that the treatments they receive can be 
compared objectively. At the time of the trial, it is not known which treatment is best. It 
is the patient’s choice to be in a randomized trial” (NCI, 2014a, Randomized clinical trial 
section, para.1). 
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Risk factors: “Something that increases the chance of developing a disease” (NCI, 
2014a, Risk factor section, para. 1). 
Schema theory: Describes the cognitive structure of how an individual acquires, 
processes, and organizes knowledge (Erasmus et al., 2002).  
Screening mammography: “X-rays of the breasts taken to check for breast cancer 
in the absence of signs or symptoms” (NCI, 2014a, Screening mammogram section, 
para. 1). 
Tumor: Abnormal cells that combine to create a lump. Tumors can be either 
cancerous (malignant) or noncancerous (benign) (NCI, 2014b). 
Assumptions, Limitations, Scope, and Delimitations 
In the section immediately following, the parameters used to determine the 
assumptions, scope, limitations, and delimitations of this research are addressed. Each 
item outlined establishes the rationale for the selected research method and design. Also 
clearly highlighted are the various considerations entailed in the development and 
execution of an accurate, reliable, valid and ethically sound study. 
Assumptions 
In this research, it was critical to identify a community partner that was a credible 
source and that would facilitate data collection focused on determining (a) the 
relationships of knowledge of breast cancer, (b) the benefits and risks (including 
overdiagnosis) of breast cancer screening, (c) decisions related to screening 
mammography participation, and (d) the perceptions of how information is presented as it 
relates to breast cancer screening. With these above-noted assumptions in mind, salient 
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findings were made about the nature of the relationship between the two study variables. 
Specifically, the study’s results assisted in the identification of a potential predictive 
relationship between the variables examined. The identification of the possibly predictive 
correlation with the variables establishes the need for further exploration of this research 
topic. In particular, further study should be conducted to identify guidelines for efficacy 
in the presentation of (balanced) information about overdiagnosis in breast cancer 
screening. These identified guidelines would be advantageous in the event future research 
findings on breast cancer screening suggest there are other seemingly negative outcomes 
from screening participants.  
This study also assumed that the key population of analysis consisted of women 
aged 50–69 years who (a) can read and write in English, and (b) live in the GTA of 
Ontario (regardless of whether or not they had previously participated in breast 
screening). More assumptions were that knowledge of the associated risks and benefits of 
breast cancer screening, including overdiagnosis correlated well with decisions on 
whether or not to participate in screening mammography. It was assumed that 
correlations of benefits, barriers, and health motivations for women (eligible for breast 
screening) living in the GTA of Ontario were similar to Champion’s (1999) findings that 
established the revised CHMBS. Finally, it was assumed that any missing and/or 
excluded information in the analysis of the secondary data (during the review of 
literature) that would have impacted trends and conclusions were clearly indicated. All 
the above outlined assumptions were relevant for this study because they enabled me to 
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better understand how to accurately account and adjust for any unexpected findings 
(anomalies) in the data set collected. 
Limitations 
This research used a group administered, closed-ended 5-point Likert-format 
survey questionnaire to collect primary data. Based on this approach one limitation of the 
study was not being able to provide comprehensive confirmation that all participants had 
the potentially same/similar level of access to the various communication media 
(channels) through which screening mammography is promoted and accessed. Because 
the study’s intent laid in determining the correlation between two numerically measured 
variables—rather than to answer questions concerning cause-effect relationships, best 
practices, or how to improve breast cancer screening content and/or information 
presentation—the findings of the study have limited generalizable application. Given 
survey participants were limited to those contacted by the TCS organization, this 
geographically specific and small sample restricted the study’s ability to draw inferences 
or conclusions beyond Ontario’s GTA. Another limitation of the research related to 
concerns of participants’ available time and their ability to focus over an extended period. 
Consequently the goal to gain accurate evaluations was balanced with the objective of 
obtaining larger quantities of participants that would have provided more meaningful and 
generalizable results. Along the same line of concern for participants’ availability and 
attention span, the number of scales in CHBMS were reduced from eight scales to three. 
Despite the removal of five of the CHBMS its impact on the study’s findings were 
minimal as the eliminated scales were not directly related to the research topic.  
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In terms of considerations for reliability, validity, and credibility, other potential 
limitations specific to this study included (a) the inability to control and/or manipulate the 
variables being studied, as such attempts would be unrealistic and artificial; (b) concern 
that this sample population is not a true representation of the general populous; and (c) 
confounding factors resulting from a variety of biases that may affect the findings. Such 
biases include selection biases, researcher biases, information misclassification, or 
information biases as a function of the nature of the research approach (Black, 2012; Lee, 
2007; Vogt, 2007). The final limitation was from a sampling perspective. Because 
purposive sampling (nonprobability strategy) was used—rather than stratified random 
sampling (probability strategy)—it was not possible to conduct a study that could be 
considered generalizable to the target population. 
Scope 
This cross-sectional, correlational (nonexperimental, quantitative) study used a 5-
point closed-ended Likert-format survey instrument. This survey instrument was 
group/cohort administered (see Appendix A) to examine the relationship (correlation) 
between knowledge of overdiagnosis and decisions to participate in breast cancer 
screening. This survey instrument was modified from Champion (1999) HBM scale that 
evaluated the benefits, barriers and health motivations for participations in screening 
mammography. Validity and reliability for each adopted aspect of Champion’s survey 
instrument—which by extension enabled the exclusion of parts of the survey scale—is 
further detailed in Chapter 2 and Appendix B. Cronbach’s alpha was calculated to assess 
the reliability of the overall 38 question survey. Cronbach’s values of 0.7 or greater are 
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required for early research (Black, 2012; Nunnally, 1978, p. 245). The Cronbach’s alpha 
value for this survey was 0.79. This showed good consistency and allowed the creation of 
a summary score for analysis purposes. 
Delimitations 
This quantitative study used a Likert-format instrument—a group administrated, 
closed-ended survey questionnaires (Appendix A)—to gather data that examined the 
relationship between one of each identified independent and dependent variable. As such, 
there was a potential for confounding factors. This threat to internal validity related to the 
potential for other unidentified factors being responsible for influencing the dependent 
variable. Some examples of confounding errors for this type of study include: errors due 
to history, maturation, instrumentation, selection bias, information biases, and loss to 
follow-up biases (Salkind, 2010). To address this problem of confounding factors, the 
study restricted the sample population to English-speaking women aged 50–69 years 
living in Ontario’s GTA who were contacted by TCS. Additionally, a logistic regression 
analysis was carried out that controlled for the completed educational level of the 
respondent, thereby adjusting for this potential confounder. Prior to completing this 
logistic regression analysis, the education level completed variable was made into a 
binary variable with 2 representing participants who graduated with a bachelor’s degree 
or higher and 1 representing those who graduated with a college diploma/certificate or 
less. 
Relevant to note was that for the internal validity threat of selection bias to have 
occurred, it meant that the participants retained in the sample population led to results 
34 
 
 
that were different from what would have been found if the entire target population was 
used. With regards to information (observation/ misclassification) bias, because the study 
used primary data, erroneous observations and misclassifications that are inherent in 
secondary data set was not a major issue. However, to further significantly minimize the 
small potential for information bias in the primary data, SPSS was used to assess and 
address such potentials. For loss to follow-up bias to have occurred, it would have meant 
that this study had initial participants that were not retained for both the independent and 
dependent variables, thereby increasing the odds that the results were underestimated. 
This was however not the case for the study given the data were collected via a group 
administered questionnaire, at the same time, in one setting (cross-sectional research 
design (Cohort Studies, n.d. “Follow up in cohort,” para. 5).  
From the perspective of external validity, because this study did not seek to 
provide generalizations of the findings across the population of interest (women aged 50–
69 years), purposive sampling was used to select participants for the study. This sampling 
method enabled targeted identification of—Ontario GTA women, who read and write in 
English, who were contacted by TCS, and who were eligible to participate in screening 
mammography (participants and nonparticipants)—participants of interest to the study 
(Patton, 2002). Finally, as it related to issues of content, criterion, and construct 
(predictive) validity, this study was further able to assess each following the data set 
collection and analysis, details are outlined in Chapters 3 and 4. 
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Significance of the Study 
This research is significant because it allowed for critical assessment and 
consideration of how currently aggressive (Favaro, 2012, para. 10) and unbalanced—
benefits without much mention of the associated risks—promotion of breast cancer 
screening have a direct or indirect relationship to the reported increase in rates of breast 
cancer screening participation. This understanding, in turn, offered some perspective on 
the efficacy of current breast cancer statistics and the purported successes in cancer 
treatment as a consequence of screening participation. Another potential benefit was the 
contribution of this information to objective decision-making on the part of the screening 
participants. Screening participants would be more informed because they were given a 
more comprehensive outline of the benefits and risks of the screening process. As such, 
they can now make informed decisions about screening participation. Finally, it offered 
an opportunity for the Government of Ontario, in conjunction with the relevant public 
health policy makers and health care providers, to establish comprehensive criteria of 
how information related to screening mammography ought to be disseminated to the 
public and future possible participants. 
This research also provides (the Government of Ontario, health care providers, 
policy makers, and other key stakeholders) a better understanding of the ways that 
information presented in health care media communication campaigns may or may not 
positively or negatively impact the rates of participation in publicly-funded breast cancer 
(and other types of) screening programs. This study was socially significant because it 
indicates that, in cases where health care media communication campaigns present 
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balanced and comprehensive (outlining both potential benefits and associated risks) 
information, there is more efficacy in the rate of participation in public-sector screening 
services when compared to the current rate of success garnered via the predominant use 
of the one-sided (and potentially biased) information presentation. As a consequence, this 
might increase the level of balanced and comprehensive health care media 
communication campaigns used, and subsequently generate greater rates of success in 
breast cancer service delivery because participants are presented with all the facts. In 
addition, this research serves as a (a) litmus test for how participants may react to 
information presented that clearly outlines risks (such as overdiagnosis), and (b) guide of 
what communication strategies are to be established and implemented to mitigate against 
the intuitive reaction of participants to perceived negative information. 
Importance for Social Change 
From a positive social change perspective, this research identifies and suggests a 
few more balanced, comprehensive, and effective health care communication guidelines 
to aid in more transparent present information. This, by extension, creates opportunities 
for ensuring more accurate reporting (than currently noted) of the rates of success in 
screening programs. Additionally this study may better equip the Government of Ontario 
with an understanding and awareness of the concerns and barriers women aged 50–69 
years face in accessing a holistic view of the positive and negative potentials of 
participating in breast cancer screening programs. In turn, this may improve the current 
rate of success noted. It also may reduce the levels of and potentials for overdiagnosis, 
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and may help the Ontario government develop awareness campaigns that are ultimately 
more successful because patients are better informed. 
Summary 
In this chapter, information necessary for the identification of a gap in knowledge 
and the justifications of the need for this study were presented in the following sections: 
introduction; background; problem statement; theoretical framework; purpose of the 
study; research question; research method; nature of the study; definition of terms; 
assumptions, limitations, scope, and delimitations; significance of the study; and 
summary. The chapter specifically presented background information about breast cancer 
and screening mammography statistics for the Province of Ontario. Also outlined was the 
need for attention to be paid to females aged 50–69 years who ought to be presented with 
a balanced overview of the benefits and risks of screening programs, prior to any 
decision-making about screening participation. Evidence from key researchers in the field 
of breast cancer and breast cancer screening was provided. The indication was that the 
issue of overdiagnosis, an associated risk of breast screening, was noted in the U.S. to be 
one in every three women. The theoretical framework that guided this study was schema 
theory, along with the support of the effective health communication model. Key 
definitions of terms were highlighted. A general overview of the rationale for the selected 
research design—quantitative, nonexperimental study—was outlined. Mention was made 
of the logistic regression and correlation coefficient statistical tests selected to analyze the 
data collected.  
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The coming chapter provides a discussion of the examined literature relevant to 
the importance of knowledge of overdiagnosis and breast screening decision-making. As 
well, Chapter 2 gives an overview and background of breast cancer and breast cancer 
data from the Ontario perspective. Further detail is provided on schema theory and the 
effective health communication model. In Chapter 3, an overview of the research 
methodology and its rationale, along with the setting and sample, data collection method, 
data analysis approach, feasibility and appropriateness of the study, validity and 
reliability, instrumentation, and other relevant information is discussed. Chapter 4 
provides a detailed report of the descriptive and inferential statistical tests conducted. 
Chapter 5 offers an overview of the study, its findings and conclusions, along with 
recommendations for future research.  
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Chapter 2: Literature Review 
Introduction 
The Public Health Agency of Canada [PHAC] (2013; 2014) noted that cancer is 
the primary cause of death in Canada, and the Canadian Cancer Society (CCS) specified 
that of all deaths in Canada, 30% were from cancer (CCS, 2014b). The PHAC also 
indicated this trend was expected to continue and increase as the population grew and 
aged (PHAC, 2013; PHAC, 2014). Statistics reported by the PHAC, the CCS, and other 
Canadian-affiliated organizations show breast cancer is the second leading cause of death 
amongst all the types of cancers found in Canadian women. Breast cancer is the most 
prevalent form of cancer in women in Canada (CCS, 2014b; PHAC, 2014). The 
Government of Ontario and the Ontario Ministry of Health and Long-Term Care 
(MHLTC) actively promote breast cancer screening and early detection through regular 
participation in Cancer Care Ontario (CCO)’s publicly available and funded Ontario 
Breast Screening Program (OBSP), with an objective of reducing the mortality rate of 
death by breast cancer (CCO, 2011a; CCO, 2012).  
In 2011, the MHLTC acknowledged screening mammography as an effective 
means of lowering the rate of breast cancer mortality (MHLTC, 2011). The MHLTC also 
noted that approximately 17 cancers are detected annually in every 1,000 women 
screened via breast MRI and mammography. According to the MHLTC, breast screening 
facilitated the detection of more cancers at earlier stages, leading to (a) an increased 
chance of survival, (b) potentially less invasive treatments being used, and (c) ultimately, 
improved health outcomes for women (MHLTC, 2011). However, the use of breast 
40 
 
 
screening mammography introduced issues of false-positive, false-negative, 
mammography-related radiation exposure, and overdiagnosis. This study was established 
to address the issue of overdiagnosis. It was specifically designed to determine if and 
what relationship exists between knowledge of overdiagnosis (the study’s independent 
variable) and the decision to participate in breast cancer screening (the study’s dependent 
variable) amongst women aged 50–69 years. The literature review was designed to 
provide background information, an overview, and a synthesis of existing literature on 
this topic. In addition, this review established support for the need for continued research 
concerning the relevance of knowledge of overdiagnosis and its relationship with the 
level of participation observed in breast cancer screening programs. Although inquiry on 
this particular topic was documented to have started in Canada as early as 1992, limited 
prior research extensively or definitively examined the existence of and/or the nature of 
the relationship between the two variables. 
This chapter reviews the existing and relevant literature on (a) breast cancer, (b) 
screening mammography, (c) the benefits and risks of screening mammography, and (d) 
the current dissemination approaches used to give information about breast cancer and 
breast cancer screening. It also presents detailed information and statistics on breast 
cancer as it relates to Ontario, Canada. In addition, the chapter discusses and critically 
assesses a variety of research designs implemented by previous researchers whose studies 
focused on breast cancer. The chapter’s main sections are as follows: theoretical 
foundation, overview of key concepts, statistics on breast cancer in Canada, statistics on 
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breast screening in Canada, research related to overdiagnosis and breast screening 
programs, other risks associated with breast cancer screening, and summary. 
Strategies for Searching the Literature 
The literature search for this dissertation primarily consisted of electronic 
searches through the online databases of the Walden University Virtual Library and the 
International School of Management Virtual Library. It also included a search of 
hardcopy documents at the University of Toronto in Toronto, Ontario. The information 
for this review was searched and/or obtained from peer-reviewed journals found through 
the following databases: EBSCOhost databases (Academic Search Complete, Academic 
Search Premier, MEDLINE with Full Text, SocINDEX with Full Text, CINAHL Plus 
with Full Text, ebook Collections, and Political Science Complete); ProQuest databases 
(Dissertations & Theses at Walden University, ebrary®  ebooks, ProQuest Nursing & 
Allied Health Source, ProQuest Dissertations & Theses Full Text, ProQuest Education 
Journals, and ProQuest Central); Thoreau: Search Multiple databases; SAGE Full-text 
Collections (SAGE Encyclopedias and Handbooks, Sage Research Methods Online, and 
Gale Virtual Reference Library); evidence-based resources (The Cochrane Library, and 
health-evidence.ca); OvidSP (Nursing Books, and Journal of Public Health Management 
& Practice); and Google Scholar.  
Other relevant information, including current statistics on breast cancer incidences 
in Canada, was gathered from medical, governmental, and affiliate agencies whose 
mandate focused on research related to cancer, breast screening, screening participation, 
and overdiagnosis. These organizations included: PHAC, CCS, Cancer Care Ontario 
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(CCO), MHLTC, Breast Cancer Society of Canada (BCSC), Canadian Breast Cancer 
Foundation (CBCF), Cancer Quality Council of Ontario (CQCO), Canadian Task Force 
on Preventive Health Care (CTFPHC), American Cancer Society (ACS), National Cancer 
Institute (NCI), and Statistics Canada. The search for salient information was also 
extended to reference sections of identified publications and web sites referenced in the 
peer-reviewed articles. From these identified sources, more refined searches were 
conducted to find information specifically related to breast cancer screening for women 
living in Ontario, Canada, aged 50–69 years. Relevant references from each of the studies 
covered in this literature review were also reviewed. 
Numerous studies were assessed in searches and the abstracts reviewed. However, 
several were discarded because they were not directly applicable to this study. The 
articles selected for this review were predominantly written over the last five years. In 
instances where literature was more limited and where greater historical context was 
needed, older studies were included. The preliminary literature search determined that 
although significant research had been done on various aspects of breast cancer 
screening, there was limited knowledge and research addressing the issue of 
overdiagnosis as a factor in determining breast screening participation. 
The keyword strings used in the literature search process included: cancer, breast 
cancer, breast cancer screening, breast screening, mammogram, mammography, 
screening mammography, diagnostic mammogram, diagnostic mammography, mass 
screening, false-positives, false-negatives, disease, overdiagnosis, overtreatment, 
knowledge, social learning theory/social cognitive theory, and health behavior models. 
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Search terms utilized for the additional variables were: cancer incidence, overdiagnosis in 
cancer, breast cancer in men, early detection of cancer/methods, gender, age, risk factors, 
benefits and harm(s), benefits and risks, participation in breast cancer screening 
programs, randomized clinical trials (RCTs), lead-time approach, focus groups, survey, 
Likert-type, Likert-format, questionnaires, observational studies, cohort studies, 
correlation studies, ex post facto research, pilot study, and retrospective studies. 
Structure of the Literature Review 
The sections that follow in this chapter provide an outline of the theoretical 
frameworks that acted as a guide for this study, followed by an overview of cancer, breast 
cancer, and screening mammography. It also provides background information with 
statistics related to cancer, breast cancer, and screening mammography programs within 
the Canadian landscape, including descriptions of relevant studies. The chapter concludes 
with an analysis of the selected methodology outlined in each evaluated study. 
Theoretical Foundation 
Before identifying the theoretical foundation that was used this study, I 
considered in general terms the relevance of theory in the development of a quality 
research paper. As noted by Swanson and Chermack (2013, as cited by the University of 
Southern California, 2014) “theories are formulated to explain, predict, and understand 
phenomena . . .and . . .to challenge and extend existing knowledge, within the limits of 
the critical bounding assumptions. . . .[Therefore] the theoretical framework introduces 
and describes the theory that explains why the research problem under study exists” 
(University of Southern California, 2014, Theoretical framework section, para. 1). With 
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this understanding in mind, outlined below is an overview and critique of the effective 
health communication model and schema theory. Both the effective health 
communication model and schema theory are assessed in relation to their respective 
relevance to the topic under investigation. 
Effective Health Communication Model 
The extensive promotion of breast-screening programs by the OBSP was justified 
by the CCO (2011b) in a summative statement that “breast cancer screening saves lives” 
(CCO, 2011b, para. 1). This health care media communication campaign was paid for by  
three-year, $15-million Canadian dollar commitment from the Government of Ontario 
(MHLTC, 2011). This particular focus on and increased media campaigning to improve 
the public’s awareness of breast-screening programs (like OBSP) have been attributed to 
the increasing reported incidences of breast cancer (MHLTC, 2012a). Despite there being 
several highly publicized benefits associated with early detection (screening) programs, 
the information presented had not offered a balanced perspective that outlined not only 
the benefits but also any associated risks. This lack of emphasis on balanced information 
presentation to facilitate informed decision-making was also evidenced in the PHAC-
funded 50 Over 50 Challenge for increasing breast-screening participation in Ontario.  
The 50 Over 50 Challenge was coordinated and operated by South Riverdale 
Community Health Centre, Mount Sinai Hospital, and Toronto Public Health. Its key 
implementation steps focused on such things as 
 Getting public health care providers’ internal buy-in, 
 Sourcing media sponsors for free advertising, 
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 Using radio stations that had a targeted demographic of women aged 50–69 
years, and  
 Providing shuttle service to transport women to screening sites (South 
Riverdale Community Health Centre, Mount Sinai Hospital, & Toronto Public 
Health, 2010). 
What was, however, absent in those key implementation steps were considerations that 
ensured a balanced presentation of information about screening benefits and the 
associated risks. Bleyer and Welch (2012) highlighted this unbalanced information 
presentation in a recent study they conducted in the United States of America (U.S.) that 
found “one in three women had been overdiagnosed” (a risk associated with breast cancer 
screening) (Results section, para. 1). Hersch et al. (2013) also suggested that, if more 
information was presented on the risks of overdiagnosis, screening participants would be 
better-equipped to make informed decisions about whether to participate in screening 
programs (p. 6). 
Other researchers, including Entwistle et al. (1998) and Goyder et al. (2000, as 
cited in Giordano et al., 2006) provided a detailed and still timely overview and analysis 
of key considerations necessary for communicating information to enable informed 
decision-making. The authors noted that, for health communication, specifically in the 
context of screening, communication was not limited to only information transmitted but 
rather, for effective communication, it was necessary that “health 
professionals . . .provide individuals with such information that . . .[would] allow them to 
‘knowledgeably’ decide whether or not to undergo an intervention, taking into 
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consideration available alternatives, potential risks and foreseeable outcomes” (p. 382). 
For Entwistle et al. (1998) and Goyder et al. (2000, as cited in Giordano et al., 2006), it 
was imperative that women knew “the pros and cons of breast screening” to assist in their 
ability to be informed decision-makers in the screening process (p. 382). Further to this, it 
was therefore vital to have an established framework tailored to the presentation of health 
information in an ethical way.  
Beauchamp and Childress (1979, as cited in Giordano et al., 2006) listed four 
principles that underpinned this framework: autonomy, nonmaleficence, beneficence, and 
justice. The framework’s first principle, autonomy was defined as “the obligation to 
respect the decision-making capacities of autonomous persons,” with the authors nothing 
that patients had a right to refuse interventions (p. 382). Nonmaleficence was defined as 
“the obligation to avoid causing harm intentionally or directly (the principle [wa]s not 
necessarily violated if a proper balance of benefits exists; That is, if the harm [wa]s not 
directly intended, but [wa]s an unintended side effect of attempts to improve a person’s 
health)” (p. 382). Principle three, beneficence, referred to “the obligations to provide 
benefits, balancing them against risks, [and the final principle] justice [was noted as] the 
obligation of fairness in the distribution of benefits and risks” (p. 382). Of these four 
principles, the research observations of Bleyer and Welch (2012), Hersch et al. (2013), 
and Giordano et al. (2006) indicated that little or no attention was paid to considerations 
of autonomy and beneficence.  
Much like Bleyer and Welch and Hersch et al., Giordano et al. (2006) had noted 
that there were growing concerns that women being invited to participate in screening 
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“often [were] told about the positive aspects of screening, ignoring any negative aspects 
in order to increase the attendance rate and ensure the effectiveness of the screening 
programme” (pp. 382-383). Giordano et al. also highlighted that usually media 
communications/campaigns about medical services tended to favor optimistic messaging 
and so the information distributed often times underlined the benefits, but “gloss[ed] over 
uncertainties, adverse events and side effects and ignor[ed] legitimate scientific 
controversies” (p. 383). Screening programs were (and to some extent have continued to 
be) presented with a 100% accuracy rate. As such, any false-positives or false-negative 
results noted were attributed to errors on the part of the service providers. “This . . .[led] 
to the perception that all cancers arising after a normal screening examination [were] 
‘missed’ and that delays in diagnosis [had] prognostic significance” (p. 383). Ultimately, 
Giordano et al. indicated that any screening information presented “should be honest, 
adequate, evidence based, accessible, unbiased, respectful, and tailored to individual 
needs” (p. 383), which then results in an informed screening participant. 
Effective health communication was therefore possible only when adequate 
consideration was given to address each individual’s specific needs, and differences in 
values and beliefs. With an understanding of context, culture, educational status, 
personality, and other myriad factors, including the influence of “mass media on 
individuals’ perception and understanding of health issues” (Giordano et al., 2006, p. 
383), it would then be easier to establish effective health communication. This would be 
so as the information presented would address specifically the way each individual 
processed health information. By extension, it would also address how that individual’s 
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processing approach impacted their motivation to participate in screening (Giordano et 
al., 2006, p. 383). In the context of presenting the risks associated with screening, 
effective health communication therefore meant that the risk of overdiagnosis ought to be 
addressed alongside the outlined benefits, in any communication material. 
Schema Theory 
Schema theory was the theoretical framework for this research. The benefit of 
using schema theory laid in “its ability to both explain and predict 
learning. . . .If . . .familiar with the established schemata of learners, we can greatly 
increase the likelihood that they will understand new information by presenting it in a 
manner that will be meaningful to them” (Edublogs, 2012, Strengths and Weaknesses 
section, para. 4). First introduced by Jean Piaget in 1926, then Sir Frederic Bartlett in 
1932, schema theory describes the cognitive structure of how an individual acquires, 
processes, and organizes knowledge. Grounded in Bandura’s (1997) social cognitive 
theory (also called the social learning theory), the key tenet of schema theory states that 
“every act of comprehension involves one’s knowledge of the world,” (Carrell & 
Eisterhold, 1983, p.73). Thus, knowledge is a network of mental frames or cognitive 
constructs referred to as a schema (Erasmus et al., 2002).  
For schema theory, the mind of a human being is organized by a series of schemas 
that categorize and interpret information to create a general picture of how that individual 
views a specific topic. This general picture is a consequence of that individual’s use of all 
the various information present, along with their associations, to create a cognitive 
construct. Therefore, individuals use schemata (scripts) to structure existing knowledge 
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and establish context for future understanding (Erasmus et al., 2002). So schemata 
expand and evolve with time as new information is acquired. However, deeply-rooted 
schemata are slower to change. As schemata develop and evolve, they assist an individual 
(the learner) to better understand and interpret the world in which they live.  
As schema theory relates to this study, I purport that the schemata (script) 
currently established for identifying how people decide to participate in breast screening 
programs suggested that, only if benefits of screening mammography were 
predominantly promoted, then would there be higher rates of screening participation. 
Consequently, most information presented about screening mammography failed to offer 
a truly balanced (both positive and negative) outline of the implications of participation. 
If this purported schemata is correct, then it has limited participants’ opportunity to make 
informed decisions about participating in screening programs. I further believed that, if 
media campaigns by the Government of Ontario used Giordano et al.’s (2006) framework 
of ethical principles to guide the development and presentation of health information 
about screening mammography, including the risk of overdiagnosis, it would be possible 
that a new schema could be created. Specifically, a new schema that facilitates 
comprehensive information presentation, while maintaining high levels of screening 
participation. 
It is essential to note that Jean Piaget’s theory of cognitive development preceded 
and laid the foundation for schema theory. However, “schema theory addresses some of 
the criticisms of its forerunners” (Edublogs, 2012, Strengths and Weaknesses section, 
para. 2). For example, even though Piaget’s theory “was criticized for ignoring the 
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influence of gender and culture on cognitive development, schema theory suggests that 
schema are built on individual experience. Thus where gender and culture influence the 
lived experience of any individual, schemata develops accordingly” (Edublogs, 2012, 
Strengths and Weaknesses section, para. 2). Schema theory also built on its forerunners’ 
notion of memory. Here, schema theory proposes that “schemata help us to remember, 
comprehend and problem-solve. At the same time, the encoding of an experience is 
hindered by selection, gist-extraction, and interpretation” (Edublogs, 2012, Strengths and 
Weaknesses section, para. 3). Based on this selective understanding and interpretation, in 
stances where individuals experience the same event, the respective schema developed is 
not identical. 
According to Byrnes (2001, as cited in Edublogs, 2012) one limitation of schema 
theory is “that it is fairly imprecise on the issue of developmental mechanisms” 
(Strengths and Weaknesses section, para. 3). According to Holland (1992, as referenced 
by Edublogs 2012), another limitation of the theory is its “inability to explain human 
behavior in unprecedented circumstances” (Strengths and Weaknesses section, para. 5). 
When there is no existing schema to reference “for a situation with which [an individual 
is] confronted, schema theory is [unable] to explain why we do what we do” (Edublogs, 
2012, Strengths and Weaknesses section, para. 5). Further to this point, schema theory is 
also not able to provide a rationale for acting the way we do. 
Overview of Key Concepts 
Immediately below is a brief, yet detailed, overview of some key concepts. These 
concepts include cancer, breast cancer, risk factors associated with breast cancer, and 
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breast cancer screening (mammography). Also outlined is the purported benefits of breast 
cancer screening, the screening guidelines for participation in Ontario, and overdiagnosis. 
This overview is given because each concept mentioned has been and will continue to be 
encountered during this study. With a review of these concepts, readers have a greater 
chance of assimilating the information presented and discussed throughout this research. 
Cancer 
Cancer covers a wide range of diseases that involve irregular cell growth. As 
highlighted by the CBCF (2014e), cancer is the general classification “of more than 100 
diseases that affect the body at a cellular level” (“What is cancer” section, para. 1). 
Medically referred to as malignant neoplasm, cancer results from “extra cells [that] form 
a mass of tissue called a lump, growth or tumor” (U.S. Department of Health and Human 
Services, National Cancer Institute, 2012, p. 2), because the cells grow and divide 
uncontrollably. In normal cell growth, the “body cells grow, divide and die and are 
replaced by new cells” (CBCF, 2014f, What is cancer section, para. 2). However, in the 
instance of cancer cell growth, cells that ought to have died instead “continue to grow and 
form new, abnormal cells” (Mandal, 2013, “Cancer at the molecular,” para. 2). In some 
instances, these tumors are benign (noncancerous) and in other instances they are 
malignant (cancerous).  
Cells become cancerous or malignant as a result of damages (cell mutation) to 
their DNA (deoxyribonucleic acid). “When DNA is damaged in a normal cell the cell 
either repairs the damage or the cell dies. . . .[For] cancer cells, the damaged DNA is not 
repaired, and the cell does not die” (Mandal, 2013, “Cancer at the molecular,” para. 3–5), 
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as it should. Rather than dying, this damaged cell continues to make new abnormal DNA. 
The “cells from malignant tumors can spread (metastasize) to other parts of the body” 
(U.S. Department of Health and Human Services, National Cancer Institute, 2012, p. 40). 
The period of dormancy for cancer is long and as such it may take several years from the 
first time the cell mutates to when evidence of the disease manifests (CBCF, 2014f). 
Breast Cancer 
Breast cancer is “cancer that forms in the tissues of the breast” (NCI, 2014b, 
Breast cancer section, para. 1). As outlined by the BCSC (2014c), the “most common 
forms of breast cancer begin in the milk ducts, lobules or glands” (noninvasive breast 
cancers) (Types of breast cancer section, para. 1). Noted by ACS (2014a), CBCF 
(2014d), and NCI (2014b), the main types of breast cancer include 
 Ductal carcinoma in situ (DCIS), where the cancer “cells have not spread 
(invaded) through the walls of the ducts into the surrounding breast tissue [and 
therefore] cannot spread to lymph nodes or other organs” (ACS, 2014a, 
Ductal carcinoma in situ section, para. 1). For women with this type of breast 
cancer, they (the women) can be cured and mammograms generally find many 
cases of DCIS (NCI, 2014d; Welch, 2004). 
 Lobular carcinoma in situ (LCIS), which “is not considered to be a true cancer 
and is not life-threatening, but it is an indicator that a woman is at increased 
risk for developing invasive breast cancer in either breast in the future” 
(CBCF, 2014d, “Noninvasive or in situ,” para. 6). “LCIS . . .[begins] in the 
milk-making glands (lobules), do[es] not go through the wall of the lobules, 
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and [therefore does not usually] spread to other parts of the body. . . .[It 
infrequently results in] a lump or changes that can be detected by 
mammography” (CBCF, 2014d, “Noninvasive or in situ,” para. 6–7). “It is 
[however typically] identified during investigation of other breast changes” 
(CBCF, 2014d, “Noninvasive or in situ,” para. 8). LCIS on its own generally 
does not need treatment, but both breasts of the patients are closely monitored 
by trained health care provider (using regularly scheduled clinical breast 
examinations) (CBCF, 2014d).  
 Invasive (or infiltrating) ductal carcinoma (IDC), which  represents 
approximately “80% of invasive breast cancers” (CBCF, 2014d, Invasive 
breast cancer section, para. 1). IDC “is the most common type of [breast] 
cancer . . .[and] starts in a milk passage (a duct). [It then] breaks through the 
wall of the duct and invades the surrounding tissue of the breast” (CBCF, 
2014d, Invasive breast cancer section, para. 1). Once the damaged cells have 
passed through the wall of the duct, it may spread (metastasize) to other body 
parts (CBCF, 2014d).  
 Invasive (infiltrating) lobular carcinoma (ILC), which represents “10% of 
invasive breast cancers cases. ILC starts in the milk glands (the lobules) of the 
breast, breaks through the lobules, and invades the surrounding tissue of the 
breast” (CBCF, 2014d, Invasive breast cancer section, para. 6). Much like 
IDC, the damaged cells, for ILC, may spread (metastasize) to other body 
parts. However, the key difference between IDC and ILC is that IDC passes 
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via the wall of the duct, and ILC passes through the lobules and surrounding 
breast tissues (CBCF, 2014d). 
 Inflammatory breast cancer (IBC), an “uncommon type of invasive breast 
cancer, accounts for [roughly] 1% to 3% of all breast cancers. [In this form of 
breast cancer] there is no single lump or tumor, [but rather] IBC makes the 
skin of the breast look red and feel warm” (ACS, 2014a, “Less common types 
of,” para. 1). In addition, it may make the skin have “a pitted, orange peel-like 
texture (referred to as peau d’orange). The breast may get bigger, hard, tender, 
or itchy” (CBCF, 2014d, Inflammatory breast cancer section, para. 3). In the 
“early stages, inflammatory breast cancer, is often mistaken for an 
infection . . .[and, given there are] no actual lump, it [may be] even harder to 
find it early” (ACS, 2014a, “Less common types of,” para. 2). Meaning that it 
may be easier to be missed on a mammogram. IBC has a greater probability of 
metastasizing, and more dire prospects (prognosis) relative to lobular or 
invasive ductal cancer (ACS, 2014a). 
 Paget’s disease of the nipple, which is also a “less common type of breast 
cancer [and accounts] for [under] 5% of all breast cancers. [Its] symptoms 
include: persistent itchiness and scaling of the nipple. [This worsens as] time 
[passes and leads] to weeping, crusting and nipple pain. The nipple 
[sometimes] also appear flattened . . .[and is usually] found on . . .one nipple” 
(CBCF, 2014d, “Paget’s disease of the,” para. 1–2). It has been noted that 
many individuals “with Paget’s disease . . .may also have another form of 
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cancer in the same breast. [Roughly 50%] of the [individuals found] with 
Paget’s disease [exhibit] a lump or mass in the breast that can be felt during 
physical examination” (CBCF, 2014d, “Paget’s disease of the,” para. 3). 
There have been some instances where Paget’s disease spread to the areola 
and throughout the breast (CBCF, 2014d). 
Risk Factors Associated with Breast Cancer 
Although the exact cause of breast cancer is not known, the explanation for breast 
cancer development has been attributed to the following risk factors:  
Age, personal history of breast cancer, family history, ancestry, certain breast 
changes, gene changes, reproductive and menstrual history, race, radiation 
therapy to the chest, breast density, taking DES (diethylstilbestrol), being 
overweight or obese after menopause, lack of physical activity, and drinking 
alcohol. (Bellenir, 2009, p.37) 
Other risk factors being studied include considerations of: sex, socio-economic status, 
sedentary behavior, stress, viruses, bacteria and other infectious agents, weakened 
immune system, the effect of diet, physical activity, genetics as well as certain substances 
in the environment that may impact and/or increase possibility of breast cancer (ACS, 
2014a; Bellenir, 2009; CBCF, 2014a; Nguyen & Clark, 2014). It is important to note that 
not all risks are equal. Some risks have a higher degree of association for breast cancer, 
while others have a moderate or lower degree of association. For this reason, there are a 
variety of advantages to knowing the various risk factors of breast cancer.  
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One such advantage to knowing the types of risk factors of breast cancer is that it 
helps individuals to establish modifications to behaviors that can possibly reduce their 
chances of having breast cancer. Examples of behavior modifications include (a) an 
increase in physical activity, (b) exercise to reduce body weight, (c) reduction in alcohol 
consumption, (d) quitting smoking, and (e) reducing exposure to radiation. Another 
advantage is that via the establishment of a cognitive construct/schemata that highlights 
the relevance to actively look for and monitor potential signs of possible cancer, 
individuals using this schemata will be more likely to make the necessary checks. This 
active surveillance increases the chances of potentially detecting cancers in their early 
stages, thus leading to more treatment options. There are however some nonmodifiable 
risk factors of breast cancer, for example, gender, family history, age, personal history, 
and breast density. For nonmodifiable risk factors, behavior modifications cannot help in 
reducing the chances for having breast cancer. But knowledge of these nonmodifiable 
risk factors may help to reinforce the potential benefits to be gained from developing 
schemata focused on active surveillance/monitoring of possible signs of cancers (CBCF, 
2014a). 
Breast Cancer Screening (Mammography) 
Screening is the process by which a disease is looked for in persons who have no 
symptoms (asymptomatic) of the disease for which they are being examined (Welch, 
2004). In other words, screening is performed on people who, by appearance, are in good 
health. In cancer, screening is aimed at reducing mortality and suffering from the disease 
through regularly scheduled testing as a means of possibly detecting and treating the 
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disease in the early stages. When screening for breast cancer, the process referred to as 
mammography involves the use of low-dose x-rays to check for cancer in the breast. 
Mammograms are used as a means of both screening and diagnosis.  
On the one hand, a screening mammogram looks for changes in the human breast, 
even though there are no signs of breast cancer. “The purpose of screening is to prevent 
cancer by identifying precancerous changes, or to find early stage cancers when [they] 
are easier to treat” (CQCO, 2014b, “Cancer screening – breast, cervical,” para. 3). On the 
other hand, “diagnostic mammogram . . .[provides a] more detailed image of the 
breast . . .[and is] used to rule out other breast problems”(U.S. Department of Health and 
Human Services, National Cancer Institute, 2004, p. 7). As well more x-rays of both 
breast are taken during diagnostic mammograms so that doctors can conduct a 
comparison of the scanned breasts (CCS, 2015). 
As noted by Welch (2004), the primary assumptions of screening are that (a) 
“tests can find early cancers, and (b) early treatment works better than late treatment” (p. 
19). This, however, has been noted as an inaccurate statement for two reasons: (a) there is 
a window of opportunity (preclinical phase) for early detection via screening; As such, if 
a cancer grows rapidly, this preclinical phase is significantly reduced; and (b) cancers 
develop and grow at different rates; Thus a cancer can be missed simply because the 
“individual was not screened at the right time” (p. 20). Therefore, if the Government of 
Ontario, through its various health care providers, hopes to have an enhanced awareness 
of the OBSP and, by extension, an increased rate of screening participation, it is essential 
that potential screening participants be provided with health information that employs the 
58 
 
 
above-mentioned ethical tenets of Giordano et al. (2006). In addition, as explained by 
schema theory—understanding that each individual’s schema (cognitive construct) 
differs—the information presented “should be honest, adequate, evidence based, 
accessible, unbiased, respectful, and tailored to [that] individual[’s] needs” (p. 383). In so 
doing, this will facilitate the creation of a schemata that includes information not only of 
the benefits of screening, but also of overdiagnosis and its other associated risks. 
Individuals that acquire this new schemata can then potentially establish a cognitive 
construct that allows for informed decision-making about screening participation. 
Purported Benefits of Breast Cancer Screening  
According to the CCO’s 2010 anniversary report, the World Health 
Organization’s (WHO) International Agency for Research on Cancer (IARC), the United 
States Preventive Services Task Force (USPSTF), and the CTFPHC maintain that 
“mammography is [still] the gold standard for [the] early detection of cancer” (CCO, 
2010, p. 11). For the NCI (2013a, 2013c), some of the advantages of screening 
mammography include (a) decreased mortality in breast cancer by up to one third; and (b) 
an increased five-year survival rate for women screened annually for breast cancer. 
Another advantage is that for women older than 65 years, screening results may lead to 
more diagnostic test. This in turn leads to earlier detection, resulting in less invasive 
treatment options and potentially a better quality of life (NCI, 2013a; NCI, 2013c). 
Changes in Ontario Breast Cancer Screening Age Range  
As of July 1, 2011, the MHLTC announced that the OBSP started to offer an 
additional 90,000 mammograms given its (then) new screening parameter. This new 
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screening parameter include women 30–69 years old who have a greater risk of 
developing breast cancer. The previous guidelines limited screening to women aged 50–
74 years. These additional screening average 30,000 per year over three years. The OBSP 
guidelines also included (a) annual screening mammography and MRI for persons 
considered at high risk for breast cancer; (b) biennial screening for women aged 73 years 
and older; (c) follow-up breast evaluation for those requiring additional tests; and (d) 
referrals for genetic (DNA) evaluation of women who may have a higher probability for 
breast cancer (if appropriate) (CCO, 2012). 
Overdiagnosis  
Overdiagnosis happens when a nonprogressive cancer and/or slow-growing 
cancer is detected; It occurs in cases where a disease is identified correctly, but that 
identification is unnecessary (irrelevant). In other words, it is “the systematic evaluation 
of asymptomatic patients to detect early forms of cancer” (Welch et al., 2011, p. xiv-xv). 
As such, overdiagnosis is the consequence of testing for the initial stages of disease that 
potentially turn individuals into unnecessary patients. It also potentially leads to 
treatments that possibly are of no benefit, but rather may cause harm.  
Collectively, nonprogressive cancer and slow-growing cancer are known as 
pseudodisease (meaning false disease), as they do not cause symptoms or death in the 
affected individual. Pseudodisease is not distinguishable by screening mammography, 
and therefore the only way overdiagnosis can be confirmed is after an individual is never 
treated, develops no symptoms of cancer, and ultimately dies of something not cancer-
related (Welch, 2004; Welch et al., 2011). As it relates to cancer diagnosis, the 
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subsequent notion of overdiagnosis gained significant popularity during the increased use 
of screening for prostate cancer. From the experiences with screening for prostate cancer, 
the lesson learned was that, while finding the disease has importance, “find[ing] the right 
cancers, the cancers that matter” (Welch et al., 2011, p. 60), was of greater value (Welch 
et al., 2011). 
An accurate prognosis of a disease can be considered unnecessary because any 
treatment for that disease was unavailable, not needed, or not wanted. For this reason, 
those such as Johnson (2012) and Smith, Duffy, and Tabár (2012) contended that the use 
of the term overdiagnosis was inappropriate, but rather overtreatment was a more 
representative classification of the phenomenon under examination. This suggestion 
stemmed from the knowledge that a majority of the individuals diagnosed for cancer 
were also treated for the disease. It was therefore harder to ascertain when there were 
instances of overdiagnosis for that specific individual. As such, the inferences about 
overdiagnosis usually came from studies of populations. One example that strongly 
indicated possible overdiagnosis was generally observed in the increasing levels of 
testing and disease diagnosis to establish stable rates for the outcome of the disease 
(death). Another compelling example of overdiagnosis tended to be evidenced in 
randomized trials of screening tests that were intended to detect preclinical disease. 
However, the most definitive examples of overdiagnosis were in any continuous and 
prolonged excess of identified disease in a group being tested, several years post 
completion of a trial. 
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While proponents of screening mammography consistently acknowledged the 
benefits of early detection through screening, less focus was placed on the associated 
risks. More specifically, as it relates to overdiagnosis, there has been limited information 
outlining the additional risks that result from overdiagnosis. The three forms of risk 
related to overdiagnosis include  
 The physical impact of needless diagnosis and treatment—such as, surgery, 
radiation, and chemotherapy;  
 The psychological effects from being identified as a cancer patient—resulting 
in possible depression, emotional stress, and an enhanced feeling of 
vulnerability; and 
 The financial implication/problem of not only any unnecessary treatment costs 
but also future premiums for health and life insurance because of preexisting 
conditions (Welch et al., 2011). 
Ultimately, an overdiagnosed patient does not and will not benefit from the identification 
or treatment of their disease, because the disease (cancer) would never have resulted in 
any exhibited symptoms, or their death (Welch et al., 2011). As such, considering the 
information presented above, in conjunction with the statistics that is outlined in the 
section below, the findings from this research add to the current knowledge about the 
efficacy of information presented for health-related decision-making. Note importantly 
that overdiagnosis was selected as the study’s topic of focus because it is an area of breast 
cancer research that is still in its infancy in the Province of Ontario, Canada. 
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Statistics on Breast Cancer in Canada 
Throughout Canada, the incidence rates for breast cancer in women have been 
generally consistent, do not vary significantly by geography, and have continued to be 
somewhat stable as of the late 1980s. Although the actual numbers each year have 
increased, this increase has been proportionate to increases in the country’s population 
(CBCF, 2014b). In 2014, the CCS estimated 191,300 new cases of cancer (not including 
the roughly 76,100 cases of nonmelanoma skin cancers) and 76,600 deaths. Of the 
identified cases, 97,700 and 93,600 Canadian men and women respectively would be 
diagnosed with cancer, of which 40,000 and 36,600 respectively would die. Of all the 
new cases, more than 52% were estimated to be lung, breast, colorectal, and prostate 
cancers (CCS, 2014c; CCS et al., 2014, p. 24). Specifically within the Province of 
Ontario, the CBCF and CCS estimated that, for 2014, for women, breast cancer was the 
most commonly detected cancer, with 9,500 new cases (see Table 1) and an estimated 
1,950 dying from the disease (CCS, 2014c, “Cancer statistics for women,” para. 1–4). 
During 2012 to 2013, the Canadian female population grew by approximately 200,000, 
whereas the estimated number of diagnosed women with breast cancer increased by 800. 
The CCS, however, estimated that, for 2014, there would be a slight, yet statistically 
significant, decrease in the incidence rate for breast cancer. Currently, there are fewer 
women in Canada who die from breast cancer (CBCF, 2014b).
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Table 1 
Estimated New Breast Cancer Cases by Province in Canada in 2014  
Province # of New Cases % 
Alberta 2,200 9 
British Columbia 3,200 13 
Manitoba 850 3 
New Brunswick 560 2 
Newfoundland and Labrador 330 1 
Nova Scotia 760 3 
Ontario 9,500 39 
Prince Edward Island 110 0.4 
Québec 6,000 25 
Saskatchewan 700 3 
Total 24,000 100 
 
Note. Rates of incidence are comparable throughout all provinces. Provinces that have 
larger populations have more cases of breast cancer. Data for each Canadian territory 
(Northwest Territories, Yukon, and Nunavut) are not listed individually as the numbers 
are small. However, they are included in totals for Canada. Adapted from “Breast cancer 
in Canada, 2014” by Canadian Breast Cancer Foundation, 2014b. Retrieved from 
http://www.cbcf.org/central/AboutBreastCancerMain/FactsStats/Pages/Breast-Cancer-
Canada.aspx. Copyright 2014 by the CBCF. 
 
Relative to previous years, death by breast cancer was noted to have reduced by 
43% (18 deaths per 100,000), since its peak in 1986. CBCF (2014c) projected that in 
2014, 5,000 women would have died of breast cancer in Canada (see Table 2), a 
reduction relative to the roughly 5,100 deaths in 2012 (Breast cancer survival section, 
para. 1). This noted decreased rate of mortality (increased rate of life expectancy) was 
attributed to the purported benefits of screening mammograms and is still used as 
evidence by the Government of Ontario for support of their active and continued 
advocacy of the OBSP. The CCS (2014d, “Cancer statistics at a,” para. 10-18) noted 
cancer could occur at any age and that roughly two in five Canadians would develop 
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cancer in their lifetime, of which 25% would die of the disease, and approximately 63% 
of those diagnosed would survive for at least five years. Of relevance was the CCS’s 
indication that Canadians over the age of 50 years were predominantly affected by 
cancer. The CBCS (2014b) further stated that, although breast cancer occurred in both 
females and males, a larger percentage of cases were found in women. Specifically 
highlighted was that “less than 1% of all breast cancer cases” were found in males 
(BCSC, 2014b, Male Breast Cancer section, para. 1). In 2014, breast cancer would be 
identified in 210 men and of that amount 60 would die. For men diagnosed with cancer, 
there was a five-year, 80% survival rate after being diagnosed, while for women, this 
five-year survival rate increased by 8% (from 80% to 88%). This increase was partly 
because the disease was identified at a more advanced stage in men, consequently the 
diagnosed male had fewer treatment options available (CBCF, 2014b). 
The CCO (2011b) supported the CCS’s assertion that “breast cancer is the second 
most common cancer killer among women” when it indicated that 20 per 100,000 women 
would be killed by cancer (“Overall rate of cancer,” para. 6). Other statistics that further 
supported the notion that breast cancer is the second foremost reason of cancer-related 
death in Canadian women was presented by the CBCF (2014b) and the CCS (2014c). 
Both the CBCF (2014b) and the CCS (2014c) indicated that of the estimated 24,400 
women diagnosed with some form of cancer (see Table 2), 26% of all first-time cases of 
cancer in those women would be breast cancer (CBCF, 2014b). Current data as of 2014 
suggested approximately 157,000 women in Canada who had been diagnosed with 
“breast cancer in the last 10 years [were still] living [this] compared to other types of 
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cancer” (CBCF, 2014b, “Prevalence of breast cancer,” para. 1). These statistics pointed to 
a conclusion that “women with breast cancer [were] surviving for longer periods” 
(CBCF, 2014b, “Prevalence of breast cancer,” para. 1), a result partially attributed to 
early detection and screening. 
PHAC (2009) also highlighted that “breast cancer is rarely diagnosed in people 
younger than 40 years [and current statistics have shown that] incidence rises 
steeply…peaking in women aged 75–79 years” (Incidence section, para. 3). Given age is 
a risk factor for breast cancer, and as an individual ages, this associated risk increases, a 
collaborative report produced by the CCS, Statistics Canada, PHAC, & 
Provincial/Territorial Cancer Registries (2014), and further confirmed by the CBCF 
(2014b) estimated that “women over 50 years of age make up 82% of breast cancers” 
(CBCF, 2014b, “Breast cancer mortality and,” para. 1–5). Specifically, 52% of the cases 
would be in women aged 50 to 69 years, 30% for women aged 69 years and older, and 
19% among women aged 50 years and under (see Table 2) (CBCF, 2014b). “For women 
30 to 49 years of age the risk of being diagnosed with any type of cancer [wa]s 1 in 500 
(or 0.2%)” (CBCF, 2014b, “Breast cancer incidence and,” para. 1–2). Despite this 
number being considered very low risk, roughly 36% of those women, aged 30–49 years, 
would be diagnosed with breast cancer (CBCF, 2014b). 
Significant to note was that, while 25% (see Table 2) of the first-time cases of 
breast cancer had been projected to occur in women aged 50 to 69 years, there were more 
deaths in women aged 80 years and over (CCS et al., 2014). This suggested that those 
who were diagnosed and treated in their 50s were more likely to live into their 80s. 
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However, much like the observed decreased rate of mortality noted above, earlier 
detection via “regular mammography screening, advances in screening technology, and 
improved treatments” were credited for this overall increase in life expectancy (CBCF, 
2014b, “Breast cancer in Canada,” para. 2; CCS et al., 2014, pp. 40, 58). Because this 
research is focused on women aged 50–69 years and their decisions about screening 
participation, an understanding of the rates of incidence for breast cancer in Ontario 
helped to create greater context for interpreting (a) the Ontario-specific data presented; 
(b) screening participation rates documented; and (c) any impact knowledge of 
overdiagnosis had on participation levels currently observed.  
Table 2 
Estimated New Breast Cancer Cases Diagnosed and Deaths of Women in Canada, by 
Age Group  
 Estimated new breast cancer cases Estimated deaths from breast cancer 
Age Actual number (%) Actual number (%) 
80+ 3,000 12.3 1,550 31 
70-79 4,400 18 1,050 21 
60-69 6,500 26.6 1,100 22 
50-59 6,100 25 860 17.2 
40-49 3,300 13.5 380 7.6 
Under 40 1,115 4.6 100 2 
Total 24,400 100 5,000 100 
 
Note. Adapted from “Breast cancer in Canada, 2014” by Canadian Breast Cancer 
Foundation, 2014b. Retrieved from 
http://www.cbcf.org/central/AboutBreastCancerMain/FactsStats/Pages/Breast-Cancer-
Canada.aspx. Copyright 2014 by the CBCF. 
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As breast cancer is the most commonly identified cancer among Canadian 
women, the CCS pointed out that it was also the most actively researched/studied area of 
cancer in Canada. In 2011–2012, the CCS funded more than $46 million Canadian 
dollars in cancer research, of which $4.1 million dollars was dedicated to breast cancer 
research (CCS, 2014a). Although not funded by PHAC or the CCS, the studies and their 
respective methodologies (outlined below) provided appropriate evidence of the 
importance of overdiagnosis research in the context of participation in screening 
mammography. The analyzed studies in question addressed the issue of breast screening 
from varying perspectives, with different objectives in mind. Nevertheless, all in some 
respect acted as building blocks for this current research. 
Statistics on Breast Cancer Screening in Canada 
The CTFPHC (2014) reported that, among women aged 50–69 years, 900 die of 
breast cancer annually, relative to the approximately 470 and 480 that die among women 
aged 40–49 years and 70–74 years, respectively (Basis of recommendation section, p. 1). 
CTFPHC further pointed out that, in order to save one life from breast cancer over the 
span of 11 years, screening would be needed every two to three years. The research 
findings indicated that, among women aged 40–49 years, for every 1,000 women that 
would need to be screened, 36 (3.60%) would have an unnecessary breast biopsy, and 
roughly 329 would have a false-positive mammography (32.90%). Among women aged 
50–69 years, out of roughly 1,000 women that would need to be screened, 36 (3.60%) 
would have an unnecessary breast biopsy, and approximately 283 (28.30%) would have a 
false-positive mammography. Finally, among women aged 70–74 years, for every 1,000 
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women that would need to be screened, 24 (24.40%) would have had an unnecessary 
breast biopsy, and an estimated 213 (21.30%) would have a false-positive 
mammography. CTFPHC also indicated that, for each identified case of false-positive, 
the effects on these screened women (overdiagnosed) were “unnecessary anxiety and 
follow-up testing” (“To save one life,” p. 1). For every 1,000 women screened, CTFPHC 
noted that 5 will undergo unnecessary surgery for breast cancer (“To save one life,” p. 1).  
In its postanalysis of 2011–2012 statistics, the CQCO (2014a) reported that, in 
Ontario, roughly 60% (1,138,000) women aged “[50–]74 years were screened for breast 
cancer with a mammogram” (Key findings section, para. 1). During that period, 
1,884,000 were eligible for screening. The CQCO outlined that “although the breast 
cancer screening participation rate has remained steady at 60%–61% since 2007–2008, 
more women are being screened within the . . .OBSP which offers important advantages 
for women and physicians” (Key findings section, para. 1). An estimated 841,000, or 
more than three-quarters, have been screened via the OBSP (CCS et al., 2014; CQCO, 
2014a). However, in spite of increasing levels of eligibility for screening among the 
population, the rate of participation had remained steady from 2007–2012, as noted in 
Figure 2.  
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Figure 2. Bar chart of the age-adjusted percentage of women in Ontario, 50–74 years old, 
who completed one or more mammogram in a 2-year interval. Based on a national target 
of 70%, the data shown highlights the percentage of mammograms conducted from 2005 
to 2012 by OBSP programs = green, and NonOBSP programs = blue. Adapted from 
“Age-adjusted percentage of Ontario women, 50–74 years old, who completed at least 
one mammogram within a two-year interval, by OBSP/Non-OBSP, 2005–2012,” by 
Cancer Quality Council of Ontario, 2014a, Retrieved from 
http://www.csqi.on.ca/cms/one.aspx?portalId=289784&pageId=296132. Copyright 2015 
by CQCO c/o Cancer Care Ontario. 
 
During 2010–2011, more than 50% of the screening mammography in each Local 
Health Integration Network (LHIN) was conducted at OBSP centers, and 55% to 88% of 
all Ontario women screened came from women who participated in the OBSP. The range 
observed was attributed to a variety of sociodemographic factors that were influenced by 
age group, neighborhood income range (highest/lowest income areas), urban/rural 
residence, and neighborhoods with high percentages of Aboriginal peoples, as shown in 
Figure 3. The highest amounts of women taking part in organized screening were from 
LHINs in “North East (89%) and South West (83%) [Ontario]. Toronto Central LHIN 
had the lowest proportion of screening – 56% of those screened did so through the 
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OBSP,” shown in Figure 4 (CCS et al., 2013, 56-57, 61-63; CCS et al., 2014, pp. 58-59, 
61-64; CQCO, 2014a, “What do the results show” para. 3). Further examination of the 
report indicated that the highest rates of participation were among women aged 60–64 
years and 65–69 years old (65%), while the lowest participation rates were found in 
women aged 70–74 years (53%). In relation to the objective of this study, it was 
important to note that the currently recorded rates of participation for breast screening 
would potentially be impacted if it was found that there was a relationship between 
knowledge of overdiagnosis and the decision to participate in breast screening (the 
independent and dependent variables). Two of several questions considered during this 
literature review were (a) whether the high levels of participation documented for Ontario 
women 60–69 years was the result of the OBSP’s targeted media campaigns for this 
specific demography; and (b) with the July 2011 change in eligible screening age from 
50–69 years to 30–69 years for women at high risk of developing breast cancer, would 
the rates of participation outlined above remain consistent, and, if not, what changes 
would be observed?  
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Figure 3. Bar chart of the age-adjusted percentage of women in Ontario aged 50–74 years 
old who completed one or more mammogram in a 2-year interval. Based on a national 
target of 70%, the data shown highlights the percentage of mammograms conducted from 
2010 to 2011. Data was grouped by sociodemographic factors: the province of Ontario = 
mustard, neighborhood income quintile = cyan, urban/rural residence = lime green, and 
Aboriginal neighborhood percentages = dusty pink. Adapted from “Age-adjusted 
percentage of Ontario women, 50–74 years old, who completed at least one mammogram 
within a two-year interval, by socio-demographic factor, 2010–2011,” by Cancer Quality 
Council of Ontario, 2013. Retrieved from 
http://www.csqi.on.ca/cms/One.aspx?portalId=258922&pageId=273161. Copyright 2015 
by CQCO c/o Cancer Care Ontario. 
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Figure 4. Bar chart of the age-adjusted percentage of women in Ontario aged 50–74 years 
old who completed one or more mammogram in a 2-year interval. Based on a national 
target of 70%, the data shown highlights the percentage of mammograms conducted 
through the Local Health Integration Network from 2005 to 2012. Data was grouped by 
geographical regions (depicted by acronyms) and years: 2005–2006 = blue, 2007–2008 = 
green, 2009–2010 = purple, and 2011–2012 = orange. Adapted from “Age-adjusted 
percentage of Ontario women, 50–74 years old, who completed at least one mammogram 
within a two-year interval, by Local Health Integration Network, 2011–2012,” by Cancer 
Quality Council of Ontario, 2014a, Retrieved from 
http://www.csqi.on.ca/cms/one.aspx?portalId=289784&pageId=296132. Copyright 2015 
by CQCO c/o Cancer Care Ontario. 
 
On the one hand, despite a greater push and more media communications that 
highlighted the benefits of screening, over the years (2009–2010 and 2011–20112), a 
similar pattern, as mentioned above, was noted among the various age groups that did 
participate in screening. On the other hand, it was interesting to note that, across all age 
groups, there was only a 2%–6% increase in participation rates, when 2005–2006 and 
2011–2012 data were compared, as shown in Figure 5 (CQCO, 2014a). From an 
international perspective, CQCO (2014b) indicated that participation levels for screening 
programs in Ontario were notably lower than those observed in such countries as 
73 
 
 
Australia, Finland, Norway, the Netherlands, and the United Kingdom (England only). 
Relative to Ontario, Norway was documented as having a 16% higher level of screening 
participation among women aged 50–69 years (CQCO, 2014b). These reported statistics 
raised yet another question; For those countries with higher overall participation rates 
observed, had screening information been presented in a balanced manner—outlining the 
benefits of screening and the associated risk of overdiagnosis, thereby enabling its 
participants to be better-equipped to make an informed decision on whether to participate 
in screening—would their documented rate of screening participation be the same?  
Figure 5. Bar chart of the age-adjusted percentage of Ontario women aged 50–74 years 
old who completed one or more mammogram in a 2-year interval. Based on a national 
target of 70%, the data shown highlights the percentage of mammograms conducted from 
2005 to 2012. Data was evaluated along the lines of age group and covered the period: 
2005–2006 = blue, 2007–2008 = green, 2009–2010 = purple, and 2011–2012 = orange. 
Adapted from “Age-adjusted percentage of Ontario women, 50–74 years old, who 
completed at least one mammogram within a two-year interval, by age group, 2005–
2012,” by Cancer Quality Council of Ontario, 2014a, Retrieved from 
http://www.csqi.on.ca/cms/one.aspx?portalId=289784&pageId=296132. Copyright 2015 
by CQCO c/o Cancer Care Ontario.  
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As documented by CQCO (2014a), the CTFPHC (2014) in their previously 
published report outlined evidence that, among women aged 50–69 years, there was a 
21% reduction in the rate of breast cancer mortality. The reason for this reduction was 
stated to be a consequence of screening mammography, and was considered statistically 
significant. The CTFPHC also indicated that roughly one in every 10 women tested 
would require more examination because of unclear and/or abnormal mammography 
(CQCO, 2014a). However, despite unclear and/or abnormal mammograms, according to 
MHLTC (2013a), since the commencement of the OBSP in 1990, there have been “over 
3.6 million screens conducted for more than 1.1 million women, which resulted in more 
than 19,000 detected cancers,” most of which were in the early stages (Quick facts 
section, para. 2). In the final analyzes, the rate of success for screening participation was 
noted to be impacted by several factors. Given the observed schemata for an average 
Ontario participant in the OBSP was based on one-sided (predominantly benefits only) 
screening information, any knowledge gained from this study (that examined the 
relationship between knowledge of overdiagnosis and decision-making to participate in 
screening) would aid in possibly predicting future rates of participation. It would also 
help in the establishment of a framework for understanding how associated risks 
(negative outcomes) should be presented, without adversely affecting an individual’s 
decision to get screened.  
Research Related to Overdiagnosis and Breast Screening Programs 
Cancer Australia (2004) in its report noted that, “for all women, there [was] a 
chance that mammography [would] either miss a change due to breast cancer (false-
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negative) or that further tests [would] be performed to examine a change that [was] not 
due to breast cancer (false-positive)” (Mammography section, para. 1). They also noted 
that the possibility of a false-positive or false-negative result was greater for younger 
women, as the density of a young woman’s breast tissue made it harder to identify 
changes. For older women the breasts becomes generally less dense, particularly after 
menopause, and this was the justification for mammograms being more effective for 
women aged 50 years and older (Cancer Australia, 2004). Within the context of the 
residents of Ontario, this research does support the rationale for screening the selected 
age group for this current study, given the distinction in breast density that lends greater 
benefit to women older than 50 years. Gøtzsche et al. (2009) conducted a survey on 
females who were invited to participate in six countries’ publicly-funded screening 
programs. The survey found that the key risks of screening mammography, including 
overdiagnosis and subsequently overtreatment, had not been outlined in the 31 invitations 
distributed. Also noted was that 10 of the 31 invitations purported that the screening 
resulted in fewer invasive surgeries or simpler treatment. The findings of the survey, 
however, revealed that there was more surgeries (30%), mastectomies (20%), and 
radiotherapy, all as a consequence of overdiagnosis (Gøtzsche et al., 2009).  
Kalager et al. (2012) sought to roughly determine the proportion of overdiagnosis 
of breast cancer as a result of screening mammography. The research found that an 
estimated 15% to 25% of the cases of cancer in the Norwegian female population were 
overdiagnosed. In numerical terms “six to 10 women for every 2,500 women invited to 
screen had been overdiagnosed” (p. 495). Another study that underscored the relevance 
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of researching the relationship between knowledge of overdiagnosis and the decision to 
participate in breast screening programs was done by Bleyer and Welch (2012). 
Published in the New England Journal of Medicine, the research sought to evaluate the 
effect of 30 years of screening mammography on breast cancer incidence. Using 
observation, epidemiology, and the data from end results, trends from 1976 to 2008 were 
examined in early-stage breast cancer incidence and late-stage breast cancer, among a 
cohort of women aged 40 years and older. The study found that the U.S. incidences of 
early-stage breast cancer increased by 122 cases per 100,000 women. Of that amount 
only eight were expected to progress to the advanced disease. It further found that 1.3 
million U.S. women in the preceding 30 years were overdiagnosed; more than 70,000 
were noted in 2008 accounting for 31% of all diagnosed breast cancer. The study also 
found that notwithstanding the significant rise in the instances of early-stage breast 
cancer identification, mammography screening had only slightly decreased the frequency 
“at which women presented with advanced cancer. [Additionally,] although it [was] not 
certain which women [had] been affected, the imbalance [in the diagnosis rates 
suggested] that there [was] substantial overdiagnosis, accounting for nearly a third of all 
newly-diagnosed breast cancers” (Holloway, 2015, “Effect of three decades,” para. 2). 
For Bleyer and Welch (2012 as cited in Holloway, 2015) the conclusion was therefore 
that breast “screening [was] having, at best, only a small effect on the rate of death 
[mortality] from breast cancer” (“Effect of three decades,” para. 2). de Gelder et al. 
(2011) reviewed research conducted on a sample population from screening 
mammography participants in the Netherlands from 1990 to 2006. Similar to other 
77 
 
 
studies assessed in this review of literature, the issue of overdiagnosis was mentioned and 
supporting statistics were provided, indicating the occurrence of overdiagnosis.  
In BC, Canada, as recently as 2013, research related to overdiagnosis as a 
consequence of breast cancer screening was conducted by researchers Coldman and 
Phillips (2013). The research design implemented in the study entailed the retrospective 
study of secondary data collected by the BC Cancer Registry between 1970 and 2009, 
and was cross referenced with the Vital Statistics Agency of British Columbia records of 
deaths, to identify deaths and cases of breast cancer. The population of focus was women 
identified with invasive and ductal carcinoma in situ cancers, aged 40–89 years, during 
2005–2009. The (participation and population) methods used to estimate overdiagnosis 
was based on the collective breast cancer rates among women, and included the estimated 
difference between (a) women who underwent ongoing screening, and those who did not 
have screening or stopped screening (the participation method); and (b) observed and 
projected aggregate population rates in 2005–2009 (the population method) (Coldman & 
Phillips, 2013, pp. E492–E493). The research found that on the one hand, among women 
aged 60–79 years, there were significantly increased incidences of invasive breast cancer 
in 2005–2009, relative to 1970–1979. On the other hand, in women aged 40 to 59 years 
old, there was no continued rise. This suggested and supported the concept that the 
consequence of screening on overdiagnosis might dependent on age. It was estimated that 
there was “a modest association between screening and overdiagnosis after allowing a 
period of 10 years for a compensatory drop after screening had stopped” (p. E498). The 
rate of overdiagnosis estimated for breast cancer in women over the age of 60 years was 
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at 5.4% for invasive diseases and 17.3% for both invasive diseases and ductal carcinoma 
in situ (p. E492). 
The observed limitations of the research included (a) self-selection bias, because 
the researchers removed the effect of first screens (which tended to yield high detection 
rates and inflated incidence) after the age of usual screening initiation, (b) over 
estimations of the populations of overdiagnosis over a 30 year period, and (c) the 
potential influence of other factors (Coldman & Phillips, 2013, pp. E492, E498). Despite 
not using the RCT research design, Coldman and Phillips (2013) “reviewed findings from 
clinical trials, included results on both invasive and in situ [cancers, and outlined that the 
RCT approach was the] most rigorous method to measure the extent of overdiagnosis” (p. 
E497). This provided validation for the relevance of the research design, as it was 
identified in more than 40 years’ worth of conducted studies related to breast cancer 
screening. The results of that research were pertinent to this current study because they 
provided an examination of the issue of overdiagnosis specific to the Canadian landscape. 
They also supported and validated the appropriateness of the selected age group under 
evaluation. 
Randomized Clinical Trial (RCT) Research Design Implemented 
Conducted between 1963 and 1975 and considered probably to be the first 
research that implemented the RCT design, the Health Insurance Plan “(HIP) Breast 
Cancer Screening Project [sought] to [examine] whether periodic screening with clinical 
examination and mammography [resulted] in reduced breast cancer mortality among 
women 40–64 years at the start” (Shapiro, 2006, p. 2772). Reevaluated by Sam Shapiro 
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in 2006, it was noted that the study’s sample population consisted of women aged 40–64 
years living in the Greater New York area, and included 62,000 participants, of which 
50% were placed in a study group, with the remaining 50% placed in a control group. On 
the one hand, study participants were offered screening examinations, and it was noted 
that 65% of that group “appeared for initial examinations, and a large majority of [them] 
had at least one of the three additional screenings at annual intervals” (Shapiro, 2006, p. 
2772). On the other hand, the women in the control group were administered their regular 
medical care (Shapiro, 2006). After nine years’ wait from the date of entry, the results 
revealed “128 breast cancer deaths in the control group compared [to 91] in the study 
group [a combination of screens and those who refused]” (Shapiro, 2006, p. 2774). Other 
results noted were that, “over an eight-year period after diagnosis, breast cancer cases 
that were positive only on mammography when screened, had a case fatality rate of 14%” 
(Shapiro, 2006, pp. 2777-2778), relative to the “32% for cases positive only in the 
clinical examination and 41% for cases positive on both modalities” (Shapiro, 2006, 
p. 2779). The final statistics excluded mammography findings based on the fact that one 
third of the estimated benefits of screening would have been reduced by such results 
inclusion (Shapiro, 2006). 
Limitations outlined in Shapiro’s study related to data collection, and included the 
following (a) there was no uniformity in the pathology protocol by the hospitals that 
conducted biopsies, (b) there were strict restrictions to the size and number of nodes, (c) 
the size of lesions were unknown for roughly “[one] third of the cases, and (d) the 
number of nodes dissected [per hospital] varied significantly” (Shapiro, 2006, p. 2779). 
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Despite its limitations, Shapiro’s study highlighted the need for more awareness of the 
effects of radiation for inducing breast cancer (Shapiro, 2006). Some of the 
recommendations from the research were that (a) consideration be given to whether a 
new randomized trial was needed, and (b) more critical assessment was necessary to 
determine the incremental value of mammography in a screening program. The research 
findings indicated that the impact of the screening program for breast cancer mortality 
continued to be confined to women aged 50 years and over, and it was strongly suggested 
that consideration was needed for whether screening and mammography would be 
beneficial to women under age 50 years. To justify screening under age 50 years, the key 
recommendation was that new information from other studies was required (Shapiro, 
2006). Based on the HIP study findings, the “strong support for periodic screening at ages 
50 years and over with clinical examination and mammography [was illustrated]” 
(Shapiro, 2006, p. 2772). As seen in Cancer Australia’s (2004) analysis, the findings 
again supported the rationale for the selected sample population (aged 50–69 years) for 
this current research. Even though the HIP study was focused predominantly on the 
benefits of screening mammography, in its analysis and conclusion, it indirectly 
addressed the issue of overdiagnosis when mention was made of further risks associated 
with increases in biopsies as a consequence of false-positive results because of increased 
screening (Shapiro, 2006; Welch, 2004). 
Similar to the HIP study that used the RCT research design, the NCI’s “Mayo 
Lung Project . . .[was aimed at] determin[ing] the effectiveness of intensive screening 
with chest radiography and sputum cytology in comparison with usual care” (Black, 
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2000, p. 1280). This project was conducted between 1971 and 1983 on a sample 
population that included 76,000 person-years of observations in each group (Black, 2000, 
p. 1280). During the trial, participants had an average three-year follow-up after their last 
screening. Although this study was focused on overdiagnosis in lung cancer, its findings 
demonstrated the existence of issues of false-positive and false-negative results. Its 
results also revealed a marked indication that there was a lack of knowledge about what 
constituted overdiagnosis, and how this lack of knowledge impacted cancer screening 
results. The research concluded that it was imperative to establish “some mechanism in 
the screening process [that would] minimize these side effects” (Black, 2000; p. 1281). 
Among the recommendations made included was the need for a compulsory surveillance 
period for small nodules as well as very close monitoring of all mortality causes, in the 
cases of RCTs, to guarantee accurate accounting of breast screening benefits and risks 
(Black, 2000).  
The final recommendation, which aligned well with this research, was the need to 
provide “a balanced presentation of the potential benefits and risks (including 
overdiagnosis) to all prospective [screening participants], to ensure they could make an 
informed decision about [whether to be] screened or enrolled in a randomized trial of 
screening” (Black, 2000, p. 1281). The main limitation of the research, as highlighted by 
Black (2000), was the possibility of contamination, given that several subjects from the 
control group had radiography during the intervention period. Black, however, noted that 
the number “of these radiographs obtained for screening, rather than for [the evaluations 
of] specific symptoms, [was unknown]” (Black, 2000; p. 1280). Additionally noted was 
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that, because of a markedly higher number of “[five-]year survival and excess cases in 
the screened group, [it strongly implied] that [the screened] group did undergo more 
intensive screening than the control group” (Black, 2000; p. 1280). Finally, it was 
highlighted that there were “no baseline differences in age, smoking habits, or other lung 
cancer risk factors in the two groups” (Black, 2000; p. 1280). Although the type of the 
cancer being assessed was lung cancer, several parallels were drawn from the findings 
highlighted in the research, and these acted as a guide in the examination of the 
knowledge of overdiagnosis and its relationship with decisions about breast screening 
participation. 
The 1963–1975 HIP project established a good foundation for the 2011 study 
conducted by Brouwers et al. (2011) that examined (a) what interventions were 
implemented, and (b) what was the rate of increase for cancer screening. Conducted as a 
“systematic review of [RCTs] and cluster randomized controlled trials [CRCTs] 
published between 2004 and 2010, [the final research sample for Brouwers et al. (2011) 
included] 66 new eligible studies with 74 comparisons” (p.1). The research findings 
concluded “that client reminders, small media, and provider audit and feedback [seemed] 
to be [effective interventions] to increase . . .screening for breast, cervical, and [colorectal 
cancers] CRCs” (p. 13). The study also found that “one-on-one education and reduction 
of structural barriers appear[ed to be] effective. [However, it was noted that] their 
[respective] roles with CRC and cervical screening . . .[were] less established” (p. 1). 
Observed in the study was that no current research had existed that had examined “mass 
media alone as a means of increasing breast . . .screening” (p. 7). Therefore the study 
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recommended that more research was “required to assess [interventions of] client 
incentives, mass media, group education, reduction of out-of pocket costs, and provider 
incentive” (p. 13), to determine their respective impact on screening uptake 
(participation). 
Some of the limitations of Brouwers et al.’s (2011) study included taxonomy 
(how concepts were classified across the various studies included in the review), 
organizational frameworks inherited from the foundational reports used, and potential 
inaccuracies in the estimates related to the absolute impact of any given intervention. 
While the research done by Brouwers et al. did not definitively indicate that media 
campaigns (small media, mass media) presented unbalanced information about the 
benefits of screening, it did reinforce the notion that further research was needed. In 
particular, research was needed to assess how media campaigns (mass media) potentially 
impacted screening participation. This by extension would facilitate considerations about 
presenting information on the associated risks (such as overdiagnosis) of screening 
participation (Brouwers et al., 2011).  
As this research focused on the examination of whether there exists a relationship 
between knowledge of overdiagnosis (independent variable) and the decision to 
participate in breast screening (dependent variable), among women aged 50–69 years 
(cohort), in Ontario, Canada, the studies conducted and/or assessed by a variety of 
researchers (e.g., Brouwers et al., 2011; Cancer Australia, 2004; Duffy et al., 2010b; Paci, 
Warrwick, Falini, & Duffy, 2004; Shapiro, 2006; Zackrisson, Andersson, Janzon, Manjer, 
& Garne, 2006) formed a part of the foundation for this study. Each provided relevant 
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evidence and support for the significance of screening research geared towards women 
aged 50–69 years. If this research confirms a relationship between the independent and 
dependent variables, then the supposition would be that any new information on 
overdiagnosis to be introduced should follow Giordano et al.’s (2006) ethical principles 
for effective health communication. The Government of Ontario also would need to 
account for the understanding that each individual’s cognitive construct (schemata) 
differs, and therefore information must be tailored to that individual. Once these 
considerations are addressed, the probability of maintaining and/or enhancing screening 
rates would improve.  
Zackrisson et al. (2006) conducted a study “to evaluate the rate of over-diagnosis 
of breast cancer 15 years after the end of the Malmö[, Sweden,] mammographic 
screening trial” (p. 689). The research design was a randomized follow-up study that 
included a sample population of “42,283 women aged 45–69 years” (p. 689). Divided 
into two cohorts, one that consisted of 21,088 (invited to be screened) and the other with 
21,195 (the control group), the research found that, during the follow-up, 9,279 and 9,514 
participants died from the cohort invited to screen and the control group, respectively. Of 
the deaths in the invited cohort, 32% were from breast cancer when compared to 46% in 
the control group (p. 691). Zackrisson et al. concluded that there was “a clear difference 
in the cumulative number of all cases of breast cancer (invasive and in situ) . . .in the 
invited and control groups” (p. 690). Among women aged 45–54 years and 55–69 years, 
who were invited to the screened group, respectively, there was a noted 16% and 10% 
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higher rate of breast cancer relative to the control group, suggesting overdiagnosis had 
occurred (Zackrisson et al., 2006).  
Zackrisson et al. (2006) also pointed to earlier studies in Norway that 
demonstrated 50% overdiagnosis (although it was indicated there were discrepancies with 
follow-up). Noted in Sweden was an illustrated “21–54% excess incidence [of 
overdiagnosis] depending on age. [Again, however, those percentages reported had not 
accounted for] hormone replacement therapy or changes in childbirth alone or in 
combination with screening” (p. 691). An interesting finding by Zackrisson et al. (2006) 
was that the rate of overdiagnosis observed may have been underestimated due to the 
exclusion of “mammography of asymptomatic women [in] the control [group]” (p.692). 
In the context of this current research focused on Ontario, Canada, the Zackrisson et al. 
(2006) study in Malmö, Sweden, much like those conducted in other countries, illustrated 
the advantage and continued use of the RCT research design in studies related to cancer 
screening. It also reinforced with evidence that overdiagnosis was a relevant topic 
necessitating further research.  
Jørgensen and Gøtzsche, in their 2009 research, examined the extent to which 
overdiagnosis occurred in publicly-organized screening programs. The research noted 
that overdiagnosis and overtreatment were inevitable, because it was “not possible to 
distinguish between lethal and harmless cancers; all detected cancers [were] treated” 
(Jørgensen & Gøtzsche, 2009, p. 1). Using linear regression analysis, the data collected 
during a seven-year period, from both screened and nonscreened age groups in Canada 
(Manitoba), the United Kingdom (UK), Sweden, Australia, New South Wales, and some 
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areas in Norway, found that overdiagnosis was estimated at 52%. “One in three breast 
cancers detected in a population offered organised screening [was] overdiagnosed” (p. 1). 
The research findings were based on a 95% Cl of 46% to 58%. The research further 
concluded “that the increase in incidence of breast cancer was closely related to the 
introduction of screening, [noting] that little of this increase was compensated for by a 
drop in incidence of breast cancer in previously screened women” (p. 1). Although the 
article did not outline clearly what recommendations were necessary to address the issue 
of overdiagnosis, it did strongly support the notion that there was a significant level of 
overdiagnosis. Within the context of this research, if there was an enhanced 
understanding of what the current levels of overdiagnosis were in Ontario, Canada, this 
could help in facilitating the establishment of guidelines that ensured the accurate, 
balanced, and transparent presentation of information about breast screening programs to 
potential participants. An added benefit in knowing the level of overdiagnosis would be 
the potential for creating mechanisms to possibly reduce such noted levels. 
Duffy et al. (2010b) sought “to estimate the absolute [number] of breast cancer 
deaths prevented and [tumors overdiagnosed in] mammography screening for women 
aged 50–69 years” (p. 25). Based on the RCT research design used in the Swedish Two-
County trial, the “quantities for mortality and incidence rates [were estimated] in England 
between 1974–2004 and 1974–2003[, and using] Poisson regression statistical [inferences 
were made]” (p. 25). The research concluded that “between 2 and 2.5 lives [were] saved 
for [each] overdiagnosed case” (Duffy et al., 2010b, p. 29). This was noted to be a 
significant departure from the results reported by Gøtzsche et al. (2009). These 
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differences noted in Duffy et al.’s (2010b) study was potentially the result of (a) using 
estimates straight from empirical data, (b) clearly identifying instances of screening 
invitation versus being actually screened, and (c) “the time frames in the two sets of 
estimates” (p. 29), during a 10-year screening period. The suggestion was that Gøtzsche 
et al. (2009) needed a longer period of follow-up prior to any assessment of 
overdiagnosis. 
Another research reviewed in the literature related to the issue of overdiagnosis in 
breast cancer screening participation included Moss’s (2005) study. This study evaluated 
eight previously conducted RCTs research designed studies spanning several countries, 
including: the United States’ HIP study; four trials in Sweden (Swedish County, 
Gothenberg, Stockholm, and Malmö); one study in Edinburgh, Scotland; and two in 
Canada. Moss (2005) found differences in breast cancer incidence possible, due to 
randomization biases. It was, however, noted that equality of incidence had been used as 
evidence of a lack of bias in randomization. Relevant to this current research, Moss’s 
analysis about and conclusion of the assessed Canadian trials (after a 13-year follow-up, 
post the trial) indicated an 11% to 14% excess of all cancers (especially DCIS). This 
result implied the existence of overdiagnosis (pp. 233-234).  
An independent UK panel that consisted of Altman, Cameron, Dewar, Thompson, 
and Wilcox (chaired by Marmot) (2012) assessed 
The benefits and harms of breast cancer screening [among] women [aged 50–70 
years]. The Panel relied mainly on findings from . . .[11 RCTs designed] breast 
cancer screening [studies] that compared women invited to screening with 
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controls not invited. [In addition, it] reviewed evidence from observational 
studies. The Panel [observed that, in a meta-analysis,] the relative risk of breast 
cancer mortality for women invited to screening compared with controls was 0.80 
(95% Cl 0·73–0·89), . . .a [20%] relative risk reduction. (Altman, Cameron, 
Dewar, Thompson, & Wilcox, 2012, pp. 1778, 1780, 1782) 
Consideration was given to how long ago the trials were completed and if there were 
internal biases within the trials. The conclusion was 
That 20% was still a reasonable estimate of . . .risk reduction. The best estimates 
of overdiagnosis [were] from three trials [where] women in the control group 
were not invited to be screened at the end of the active trial period. . . .[The] 
excess incidence [noted was] 11% (95% CI 9–12) when. . .[compared to the 19% 
noted for those] in the invited group in the long term. . . .Results from the 
observational studies support[ed] the occurrence of overdiagnosis, [however,] 
estimate[d that] its magnitude [was] unreliable. (pp. 1778, 1783)  
The Panel’s final conclusion was “that screening reduce[d] breast cancer mortality but 
that some overdiagnosis occurre[d]” (Altman et al., 2012, p. 1778). They further noted 
that “for every 10,000 UK women aged 50 years invited to screening for the next 20 
years, . . .[there would be] one breast cancer death prevented for about every three 
overdiagnosed cases identified and treated” (Altman et al., 2012, pp. 1778, 1784). This 
observation was also illustrated by Jørgensen and Gøtzsche (2009) in their research. 
Specifically it was observed that over the next 20 years more than 1% of the 
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approximately 307,000 women, 50 to 52 years old, invited to be screened annually would 
be overdiagnosed (Altman et al. 2012).  
It was observed that researchers Black (2000), Brouwers et al. (2011), Marcus and 
Prorok (1999), and Marcus et al. (2000) reviewed a RCT designed research, the Mayo 
Lung Project, in their analyzes. In addition, Altman et al. (2012), Duffy et al. (2010b), 
Gøtzsche, Jørgensen, Zahl, and Mæhlen (2012), Kaplan and Malmgren (2011); Kopans et 
al. (2011), Moss (2005), Narod (2012), Smith et al. (2012), and Verbeek (2011) all used 
and/or reviewed studies implementing the RCT research design. The use of the RCT 
research design by the various researchers above as well as others not mentioned in this 
review of literature, indicates that this research design was one of the most used and 
potentially appropriate research designs for studies concerned with the topic of breast 
screening and overdiagnosis. 
Research Designs Differing from the RCT Methodology 
The ‘lead-time’ approach. Etzioni, Gulati, Mallinger, and Mandelblatt (2013) 
focused on the topic of overdiagnosis in prostate and breast cancer screening through an 
examination of studies conducted on each cancer respectively. As it related to breast 
cancer, eight studies were selected. The analysis found that conceptual and analytic 
choices made by study investigators could significantly impact overdiagnosis estimates; 
Therefore, it was necessary to understand those choices. For studies that used the excess-
incidence approach, one limitation was that the observed excess incidence was not an 
unbiased estimate. As such, ad hoc adjustments would need to be applied to the empirical 
measures; “Understanding these adjustments [was therefore] key to evaluating these 
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studies” (p. 837). For those studies that implemented the lead-time approach, it was found 
that the links among model choices, assumptions, and results were often not transparent, 
making the evaluation of these studies difficult. However, the prior publication of the 
model in peer-reviewed statistics or biostatistics literature was a strong positive indicator 
of the model’s validity, and ongoing efforts were aimed at improving and standardizing 
model reporting for greater transparency (p. 837). Smith et al. (2012) was also noted to 
have commented on the impact different methodological approaches had on the incidence 
of overdiagnosis observed, and as such reinforced the need for efficacy in methodology 
selection (pp. 479–480). 
Another research that highlighted the lead-time approach was illustrated by 
Duffy, Lynge, Jonsson, Ayyaz, and Olsen (2008). Duffy et al. (2008) noted that, because 
this (lead-time) approach resulted in inflated rates of observed incidence (unless the 
cohort examined had ceased to be screened), it implied “that cumulative incidence in 
screened or invited cohorts compared to unscreened or uninvited [groups was the most] 
desirable source of data for [accurately estimating] overdiagnosis” (p. 1178). However, 
unlike Johnson (2012), Duffy et al. (2008) purported that in the context of Zahl’s (2004) 
research, overdiagnosis was an epidemiological concept instead of a pathological 
concept. Therefore restrictions to in situ or minimal invasive cancer was not necessary 
even though instinctively the expectation would be that most of the overdiagnosed cases 
would be in one of those two categories (Duffy et al. 2008).  
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Supporting Effective (Balanced) Health Communication 
There were earlier studies conducted by Olsen et al. (2003) in Denmark that 
concluded, in the case of Copenhagen and Fyn, organized mammography screenings 
were able to operate without the occurrence of overdiagnosis (p. 364). This finding was 
contested by Zahl (2004), who cited a lack of statistical analysis, reporting of the number 
of detected cancers, and percentage incidence increase as being vital for the correct 
estimations of overdiagnosed cases (p. 1686). Although the findings from this study are 
more than 10 years old, it offered an opportunity to view organized screening programs 
from the premise that when properly implemented (i.e., being able to illustrate the 
benefits for early detection, while reducing the consequence of overdiagnosis through the 
presentation of balanced information), there is a possibility for low levels of 
overdiagnosis despite potentially increased levels of screening mammography 
participation. However, one year later in Florence, Italy, Paci et al. (2004) looked at 
overdiagnosis in approximately 60,000 females aged 50–69 years. The period examined 
was from 1990 to 1999, and the findings indicated that approximately 5% of the invasive 
and in situ cases were overdiagnosed. The study further concluded that any “apparent 
increase[s] in breast cancer incidence [were] inherent to the screening mechanism and 
[were] mainly [the result of] early detection, rather than overdiagnosis” (p.27). Therefore 
well-informed women should not be deterred from accepting screening invitations 
(Olsen, 2013).  
Baines (2005) highlighted that Humphrey, Helfand, Benjamin, Chan, and Woolf 
(2002) noted the USPSTF had indicated that women did not understand that, “even in the 
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best screening setting, most deaths from breast cancer are not prevented” (Baines, 2005, 
p. S8; Humphrey et al., 2002). Baines posited that the explanations for why women were 
poorly informed about breast screening stemmed from “unbalanced media coverage, 
overselling of mammography, web site falsehoods, falsification of evidence in peer 
reviewed journals, and population comparisons trumping randomized trials” (p. S8). 
Welch and Black (2010) in their Oxford Journal published review of overdiagnosis in 
cancer, indicated that “the strongest evidence of overdiagnosis come[s] from long-term 
follow-up after a randomized trial of screening” (p. 607). For Welch and Black, the 
expectation was that the control group would “catch up [with] the [screened] group, 
because cancers [appeared] clinically because of signs and symptoms. [Thus, any excess 
persistence observed] in the screening group years after the trial [was] completed 
[constituted] the best evidence [of] overdiagnosis” (p. 607). To address overdiagnosis, 
Welch and Black (2010) outlined clearly that it was important patients were “adequately 
informed of the nature and magnitude of the trade-off involved with early detection” (p. 
611). While this review noted the difficulty of quantifying overdiagnosis, it did highlight 
the relevance of effective and balanced information presentation and communication. 
Welch and Black (2010) and Olsen et al. (2003) maintained that even a best guess 
estimation of the magnitude of overdiagnosis could play a relevant role in the decision-
making process (Olsen et al., 2003; Welch & Black, 2010, p. 611). 
The Moller et al. (2010) study resonated with the underlying theme that it was 
vital for health care practitioners, health care “policy makers, and women attending or 
considering screening [to be] aware of the potential extent of breast cancer overdiagnosis 
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and consequent overtreatment” (p. 281). Moller et al. highlighted that “presenting the 
benefits and harms (including overdiagnosis) of breast cancer screening to women [was] 
needed . . .to help women make an informed choice about whether to participate in 
screening” (p. 281). Moller et al. also mentioned the need for greater efforts to minimize 
overdiagnosis and overtreatment, through the use of “trials of less-aggressive treatment 
for women with screen-detected cancers, [and through the development of] methods for 
predicting which screen-detected cancers would be unlikely to progress [in] a woman’s 
lifetime” (p. 281). The need for effective communication was again reinforced by Elmore 
and Fletcher (2012) and Nelson and Hagedorn (2011) who noted it was vital that breast 
cancer overdiagnosis be carefully outlined in information related to breast screening. 
Each also indicated the need for significant assessment of how best to ensure effective 
communication since informed women deserved no less when making decisions about 
breast screening participation (Elmore & Fletcher, 2012; Nelson & Hagedorn, 2011). 
Narod (2012) discussed overdiagnosis as a problem not identified with clinically -
 detected (i.e., palpable) cancers or with node-positive cancers. It was noted that the 
assumption therefore was “that a proportion of nonpalpable mammography detected 
cancers might disappear. [The question however raised was] . . .how many and which 
ones” (p. 59)? This question was also highlighted by Kopans et al. (2011) in their article 
that mentioned the possibility of spontaneous regressions of cancer. Unfortunately, it was 
stated that there was no definitive evidence to support that notion of spontaneous 
regression (Kopans et al., 2011, p. 617). Kopans et al. concluded, from their review of 
various RCT designed studies, that “almost certainly some breast cancers [would] never 
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be lethal” and that the benefits some treated women gained remained unclear; 
nevertheless, overtreatment was not confined to only detected cancers. The final 
recommendation was that for women to make informed decisions about screening 
participation, they were to be given a balanced presentation (including the potentials for 
overtreatment, overdiagnosis, and the benefits) of the screening process (p. 619). 
The study outlined below further underscored the relevance of researching the 
relationship between knowledge of overdiagnosis and the decision to participate in breast 
screening programs. It further cemented Giordano et al.’s (2006) ethical principles of 
effective health communication and integrated the theoretical framework (schema theory) 
that guided this literature review. Conducted through the implementation of a qualitative 
study design (a noted departure from the traditional RCT research design) that used focus 
groups and incorporated presentations explaining overdiagnosis, Hersch et al. (2013) 
sought to gain insight into “women’s responses to information about the nature and 
extent of overdiagnosis, [as well as to] explore how an awareness of overdiagnosis might 
influence [the] attitudes and intentions about screening” (Hersch et al., 2013, p 1). The 
research found that there was minimal prior awareness of breast cancer overdiagnosis. 
The research further noted that some women, at the highest estimates – 50%, perceived a 
need to carefully make personal decisions related to screening. For women in the lower 
(1–10%) and intermediate (30%) estimates there was minimal effect on their attitudes and 
intentions; many of these women remained committed to screening (Hersch et al., 2013). 
Of significance was that although the level of “information preference varied: 
many women considered it important to take overdiagnosis into account [to] make 
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informed choices about whether to have screening” (Hersch et al., 2013, p. 1). The 
research concluded that the effects on screening intentions may to a large extent depend 
“on the rate of overdiagnosis[, as] overdiagnosis [was a] new notion and [it was] 
counterintuitive for many people” (p. 1). Therefore, it had the potential to influence 
screening and treatment decisions in unintended ways, if particular emphasis was not 
placed on the need for careful communication that provided “information about 
overdiagnosis [which] must be balanced with the responsibility to address 
misconceptions that may lead to problems in clinical practice” (p. 8). Hersch et al.’s 
conclusion supported the ethical principles of the effective health communication model. 
Hersch et al. also concluded that there was need for the development of communication 
strategies about overdiagnosis that applied an understanding of how individuals interact 
with/react to new information. This conclusion illustrated the underlining concept of 
schema theory. 
However, two limitations of the Hersch et al. research were that (a) to avoid 
information overload, issues of other important screening consequences (such as false-
positives and false-negatives) were not discussed; and (b) because of language barriers 
for nonEnglish speaking participants, it restricted the researchers’ “ability to accurately 
gather [those participants’] views about overdiagnosis” (Hersch et al., 2013, p. 8). 
Nevertheless, this research was vital because it demonstrated that, while some 
participants were willing to accept and make decisions with only partial information, 
there were others that would rather have all the information (both positive and negative). 
The Hersch et al. (2013) research provided crucial evidence and rationale for the 
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framework of this study. Hersch et al.’s study reinforced the relevance of conducting a 
research that focused on understanding what was the nature of the relationship between 
knowledge of overdiagnosis? As well as, how this knowledge may or may not impact the 
decision-making process of the participant. 
Overdiagnosis versus Overtreatment  
Johnson (2012) supported the belief that overdiagnosis was a misnomer for 
overtreatment. Johnson further explained that carcinoma in situ (a) were usually found by 
accident prior to screening, and (b) potentially would not have caused any further 
problems in that patient’s lifetime. As such, reports and discussions that addressed 
overdiagnosis needed to clearly distinguish in situ and invasive cancer in the represented 
statistics, as overdiagnosis could not refer to invasive cancers (Johnson, 2013, p. 319). 
Smith et al. (2012), like Johnson (2012), drew strong parallels between overdiagnosis and 
overtreatment. Smith et al.’s research also went further and outlined other implications of 
screening that included (a) patient financial cost and inconvenience, (b) anxiety 
associated with positive test results, and (c) biopsy for benign lesions. Smith et al. 
concluded that because screening was inherently imperfect, extra attention was necessary 
to reduce the adverse effects of false-positive tests (Smith at al., 2012, pp. 475-480).  
The final two studies assessed for this review of literature were done by Vigod 
(2011) and Veerbeek (2011). Vigod (2011) noted that women identified factors such as 
pain, radiation, and embarrassment as key barriers to participation in screening 
mammography (p. 11). Whereas Veerbeek (2011) suggested that more research was vital 
to assess how overdiagnosis, exposure due to radiation, and “the occurrence of interval 
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cancers [influenced morality rates]” (p. 633). Veerbeek also recommended further 
research that evaluated how “the physical and psychological effects of further 
investigation of suspicious mammographic findings in women who ultimately [were] 
found not to have breast cancer [also influenced mortality rates]” (Veerbeek, 
2011, p. 633). By using effective health communication that presents balanced 
information on both the benefits and risks of breast screening, this approach may mitigate 
against all the outlined barriers and adverse/negative implications of screening. 
In reviewing background information relevant to this research, a variety of other 
studies were not included. Some examples of those studies that were assessed, but not 
included were conducted and/or reviewed by such authors as Duffy, Sasieni, Olsen, and 
Cafferty (2010a), Hellquist et al. (2012), and Willis (2013). These studies were not 
included in this literature review because they either focused on women outside the age 
range of 50–69 years, or on women with intellectual disabilities, which were target 
populations not relevant to this current study. 
Other Risks Associated With Breast Cancer Screening 
This study is focused on overdiagnosis as a risk associated with breast cancer 
screening. To ensure one of the limitations noted in Hersch et al.’s (2013) study was not 
repeated, provided below is a brief overview of the concepts of false-positive and false-
negative. Also included is a summary of radiation exposure associated with 
mammography (all noted related risks in breast screening participation). It is, however, 
relevant to note that, although there are other risks associated with the screening process, 
only the ones highlighted above will be further explained below.  
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False-Positive  
The term false-positive refers to a result that indicates a given condition has been 
fulfilled, when it actually has not (i.e., a positive effect has been assumed erroneously). 
Generally when abnormal test results are given, they are not necessarily indicative of 
cancer (Jatoi & Gadgil, 2013). False-positive results commonly are found in younger 
women being screened. These women usually have a family history of breast cancer, 
have previously done at least one breast biopsy, and are taking hormones, for example, 
estrogen and progesterone. In some cases the radiologist’s skill may affect the chances of 
getting a false-positive result (NCI, 2013c). Notwithstanding many viewing a false-
positive result as a significant downside to screening mammography, data indicates that if 
patients are knowledgeable of overdiagnosis, the tendency is to be more worried about 
overdiagnosis relative to a false-positive result. (Welch, 2004; Welch et al., 2011). 
False-Negative  
According to the NCI (2013c), false-negative in breast screening refers to cases 
where a test result indicated a condition failed, despite the fact it was successful; That is, 
no effect has been assumed erroneously. The screening results in false-negatives are 
usually in younger women, and appear normal although breast cancer is present. One in 
five cancers may be missed by mammography, and, in the case of false-negative 
diagnoses, the diagnosed person may delay seeking medical treatment. False-negative 
results are affected by the rate of tumor growth, the size of the tumor, and the level of 
female hormones. Like false-positive results, it is impacted by the skill of the radiologist 
(NCI, 2013c; Welch, 2004, p. 36). 
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Radiation Exposure Associated with Mammography 
Aside from the above-mentioned risks of false-positive and false-negative results, 
there is also the consideration of radiation exposure as a result of screening 
mammography. However, because “modern mammography equipment requires very 
small doses of radiation, [recent] research confirm[ed] that [any associated] risk of harm 
from radiation exposure by mammography [wa]s very low, [since the] 
radiation . . .delivered to the breast tissue [would need to be] 100–1000 times higher than 
[currently] used for mammography” (CBCF, 2014c, “Radiation by mammography 
causes,” para. 1). As such, in addition to the other previously mentioned benefits, it has 
been on this premise that support for screening mammography has continued. Several 
supporters have specifically indicated that the small dose radiation disadvantage of 
screening mammography is far outweighed by the advantage of early detection/diagnosis 
and treatment of breast cancer (CBCF, 2014c). 
Summary 
Canada-wide, the rates of cancer incidence and deaths were varied, and this was 
“because of differences in the type of population, risk factors (including risk behaviours), 
early detection practices, . . .cancer screening rates, and the availability and use of 
treatment [which differed] across the country” (CCS , 2014d, “Trends in cancer rates,” 
para. 1). The CCS indicated that the number of newly diagnosed cases as well as the 
survival rates, were increasing given the growth in Canadian cancer survivors (CCS, 
2014 et al., pp. 37–38; CCS et al., 2013, pp.35–36). This increase has been credited to 
early detection and screening and is in keeping with the underlining theme of the 
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communication campaigns that state “early detection saves lives” (CCO, 2011b, para. 1). 
Subsequently, there was noted active advocacy for population-based screening that uses 
mammography and MRI because it was rationalized as the “best early detection method 
available for reducing  deaths from breast cancer” (MHLTC, 2012b, “Can anything be 
done,” para. 3). Therefore the information presented to the Ontario public predominantly 
promoted breast cancer screening as advantageous.  
As a consequence of this unbalanced presentation of information less attention 
was given to the disadvantages associated with overdiagnosis, even though researchers in 
Canada (as early as 1992) were documented to have voiced concerns about the efficacy 
of mammography. These researchers were heavily criticized and largely ignored (Favaro, 
2012). However, in recent years, researchers have become more vocal in highlighting the 
potential implications of presenting information that is not comprehensive. These 
implications include (a) misrepresentation of facts; (b) misleading conclusions; and (c) 
physical, psychological, and economic harm resulting from overdiagnosis. As such a 
wide range of research findings, positing varying degrees of benefits and risks associated 
with breast cancer screening, have generated discussions that are now aimed at further 
determining whether or not breast screening results do less good or more harm. In this 
increasingly prevalent debate, the fundamental questions include (a) how significant are 
the benefits of screening (mammography), as measured by reduction in the mortality 
rates of breast cancer, and (b) how significant is the risk in relation to overdiagnosis 
(Cassels, n.d., para. 3–4)?  
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In a follow-up interview with Dr. Welch, one of two researchers of the Bleyer and 
Welch (2012) study, suggested that it appeared that mammography was over-promoted 
and was the only test in medicine that had been as aggressively sold (Favaro, 2012, para. 
10). Dr. Welch further noted that the communications about breast cancer screening 
provided “an unbalanced view  we over-state the benefits and understate or ignore [the] 
harms” (Favaro, 2012, para. 10). In support of Dr. Welch’s statement above, commentary 
made by Danish researcher Dr. Peter Gøtzsche, in the Canadian Medical Association 
Journal, pointed to growing evidence that was now nearly irrefutable that “compelling 
data from the US, Norway and Sweden show[ed] that most overdiagnosed tumors would 
have regressed spontaneously without treatment” (Cassels, n.d., para. 8). This above 
study, the subsequent interview, and Dr. Gotzsche’s comment offered insight into the 
rationale for clear and concise health care media communication campaign guidelines. 
Particularly, guidelines that promoted transparent and balanced representation of factual 
information for public sector consumption. For this research, an understanding of what 
screening participants value as important knowledge, would greater facilitate how the 
various Canadian cancer affiliate agencies and partnerships organize and utilize 
information in their media campaigns that promote public awareness of breast screening 
programs (OBSP).  
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Aside from outlining the theoretical framework (schema theory) that acted as a 
guide for this research, this chapter provided a synopsis of existing and salient literature 
related to the major considerations of this study. This review of literature formed the 
basis of this study. In particular, it provided an overview, background, and relevant 
research and data related to breast cancer screening, levels of screening participation, and 
contemporary understandings of key concepts such as overdiagnosis, false-positive, false-
negative, and radiation exposure associated with screening. Throughout most of the 
studies evaluated in this review, it was noted that there was consistent use of the RCT 
research design for examining overdiagnosis in breast screening programs, with the 
exception of two lead-time approached studies, one observational study, one retrospective 
research, and one qualitative designed approach. Several authors, including Black (2000), 
Brouwers et al. (2011), Marcus et al. (2000), Marcus & Prorok (1999), and Zackrisson et 
al. (2006) were noted to have used the RCT study design in their respective researches. 
Based on the CTFPHC (2014) report approximately: 
 
 32.90% (329 divided by 1,000 multiplied by 100) of women aged 40–49 years 
were noted as overdiagnosed (false-positive);  
 28.30% (283 divided by 1,000 multiplied by 100) were overdiagnosed among 
women 50–69 years; and  
 21.30% in women aged 70–74 years (213 divided by 1,000 multiplied by 100) 
were overdiagnosed (CTFPHC, 2014). 
Although women aged 40–49 years demonstrated a higher level of overdiagnosis 
(32.90%), women aged 50–69 years were still the most vulnerable to the effects of breast 
103 
 
 
cancer because, in real numbers as outlined above (see Table 2), more died from the 
disease. Based on the above data illustrated in the various researches and statistical 
reports, there was significant evidence that supported the relevance for conducting this 
research. This research examined the relationship between knowledge of overdiagnosis 
and breast cancer screening participation among women aged 50–69 years. Key 
researches that supported the selected sample population were demonstrated via the data 
outlined, and through the HIP study and Cancer Australia’s (2004) report. All the 
demonstrated findings served as strong evidence and support for the examination of 
screening for women aged 50–69 years.  
Each highlighted study was focused on different aspects of the topic under 
examination, but they all indirectly supported and formed the framework of this current 
research. The literature reviewed in this chapter created an opportunity to critically assess 
and consider how the currently aggressive (Favaro, 2012, para. 10) and unbalanced 
promotion of breast cancer screening, as being predominantly beneficial, had a direct or 
indirect relationship to the reported increases in rates of breast cancer screening 
participation. This, in turn, offered some perspective on the efficacy of current breast 
cancer statistics and the purported successes as a result of screening participation. This 
review also outlined the need for effective health communication that presented balanced 
information in an ethical manner and therefore allowed for informed decision-making on 
the part of screening participants.  
Chapter 3 provides an in-depth discussion of the methodology of the study, 
including the design. The chapter also addresses considerations of evidence quality, such 
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as credibility, reliability, and ethics. In addition, Chapter 3 concludes with an outline of 
the data collection method, the sample and setting, and the selected approach to analysis 
the data. Chapters 4 and 5 respectively provide (a) a detailed analysis of the study’s 
survey results, (b) explanations of how the results relate to the underlining theoretical 
framework, (c) overall conclusions of the study, and (d) recommendations for future 
research. 
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Chapter 3: Research Method 
Introduction 
The purpose of this research was to find out if a relationship exists between 
individual women’s knowledge of breast cancer overdiagnosis and their decision to 
participate in breast screening mammography. This chapter explores the research design 
and application relevant to answering the research question. To accomplish this, the 
chapter discusses the selected research design and the rationale for that selected design, 
provides a brief summary of the target population, and outlines of the selected sample 
and sampling strategies that were implemented. Also discussed are the processes 
established to recruit, collect, operationalize, and analyze the data. This specifically 
includes (a) the pilot test, (b) the recruitment methods, (c) the planned data collection 
procedures, (d) operationalization of key constructs, (e) assessments of the instruments 
and materials used, and (f) the data analysis plan. Also included are an examination of 
issues of validity, reliability, and credibility; an evaluation of the feasibility and 
appropriateness of the study; and an outline of considerations for ethics and informed 
consent. 
The combined elements of this chapters promote the notion that if decisions are 
made based on the information presented, then the current unbalanced information being 
provided about screening mammography does not afford women the opportunity to be 
informed decision-makers in the screening process. In order to ensure effective health 
communication about preventative health care options such as breast cancer screening, 
the information disseminated in media communiqués need to present balanced, accurate, 
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evidence-based, and relevant information on both the benefits and associated risks of 
breast screening programs. This study was accordingly designed to improve the 
understanding of how knowledge of overdiagnosis correlates with levels of participation 
for screening mammography. In other words, this research sought to explore the extent 
that knowledge of overdiagnosis corresponded with whether or not women aged 50–69 
years decide to get screened for breast cancer. In accordance with this research question 
and objective, a quantitative research methodology was selected. The specific research 
design used was a cross-sectional, correlational (nonexperimental) survey study. The 
target population for the study was limited to Ontario women aged 50–69 years. 
The established research question therefore asked: Is there a relationship between 
knowledge of overdiagnosis and the decision to participate in breast cancer screening 
among women aged 50–69 years? The main objective of this study was only to assess the 
correlation between the two quantitatively measured variables, without determining 
causality (cause and effect). The study, however, tested the working hypothesis that the 
more knowledge a woman has regarding the screening process, the more likely she is to 
participate in breast cancer screening. It also tested directional hypotheses to determine if 
there was a potentially predictive relationship between the independent and dependent 
variables. Schema theory, supplemented by the effective health communication model, 
provided the theoretical framework that guided this study. 
The survey instrument used to gather data for this study was a 5-point closed-
ended Likert-format questionnaire with responses that ranged from strongly disagree to 
strongly agree, as suggested by Trochim (2006). A pilot test was used to ensure the 
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reliability of the modified Champion Health Belief Model Scales (CHBMS) 45-item 
study survey instrument. This pilot test was used to specifically ensure the internal 
reliability of how the independent variable (knowledge of overdiagnosis) being measured 
was assessed; This variable was measured using a 21-item questionnaire that included 
basic background information and asked about knowledge of overdiagnosis and how 
information is presented regarding breast cancer screening. The reliability of Champion’s 
health belief model (HBM) scale, which was used to evaluate this study’s dependent 
variable, was not tested because this was previously validated by several studies, 
including Paraska (2012), Taymoori and Berry (2009), and Zelviene and Bogusevicius 
(2007). The complete study survey is reproduced in Appendix A.  
Two sample 2-sided t tests and logistic regressions were used to analyze the 
collected data and answer the research question and hypotheses. The findings of the study 
are presented below in several tables and figures that are discussed in further detail in the 
appendices. They collectively indicate a potentially predictive correlation between the 
study variables, leading to a recommendation for follow-up research to specifically assess 
this predictive potential. 
Research Design and Rationale 
A variety of factors needed to be considered in order to determine and justify the 
study’s research methodology and research design. These included but were not limited 
to (a) what did the study aim to accomplish, (b) how the identified study variables were 
measured, (c) what types of statistical analyzes were necessary to address the study’s 
objective, and (d) how I conducted the study in an ethical way to ensure internal and 
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external validity and reliability. One of the first steps to accomplishing clear 
rationalizations for the selected methodology and research design for this study was to 
start with a clear understanding of the key variables of the study. These key variables 
have been outlined in the research question and research hypotheses. 
Research Questions and Hypotheses 
The research questions and hypotheses were as follows 
Primary Research Question. Is there a relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years? 
Working hypothesis. The more knowledge a woman has regarding the screening 
process, the more likely she is to participate in breast cancer screening. 
Null Hypothesis. There is no relationship between knowledge of overdiagnosis 
and the decision to participate in breast cancer screening among women aged 50–69 
years. 
Alternate Hypothesis 1
A
. There is a positive relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years. 
Alternate Hypothesis 1
B
. There is a negative relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years. 
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Secondary Research Question. Is there a relationship between thoughts and 
attitudes on subsections of the survey (such as mammogram barriers) and the decision to 
participate in breast cancer screening among women aged 50–69 years? 
Variables for the Study 
There were three variables in this study. These variables included one nominal 
level, categorical (discrete), dichotomous (binary), variable, and one interval level, 
continuous variables. As well, there was one categorical level variable that was made into 
a binary variable. 
Independent Variables 
Knowledge of overdiagnosis was the key independent variable examined in this 
study. This variable was an interval-level variable that was created from the sum of the 
38 individual survey questions. Because this study investigated the correlation between 
knowing about overdiagnosis and deciding to participate in the breast screening process, 
this identified variable was appropriate for the study. Education level completed was a 
categorical-level variable with integer values of 0 to 5 (0 = None of the above, 1 = High 
School Diploma, 2 = College – Diploma/Certificate, 3 = Bachelor’s degree, 4 = Master’s 
Degree, and 5 = Doctoral Degree). This variable (educational level completed) was then 
transformed into a dichotomous variable, with 2 representing participants who graduated 
with a bachelor’s degree or higher and 1 representing those who graduated with a college 
diploma/certificate or less. 
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Dependent Variable  
The decision to participate in breast cancer screening was the dependent 
(outcome) variable. This variable, also defined in Chapters 1 and 2, was a binary variable, 
where answers were limited to yes/no (participated or did not participate in screening). 
As stated above, this study was focused on examining the relationship between decisions 
about screening mammography participation and a participant’s knowledge of 
overdiagnosis. Based on the structure of the research question, whereby the decision to 
participate in breast cancer screening followed the mention of knowledge of 
overdiagnosis, the implication of this sentence structure was that decisions about breast 
screening participation rely (depend) on the introduction of the concept of knowledge of 
overdiagnosis (the exposure variable) to illustrate any possible outcome. Therefore 
making it (any such decision about breast screening) the dependent variable.  
To answer the research question and test the outlined hypotheses, this study used 
a cross-sectional, correlational (nonexperimental, quantitative) survey (cohort) research 
design (Black, 2012; Salkind, 2010). This nonexperimental approach was appropriate 
because, as stated by Kerlinger (1986) (as cited by Black, 2012), ex post facto and 
correlative studies entail “systematic empirical inquiry in which the scientist does not 
have direct control of independent variables because their manifestations have already 
occurred or because they are inherently not manipulable, [as is the case with the study’s 
independent variable – knowledge of overdiagnosis]” (Black, 2012, p. 70). The selected 
research design offered the advantage of providing access to the target population being 
investigated in a time-efficient and cost-effective manner. An additional benefit of this 
111 
 
 
chosen research design was that it enabled the study’s finding to add current and location-
specific (Ontario, Greater Toronto Area, GTA) knowledge about the topic being 
examined. In addition, it also facilitated the examination of the nature of one—
information on overdiagnosis—of many real life factors that potentially correlate with 
screening mammography decision-making. The regression model purported in this study 
could act as a guide for the assessment of other correlations between other real-life 
factors that interact with and may influence decision-making about participating in 
programs that promote preventative health care (screening) for breast cancer. 
Operationalization of the Study Variables 
Operational definitions of the key variables, as outlined in Chapters 1 and 2, 
indicated that knowledge is “the fact or condition of knowing something with familiarity 
gained through experience or association; Acquaintance with or understanding of a 
science, art, or technique; The fact or condition of being aware of something” (Merriam-
Webster’s Online Dictionary, 2014a, para. 2–3). Overdiagnosis is the identification of a 
nonprogressive cancer and/or slow-growing cancer that has been identified correctly, but 
the disease would have never caused any sign or death during the lifetime of the 
diagnosed patient (Welch et al., 2011). Therefore, the predictor variable, knowledge of 
overdiagnosis, referred to indicators that an individual was familiar with (had an 
association/experience/acquaintance with) or had an understanding that, by participating 
in screening mammography, there was the possibility that a nonprogressive cancer and/or 
slow-growing cancer, identified correctly, would never caused any signs or death during 
the lifetime of that diagnosed patient. The research-specific 5-point Likert-format 
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questionnaire that was part of the overall survey instrument was used to evaluate this 
operational term.  
The outcome variable, decision to participate in breast cancer screening, related to 
a participant’s individual choice “to take part in or experience something [such as 
screening mammography”, (Merriam-Webster’s Online Dictionary, 2014b, Partake 
section, para. 1), which is an] x-ray of the breasts taken to check for breast cancer in the 
absence of signs or symptoms” (NCI, 2013a, Screening mammogram section, para. 1). 
This binary dependent variable was coded as follows: Decision to participate in breast 
cancer screening, PARTICIPATE, 0 = No, and 1 = Yes. The logistic regression model of 
these study variables produces coefficients (bi) which illustrate “change (increase when 
bi>0, decrease when bi<0) in the predicted logged odds of having the [outcome] of 
interest for a one-unit change in the [predictor] variables” (MedCalc, 2013, Regression 
coefficients section, para. 2). In these models, it is more common to take the exponential 
of the coefficient of the predictor thereby producing an odds ratio (Black, 2012; Long, 
1997; Pampel, 2000; Salkind, 2010; Starkweather & Herrington, 2012; Vogt, 2007).  
Research Methodology 
The section below offers details on the study’s target population, survey 
population, and sample size and power. Also outlined is information on the sampling 
strategy implemented to select survey participants within the target population. Following 
this section, information is provided on the pilot study, the recruitment approach, the data 
collection method, and the instrumentation and materials used to measure participants’ 
response to the survey questionnaire. 
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Survey Population and Setting 
It is important to note that in 2011 changes were made to the age parameter for 
potential Ontario breast screening participants. Outlined in more detail in Chapter 2, this 
change by the Ontario Breast Screening Program (OBSP) and the Local Health 
Integration Network (LHIN) enables Ontario women aged 30–69 years to access breast 
screening services. Prior to the July 1, 2011, announcement, eligible women for screening 
participation ranged from ages 50 to 74 years. Despite this expansion facilitating greater 
sociodemographic information and data collection from a wider spectrum, this study 
focused on data collected for women aged 50–69 years. This decision was made because 
the increased age range geared towards women 30–49 years are specific to those who are 
at higher risks of getting breast cancer due to family history and other preexisting 
conditions. Therefore any inclusion of this information would have potentially skew 
noted correlations observed.  
To the best of my knowledge there were no data that specifically outlined the 
percentage of women aged 50–69 years living in Ontario’s GTA. However, as this 
research was focused on the above outlined target population, the study sample was 
obtained from a population of Tropicana Community Services (TCS)’ recruited women 
aged 50–69 years who (a) lived in Ontario’s GTA (at the time of the survey); and (b) 
could read and write in English. Only participants who met the sampling criteria were 
included in this study. For this primary data collected a letter of cooperation was gained 
from TCS, and informed consent was implied from each participant that completed a 
survey and returned it to me. 
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Sample Size 
Because of the unique nature of the target population it was not possible to 
identify how many women met the study criteria for inclusion. Therefore any power 
analysis to determine adequate sample size was also not possible. However, despite this 
limitation this study had a sample of 41 participants. The selected number of participants 
exceeded those recommended by researchers Baumgartner et al. (2002) and Johnson and 
Christensen (2004) who each respectively contended that groups of 8–12 and 6–12 
participants were appropriate. 
Sampling Method 
I considered using stratified random (probability) sampling prior to determining 
that nonprobability, specifically, purposive (purposeful) sampling was optimal for this 
study. The stratified random (probability) sampling method would have reduced the 
chances of sampling error in the study—thus facilitating a greater possibility the sample 
was representative of the general population (Black, 2012, pp. 120–126). It would have 
also facilitated an increased reduction in sampling error because it allowed for the sample 
population to be separated into nonoverlapping groups (strata) along the relevant line of 
the study (Salkind, 2010). Stratified random sampling was not used as generalizations 
from sample population to target population were not key priorities of this study. 
Purposive sampling. In support of the purposive (purposeful) sampling strategy 
Patton (2002) noted that this sampling method was appropriate for studies with smaller 
sample sizes. Patton explained that this technique had the advantage of “selecting 
information-rich cases . . .[from] which one can learn a great deal about matters of 
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importance and therefore [making it] worthy of in-depth study” (pp. 242-244). Through 
the use of purposeful sampling, I was better able to eliminate survey participants who 
were not appropriate for inclusion in the survey—thus retaining only the most suitable 
ones. I was also able to reduce time and cost constraints—given the narrower focus on 
relevant candidates for inclusion. As well, I was able to (a) generate results that were 
more accurate than those achieved with an alternate form of sampling, and (b) identify 
members of the study’s cohort as there was no known list of Ontario GTA women aged 
50–69 years that could have been used to guide/locate appropriate survey participants. 
One key limitation of purposive sampling was that it was prone to researcher bias, 
thereby reducing the internal validity of the study. 
Recruitment, Data Collection, and Instrumentation 
Fundamental to scholarly research paper is the collection and analysis of data. 
Therefore, if data were inaccurate and/or missing, the results and subsequent analysis, 
conclusions, and recommendations are inappropriate. As such, it was important for me to 
create and conduct a study with results that had a high level of confidence. 
Pilot Study 
Before data were collected for this research, a pilot study of the 5-point closed-
ended Likert-format survey instrument was conducted among five participants from the 
target population. Pilot study participants were not incorporated in the actual study data 
collection. The questionnaire was piloted following official approvals—01-23-14-
0229219—from Walden University Institutional Review Board (IRB). To ensure the pilot 
recruiting strategy was similar to the method used for the actual study, purposeful 
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(purposive) sampling was used to recruit each pilot participant. The pilot survey was 
distributed and group administered to the eligible women who agreed to participate. Their 
implied consent was assumed based on their willingness to listen to the presentation and 
return a completed pilot test of the survey instrument (see Appendix D). This approach 
was decided on as it offered a more comparable approach to the recruitment and data 
collection procedures for the actual study survey. Note that members of the pilot study 
served the purpose of confirming whether the data collected from participants in the 
actual study would result in reliable measurements of the study variables (Thabane et al., 
2010; Van Teijlingen, Rennie, Hundley & Graham, 2001). Even though the pilot study 
was created to be comparable to the actual study there were slight differences in 
procedure for the pilot study relative to the actual study. These variations included (a) 
pilot participants were administered the survey at a facility not belonging to TCS; and (b) 
only five participants were recruited for the pilot survey as opposed to the 41 participants 
for the actual survey. 
Recruitment 
Given the study was based on primary data there was recruitment of human 
participants. To identify potential participants for the study’s survey, TCS (the research 
community partner) was engaged to send a letter of invitation to its network (to enlist 
participants for the study survey). Once weekly, this invitation was sent via the 
organization and its elected TCS representative’s email (in the capacity as TCS vice 
president). The letter of invitation was also circulated via the various channels used by 
the community partner. For example, calls were made to individuals in TSC’s network to 
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request their participation in the study’s survey. Also the invitation letter was (a) posted 
on community notice boards used by TCS, and in some of TCS’ partner magazines, 
newsletters, and electronic notice boards; and (b) distributed through several social media 
platforms. The invitation letter outlined general details of the purpose of the study and 
included the date, time, and location for survey completion.  
In addition, the invitation letter mentioned the distribution of $5 Canadian dollar 
gift cards to survey participants as a thank you once the surveys were completed and 
collected. I tracked all emailed RSVP replies and one day prior to the selected 
presentation date I informed the elected TCS representative to discontinue weekly 
recruiting efforts that used email invitations. For convenience and without cost to me, 
TCS offered use of a room at their GTA facility to accommodate the study presentation 
and survey completion. This was beneficial as the participants—many of whom were 
assumed to be associated and familiar with TCS and its’ location—found it more 
convenient to participate in and attend an information and questionnaire session, at a 
location that was familiar and accessible to them.  
As the research design was cross-sectional, the survey was conducted at one 
specified time. Prior to conducting the actual survey, all confirmed participants were 
required to read the informed consent form. This form was distributed on the day of the 
survey before the start of the information presentation and survey completion. All 
participants that attended the presentation and returned a completed survey instrument 
were noted as having given implied consent based on their actual participation. After 
participants were provided the informed consent form I briefly (a) outlined the purpose of 
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the study, (b) described what was expected of participants, (c) answered any remaining 
questions participants had, and (d) noted that once participants had completed their 
individual surveys they were free to return (to me) the completed surveys, collect their $5 
Canadian dollar gift card and leave.  
Following the above instructions I gave a concise presentation about breast cancer 
screening, its benefits and risks, including overdiagnosis. After the presentation, I 
distributed the survey instrument. As participants completed and returned their respective 
surveys they were free to leave. Note that before the registration, information 
presentation and survey completion, I was identified to participants as the study’s 
researcher. This approach was aimed at maintaining transparency and increasing the 
study’s internal validity by reducing some of the myriad testing and procedural biases.  
Data Collection 
The data collected included information about participants’ (a) health motivations 
when deciding whether to participate in screening mammography; and (b) level of 
knowledge of the benefits and risks of screening mammography (Çam & Gümüs, 2009; 
CCO, 2012d). This information was augmented by survey questions focused on each 
participants’ (a) background information that highlighted sociodemographic 
characteristics (such as, family history of cancer, age, educational level, prior knowledge 
of screening mammography, and so forth); (b) knowledge of overdiagnosis; and (c) 
feelings on how information regarding breast cancer screening is being presented. When 
considered from the perspective of the participant, the data gathered offered insights to 
and validation for the need for this study. As well, it enabled me to identify gaps in what 
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information was being collected, thus validating the need for further research on this 
topic.  
Instrumentation and Materials 
To measure the primary data and to verify the study’s construct validity, CHBMS 
was used. Champion (1993, 1999) initially developed and then later revised this scale. 
The scale specifically measures the health belief model paradigms associated with breast 
cancer and screening behaviors. Validity and reliability studies of this scale instrument 
have been conducted by several researchers across many countries. Some recent studies 
were conducted by Huaman, Kamimura-Nishimura, Kanamori, Sui, and Lescano (2011), 
Paraska (2012), Parsa, Kandiah, Mohd Nasir, Hejar, and Nor Afiah (2008), Taymoori and 
Berry (2009), and Zelviene and Bogusevicius (2007).  
Through the use of Cronbach’s alpha (α), the reliability and internal consistency 
of the CHBMS were measured (see Appendix B). According to the findings of Taymoori 
and Berry’s (2009) research, there was a reliability coefficient of 0.74 for general 
concerns related to mammography and 0.61 for preventive health practices related to 
mammography (p. 468). The sample population of the study consisted of 606 randomly-
selected employed women (aged 20–69 years) in Sanandaj, Iran. Another research that 
illustrated high reliability of the CHBMS was conducted by Huaman et al. (2011). This 
cross-sectional, Peru-based study looked at women aged 40 to 65 years who went to an 
outpatient gynecology public hospital in Lima, Peru. There were roughly 285 participants 
and Cronbach’s alpha confidents were 0.75 (susceptibility), 0.72 (benefits), and 0.86 
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(barriers) (Results section, para. 3). In Huaman et al.’s (2011) research, for the three 
dimensions, the test–retest Pearson correlation coefficient was higher than 0.6. 
The final study to be highlighted, that provided sufficient evidence that the 
CHBMS met the criteria for construct validity, was a pilot study developed by Paraska 
(2012). This research explored the relationship between variables in the expanded HBM 
and compliance with mammography screening among women with multiple sclerosis 
(MS) who were homebound. The sample population included approximately 260 women 
aged 40–74 years in Allegheny County, Pennsylvania, U.S. The reliability coefficient for 
knowledge of benefits and barriers to mammography screening was 0.79, with test–retest 
reliability of 0.75–0.88 (p. 144). The test–retest approach used by Huaman et al. (2011) 
and Paraska (2012) was not applied in this study. As noted by Black (2012) a Cronbach’s 
alpha reliability coefficient of 0.70 or higher is considered acceptable, indicating that it 
sufficiently measures reliability and internal consistency (see Appendix B). An 
instrument is considered to have validity if it measures the intended concepts.  
Champion’s HBM scale was designed based on the original HBM that was 
developed by researchers at the U.S. Public Health Services. The HBM has been used 
since the 1950s and provides ways of predicting and explaining health behaviors that are 
protective in nature (Champion, 1993; Naidoo & Wills, 2010; Stein, 2011). Champion’s 
revised HBM scale was described by Çam and Gümüs (2009) as 
a 53-item self-report measure, representing [eight] scales, namely: 
susceptibility to breast cancer (5 items); seriousness of breast cancer (7 items); 
benefits-BSE (6 items); barriers BSE (6 items); confidence (11 items); health 
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motivation (7 items); benefits mammography (6 items); and barriers 
mammography (5 items). All the items have 5 response choices ranging from 
strongly disagree (scores 1 point) to strongly agree (scores 5 points), which are 
basically a summation of the responses. Higher scores indicate stronger feelings 
related to that construct. All scales are positively related to screening behaviors 
except for barriers, which are negatively associated. (p. 51) 
The reliability and construct validity of CHBMS have been confirmed by several studies 
(Huaman et al., 2011; Paraska, 2012; Taymoori & Berry, 2009). This instrument was 
considered appropriate for this study because it (a) evaluated screening knowledge and 
behaviors, (b) highlighted health motivations; and (c) identified some aspects of how 
information presented related to the likelihood of action (decision-making to participate 
in screening). Figure 6 and Appendix F outline the general framework for the HBM that 
formed the basis of the CHBMS. 
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Figure 6. Diagram illustrating the health belief model. The model shows how 
individuals’ perceptions of susceptibility and severity to disease “X” in relation to 
demographic and sociopsychological considerations, and cues to action inform those 
individuals’ perception of threat levels from disease “X”. This in turn informs decisions 
on how to proceed. Adapted from “Health belief model” by Nursing Information, 2013, 
Retrieved from http://www.nursing-informatics.com/N4111/HBM.jpg. Copyright 2015 
by June Kamnski. 
 
Analysis of the Research Findings 
With the assistance of a statistician and the Statistical Package of the Social 
Sciences (SPSS) software, the data collected were analyzed using two sample 2-sided t 
tests and regression analysis, specifically logistic regression. Logistic regression explains 
the correlation between the study’s dichotomous, dependent (response or outcome) 
variable and one or more continuous or categorical independent (predictor or 
explanatory) variables. Logistic regression therefore helped to provide understanding of 
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the associations and strengths between the study variables. Some of the assumptions of 
logistic regression include  
[The] functional form of the equation is correct, and hence, the predictors [xi] are 
linearly and additively related to logit(Y), but variables can be transformed to 
adjust for nonadditivity and nonlinearity [(for example,] nonlinearly transformed 
predictors or interaction terms); each case is independent of all the other cases in 
the sample, or, when cases are not independent, adjustments can be made in either 
the estimation procedure or the calculation of standard errors (or both) to adjust 
for the nonindependence; like linear regression, [the variables were] measured 
without error—all relevant predictors are included in the analysis (otherwise 
[there might be biases in the logistic regression coefficient)—]and that no 
irrelevant predictors are included in the analysis [(or else] standard errors of the 
logistic regression coefficients [might have been] inflated); no predictor may be 
perfectly collinear with one or more of the other predictors in the model, because 
perfect collinearity [occurs when] a predictor is completely determined by or 
predictable from one or more other predictors, and, when perfect collinearity 
exists, an infinite number of solutions [is available] that maximize the likelihood 
in ML estimation or minimize errors of prediction more generally; [and the] errors 
in prediction have a binomial distribution, but when the number of cases is large, 
the binomial distribution approximates the normal distribution. (Salkind, 2010, 
“Assumptions of logistic regression,” para.1)  
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As outlined by Salkind (2010) 
The equation for the logistic regression model with a dichotomous outcome is 
logit (Y) = α + β1X1 + β2X2 + . . . + βKXK, where Y is the dichotomous outcome; 
logit(Y) is the natural logarithm of the odds of Y, a transformation of Y to be 
discussed in more detail momentarily; and there are k = 1, 2, . . . , K predictors XK 
with associated coefficients βk, plus a constant or intercept α, which represents the 
value of logit(Y) when all of the XK are equal to zero. If the two categories of the 
outcome are coded 1 and 0, respectively, and P1 is the probability of being in the 
category coded as 1, and P0 is the probability of being in the category coded as 0, 
then the odds of being in category 1 are P1/P0 = P1/(1- P1) (because the probability 
of being in one category is one minus the probability of being in the other 
category). Logit(Y) is the natural logarithm of the odds, 1n[P1/(1- P1)], where ln 
represents the natural logarithm transformation. (“Logistic regression, loglinear 
analysis,” para. 2)  
In the (logistic regression) model, “the dependent variable [also referred to as Bernoulli 
variable] take either the value 1 with a probability of success , or the value of 0 with the 
probability of failure 1- ” (Information Retrieval Blog, 2013, The model section, para. 
1). Thus  
Logistic regression generates the coefficients (and its standard errors and 
significance levels) of a formula to predict a logit transformation of the 
probability of presence of the [dependent variable] 
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where p is the probability of presence of the [dependent variable]. The logit 
transformation is defined as the logged odds 
  
and 
 . (MedCalc, 2013, Description section, para. 1–3) 
In this study, the dependent variable, decision to participate in breast cancer 
screening, (PARTICIPATE) took the value 0 = No, and 1 = Yes. In essence, the research 
question asked was then answered through logistic regression analysis, because this type 
of regression analysis provided answers to the question: what was the expected 
transformation in the outcome variable for a one-unit transformation in X (the 
independent variable)? Keep in mind that the dependent variable log of odds (not the 
probability)—the value 1 = Yes—occurred (Vogt, 2007, p. 206). Note carefully that even 
though a logistic regression model has many similarities to a simple linear regression 
model, the core distribution is binomial. Also note that the parameters for each model 
(linear versus logistic) were estimated differently. In ordinary linear regression, the best 
linear model attempts to minimize the distance measured vertically (the parameter) 
between the observation point and the model line. While in logistic regression, the 
opposite is true, the logistic model finds parameters that enhance the conditional 
probability of detecting the sample values (MedCalc, 2013).  
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As outlined earlier in the chapter, logistic regression does not make assumptions 
about the independent variables’ distribution. It need not be normally distributed, nor 
does it have to be linearly related, or of equal variance in each group. The correlation 
between the predictor and outcome variables is not a direct “function in logistic 
regression. [Rather] the logistic regression function is used, which is the logit 
transformation of 
 
where α = the constant of the equation, and β = the coefficient of the [independent] 
variables” (Information Retrieval Blog, 2013, The model section, para. 2–3). The 
significance of the overall logistic regression model is assessed using a maximum 
likelihood-ratio test. The maximum likelihood-ratio test is a type of chi-squared statistical 
test used to compare the fit of two models (the null model in which no variables are 
significantly related to the outcome and the alternative model in which one or more 
variables are significantly related to the outcome). It assesses how many times more 
likely the data were present in one model rather than the other. This likelihood-ratio, or 
equivalently its logarithm, was used to calculate a p value, or was compared to a critical 
value to evaluate whether or not the null model was rejected in favor of the alternative 
model (Black, 2012; Vogt, 2007). 
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Maximum likelihood-ratio test (also considered the Likelihood ratio [LR] Chi-
square test) was selected because the logistic regression analysis approach was used to 
examine the data. The likelihood-ratio test (often denoted by D) used:  
The ratio of the maximized value of the likelihood function for the full model (L1) 
over the maximized value of the likelihood function for the simpler model (L0). 
The likelihood-ratio test statistic equals 
 
This log transformation of the likelihood functions [yielded] a chi-squared 
statistic. (Information Retrieval Blog, 2013, Likelihood-ratio test section, para. 1–
 2) 
It was noted by Agresti (1996) that a Wald test is less reliable than likelihood-ratio tests, 
particularly as it relates to small sample sizes. SAS Institute Inc. (2013) also indicated 
that the likelihood-ratio test is preferable—unless computational demands make it 
impractical to refit the model—to the Wald test, as it provides an asymptotically more 
powerful and reliable test. Based on these above reasons the maximum likelihood-ratio 
test was deemed the more appropriate of the two options for this study survey given the 
limitation of sourcing a large participant sample size. Ultimately, these two statistical 
tests— two sample 2-sided t test and logistic regression,—were conducted, because each 
helped to explore the different relationships of interest stated in the research hypotheses. 
The following statistical tests: Point biserial correlation coefficient, Wald test, Pearson’s 
chi-square (X
2
) (also referred to as chi-squared), Fisher’s exact, t tests, Pearson’s 
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correlation coefficient (Pearson’s r), McNemar’s tests, Spearman rho, Kendall tau, 
Hosmer-Lemshow goodness of fit test, among others, were not selected because they 
were less desirable tests, given the parameters of the study variables (Black, 2012; Vogt, 
2007; Salkind, 2010).  
The analyzes in this study follow the standard level of significance, 5% (0.05), 
and therefore for p values lower than or equal to this significance level, the null 
hypothesis was rejected at that level. Following this rule, the study’s p value was used to 
determine that the null hypothesis—there is no relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years—was to be rejected. The nature of correlational studies is that, in their 
examination of relationships between the independent and dependent variables, the 
possibility exists for confounding factors, a threat to internal validity. How this study 
addressed this problem was through logistic regression.  
Logistic regression enabled the identification of the relative strength of the 
predictor variable adjusting for the confounder, educational level completed. Educational 
level completed was converted to a binary variable with 2 representing those who 
graduated with a bachelor’s degree or higher and 1 representing others who graduated 
with a college diploma/certificate or less. From an external validity perspective, the study 
did not attempt to provide generalizations of the findings across the population of interest 
(women aged 50–69 years). But rather it attempted to find in-depth (information-rich) 
data to justify the need for further research on this topic. The maximum likelihood-ratio 
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test was appropriate because the study sample size for this statistical test was small 
(Agresti, 1996). 
Validity, Reliability, and Credibility 
Several threats to external and internal validity were addressed above; However, 
other threats included construct validity. Two such threats were mono-operation bias and 
mono-method bias. Mono-operation bias, a threat to measurement procedure relative to 
the independent variable, cause, program or treatment in a research—it does not pertain 
to measures or outcomes. To address mono-operation bias, relevant studies that assessed 
the validity and reliability of the CHBMS were examined. Additionally, Appendix B 
outlines the Cronbach’s alpha test for reliability for the individual scales selected from 
the CHBMS. Mono-method bias, considers the measures or observations, not to programs 
or causes. Otherwise, it was essentially the same issue as mono-operation bias. Mono-
method bias was addressed using a pilot study that was conducted before the main study 
survey to make sure that the measures established for the study’s instrument survey were 
reliable and operated in practical terms, as suggested by Trochim (2006).   
Based on the nature and design of this study there were some threats to internal 
validity. According to Babbie (2007) such threats include compensatory rivalry and 
experimental mortality. Because the main point of this study was to measure 
association/relationship between variables—rather than to compare levels of association 
between the study target sample and a control group—compensatory rivalry did not exist. 
Additionally, as the survey instrument was administered and completed at one point in 
time (cross-sectional research design), experimental mortality also did not exist (Babbie, 
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2007). However, other threats to internal validity that needed to be addressed in the study 
were selection bias and instrumentation. Selection bias in some regard was unavoidable, 
given the (purposeful) sampling strategy. The individuals who agreed to participate in the 
study survey may not have been representative of the population. Instrumentation issues 
within the study were predominantly addressed by Champion (1999) and found to be 
within acceptable limits. To address further concerns of instrumentation bias because of 
the research-specific 21-item questionnaire that was created, a pilot study was conducted. 
The validity, reliability, and credibility of the primary data used in this study were 
verified through the various statistical tests aimed at assessing (a) n—sample size—, 1-
β—statistical power—, and α—size effect—; and (b) internal, external, and construct 
validity, all of which served the purpose of confirming the level of efficacy and accuracy 
implemented in conducting this study. The credibility of the secondary data sources—that 
were the foundation of Chapter 2—laid in the fact that they had been used by many 
experts in the health care field studying the topic of breast cancer and breast cancer 
screening. The OBSP, in the context of Ontario, Canada, is the foremost expert source for 
statistical data on cancer in general, and breast cancer specifically. Via the OBSP, 
information presented by the Cancer Care Ontario (CCO) is based on the same data this 
research used in the review of literature. The repeated and frequent use of the OBSP as a 
key source for breast cancer information lends itself to continual scrutiny, resulting in 
maintained and/or enhanced validity and reliability; secondary data were data easily 
assessable for replicability (McNabb, 2008). 
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Notwithstanding all the other threats to validity, reliability, and credibility already 
outlined, statistical conclusion validity was the key threat for studies of this nature. This 
was a key threat because there was a possibility that the measured proportions was not 
sufficiently far apart to allow a conclusion. Therefore this indicated a small bias or a 
widely spread distribution. Statistical conclusion validity looked at how correct or 
reasonable statistical conclusions were about the degree to which there actually existed a 
relationship (correlation) between the study variables. In essence, it looked at whether the 
study resulted in a Type I—false positive (finding a correlation even though one did not 
exist)—or Type II error—false negative (finding no correlation even though one did 
exist). Finally, the last consideration of statistical conclusion validity was whether the 
results revealed no statistically significant bias in either direction. For any of these above 
noted statistical outcomes, a study conclusion was still possible. These study conclusions 
included (a) women aged 50–69 years were highly knowledgeable of overdiagnosis when 
making decisions to participate in breast cancer screening, (b) women aged 50–69 years 
had limited knowledge of overdiagnosis when making decisions to participate in breast 
cancer screening, or (c) women aged 50–69 years had no knowledge of overdiagnosis 
when making decisions to participate in breast cancer screening.  
Feasibility and Appropriateness of the Study 
The use of a cross-sectional survey approach, with the assistance of TCS (the 
community partner) who has a strong presence in the GTA of Ontario, was an effective 
way to find participants quickly. The research survey was hosted and administered (free 
of cost) in TCS’ GTA facility. Overall costs were minimal because pilot test participants 
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and actual survey participants were not paid. Participants were however given gifts cards 
valued at $5 Canadian dollar each as a thank you. I was solely responsible for all costs 
associated with the completion of this study. 
Ethical Considerations and Informed Consent  
Any research study that involves human participation requires the approval of the 
Institutional Review Board (IRB). I did not contact the participants for the study survey 
until approval (01–23–14-0229219) was given by Walden University’s IRB. The IRB’s 
purpose is to help protect all participants in the study, including the researcher, and to 
ensure no harm, either physical or mental, to any participant. Although direct contact was 
made with human participants, no adverse effects for any beneficiary, county, or 
participant occurred from the results of this study. However, as with all studies using 
primary data, there were participant concerns regarding anonymity and confidentially, 
therefore no patient identifiers were used in this study.  
Anonymity is a strong guarantee of privacy for the individual patients in the 
collected data, but not for the cancer organizations in this study (Trochim & Donnelly, 
2008). This was the case for those cancer organizations identified in Chapter 2 as sources 
of secondary data. Given the accessed data were publicly available, it was my belief and 
assumption that each cancer organization understood that studies conducted utilizing that 
freely accessible information/data would be made public at the time of submission. The 
primary data gathered were accessible only on my personal computer that was password 
protected at all times. I was not required to return or destroy any data publicly accessed 
or collected via the survey instrument as the information gathered was my property and 
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not that of the community partner. However, the information will be sourced for 5 years 
following the completion of this study, as is the requirement of Walden University. 
There was no conflict of interest in the conducting of this study, as I was in no 
way affiliated with the community partner whose membership network and facilitates 
were used to gather the data analyzed. Also there was no conflict of interest regarding the 
use of TCS’ facilities to conduct the survey as the organization’s resources are available 
without cost to anyone requesting its use. Additionally, I did not work in the public sector 
or any health care sector, including those related to cancer prevention or treatment. 
Finally, this topic had no personal (sentimental) value that unduly influenced or biased 
my assessments of the study findings. 
Summary and Transition 
The purpose of this chapter was to identify the research methodology and research 
design used for the study. The study’s population and setting, sampling strategy, data 
collection method, data analysis plan, instrumentation, and ethical considerations were 
outlined. Descriptions of how the research attempted to maintain validity, reliability, and 
credibility were also provided. As discussed in this chapter, the cross-sectional, 
correlational (nonexperimental, quantitative) research design was implemented to 
examine the relationship between overdiagnosis knowledge and decisions to participate 
in breast screening programs among women aged 50–69 years.  
In Chapter 4 the results of the study’s survey instrument is outlined along with a 
detailed report of the descriptive and inferential analyzes conducted. Also included is an 
interpretation of the working and directional hypotheses discussed in this chapter. As 
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appropriate, findings are illustrated in the form of tables and figures. Chapter 5 gives an 
overview of the study’s key findings. This chapter also provides the results of the study in 
relation to the theoretical foundation (the effective health communication model and 
schema theory). Final recommendations on future research is outlined as well as the 
implications for positive social change.  
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Chapter 4: Results 
Introduction 
This study implemented a cross-sectional, correlational (nonexperimental, 
quantitative) research design grounded in schema theory and the effective health 
communication model. The study examined the existence of a relationship between 
knowledge of overdiagnosis and decisions to participate in breast cancer screening 
programs, among women aged 50–69 years. To accomplish this analysis, primary data 
were collected using a 45-item closed-ended Likert-format group administered survey 
instrument (see Appendix A). The study survey instrument specifically measured each 
participant’s knowledge levels of (a) breast cancer screening and its associated benefits 
and risks, (b) what motivated their health-related decision-making, and (c) overdiagnosis. 
In addition, the survey evaluated opinions on how information related to breast cancer 
screening is presented. Survey data were analyzed using two sample 2-sided t tests and 
logistic regression models. 
As outlined in Chapter 2, the Ontario public has predominantly been presented 
with information about breast cancer screening as being advantageous, while less 
attention has been given to such disadvantages as false positives, false negatives, 
mammography-related radiation exposure, and considerations of overdiagnosis. Breast 
cancer-related overdiagnosis was a focus of this study. Researchers in Canada voiced 
concerns about the efficacy of mammography as early as 1992, but were strongly 
criticized and have been largely ignored (Favaro, 2012). This status quo of an unbalanced 
presentation of information about screening mammography still persists in Canada today.  
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This chapter presents information on the research question and hypotheses, the 
pilot test, the recruitment phase and response rates, and the data collection process. In 
addition, participants’ demographic information are outlined. Finally, the findings of the 
descriptive and inferential statistical analyzes conducted are presented. 
Primary Research Question 
Is there a relationship between knowledge of overdiagnosis and the decision to 
participate in breast cancer screening among women aged 50–69 years? 
Working Hypothesis 
The more knowledge a woman has regarding the screening process, the more 
likely she is to participate in breast cancer screening. 
Null Hypothesis. There is no relationship between knowledge of overdiagnosis 
and the decision to participate in breast cancer screening among women aged 50–69 
years. 
Alternate Hypothesis 1
A
. There is a positive relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years. 
Alternate Hypothesis 1
B
. There is a negative relationship between knowledge of 
overdiagnosis and the decision to participate in breast cancer screening among women 
aged 50–69 years. 
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Secondary Research Question  
Is there a relationship between thoughts and attitudes on subsections of the survey 
such as mammogram barriers and the decision to participate in breast cancer screening 
among women aged 50–69 years? 
Findings of the Pilot Study 
After receiving approval to conduct the study from Walden University’s 
Institutional Review Board (IRB), I first conducted a pilot test to verify the validity and 
reliability of the entire survey instrument. This pilot study specifically assessed the 
validity and reliability of the two supplementary scales I created. Cronbach’s alpha (α) 
was not calculated given the small number of pilot test participants (five). However, the 
face validity of the survey instrument was confirmed by the pilot participants, who 
indicated that they felt the survey covered the concepts it purported to measure. Based on 
this face validity, no revisions to the survey instrument were deemed necessary. 
Data Collection 
The collection of data commenced following the official receipt of Walden 
University IRB approval (Approval #01-23-14-0229219 on September 17, 2014) that 
clearly outlined the parameters that the study needed to maintain in order to appropriately 
address the various ethical considerations. The participant recruitment and data collection 
process for both the pilot test and actual survey took 18 days from September 17, 2014 to 
October 4, 2014. A variety of communication platforms were used during this time to 
post and distribute the electronic and printed letters of invitations. As part of the 
recruiting process, I tracked all advance RSVPs via my Walden University email. Prior to 
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conducting the actual study on October 4, 2014, a pilot test was held on September 22, 
2014. Overall, 41 women aged 50–69 years participated in the research survey, not 
including the five women who had participated in the pilot test.  
Recruitment Approach in the Greater Toronto Area (GTA) 
The data were collected according to the plan outlined in Chapter 3. The research 
sample was recruited with the assistance of my community partner’s elected 
representative. The research sample consisted entirely of women aged 50–69 years who 
lived in the GTA and were able to read and write in English. Ontario’s GTA covers 
roughly 2,751 square miles, 24 municipalities, and at the time of the study had a 
population of more than six million people. The GTA is bordered by the Niagara 
Escarpment to the west, Kawartha Lakes to the east, Lake Simcoe to the north, and Lake 
Ontario to the south (Statistics Canada, 2011). From September 17, 2014 to October 3, 
2014 the representative elect from Tropicana Community Services (TCS) distributed the 
study’s electronic invitation letters through various social media including Facebook, 
LinkedIn, Twitter, Instagram, and MailChimp. In addition, I posted printed invites on 
several community notice boards throughout the GTA, specifically in North York, 
Scarborough, Etobicoke, East York, and Downtown Toronto. Finally, on October 2, 2014 
the research survey was announced in The Caribbean Camera newspaper (see 
Appendix G).  
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Descriptive Analysis of the Survey Sample 
Background Characteristics of Survey Participants 
Thirty-two (78.05%) of the 41 survey participants had no family history of breast 
cancer (see Figure 7 and Figure 8). Despite having no family history of breast cancer, 33 
participants (80.49%) noted that they had previously participated in breast screening 
programs (see Table 3). A breakdown of the number and percentage of respondents who 
have previously participated in breast cancer screening (BCS) is shown in Table 3. The 
statistics outlined below therefore raise the question of why more women aged 50–69 
years still opted to get screening regardless of not having a family history of breast 
cancer. As noted by the Ontario Ministry of Health and Long-Term Care (MHLTC), 
Cancer Care Ontario (CCO), the Canadian Cancer Society (CCS), the Public Health 
Agency of Canada (PHAC), the Canadian Breast Cancer Foundation (CBCF), among 
others, a family history of the disease is associated with a higher risk of breast cancer. As 
this risk factor is part of the information presented to GTA Ontario women, follow-up 
questions were posed, asking what other factors are prompting women to still participate 
in screening mammography, and, of those factors, how significantly not having a 
balanced presentation of information on breast screening programs’ benefits and risks 
influenced their decisions.  
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Figure 7. A pie chart showing the participants’ family history of breast cancer. Of all the 
survey participants (n = 41), 78.05% had a family history of breast cancer, 19.51% had 
no family history of the disease, and the remaining 2.44% did not know if there was a 
family history of breast cancer.  
 
Table 3 
Previous Participation in Breast Cancer Screening (BCS) (n = 41) 
Previous Participation in BCS Frequency Percent 
No 8 19.51 
Yes 33 80.49 
Total 41 100 
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Figure 8. A pie chart of previous participation in breast cancer screening (BCS). This 
figure illustrates that of the sample size (n = 41), 80.49% (33) participants had previously 
participated in BCS prior to taking part in the research survey. The remaining 19.51% (8) 
participants had not participated in BCS before the study presentation/survey. 
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Figure 9 revealed that 58.54% of the survey participants had more than 15 years 
knowledge of screening mammography, and 26.83% had between 6–10 years of breast 
cancer screening knowledge. Overall the indication was that on average participants had 
11–15 years of knowledge of breast cancer screening even though 75.61% (31 
participants) had either no knowledge (none) or limited knowledge (novice level) of 
overdiagnosis in breast cancer screening prior to the survey presentation (see Figure 10). 
Based on the above outlined result, even though 85.37% of the survey sample had more 
than six years knowledge of screening mammograms (see Figure 9), 75.61% had 
no/limited knowledge of overdiagnosis (see Figure 10). This result therefore supported 
the notion that current information presenting breast screening programs to GTA Ontario 
residents (as the literature in Chapters 1 and 2 suggested) is not balanced. Hence 
participants in the screening mammography programs are making health-related 
decisions without being properly informed. As noted by Giordano et al. (2006) this issue 
needs to be addressed because effective health communication entails the disclosure of 
both the benefits and risks of an intervention so potential users of that intervention can 
make decisions based on having all the necessary information pertaining to that 
intervention. 
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Figure 9. A histogram of each participants’ knowledge of breast cancer screening 
measured in years. The figure shows that 24 of the survey participants had more than 15 
years’ knowledge of screening mammography, while three had between 6–10 years, 
another 11 had between 1–5 years, and three had less than 1 year’s knowledge of BCS. 
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Figure 10. A histogram of each participants’ knowledge level of overdiagnosis before the 
research survey presentation. Prior to the research survey presentation 19 survey 
participants had no knowledge (none) of overdiagnosis in BCS, 12 had limited 
knowledge (novice level), seven had satisfactory knowledge (intermediate level), and 
three had comprehensive knowledge (advanced level) of overdiagnosis in BCS. 
 
In Figure 11, 40 (97.56%) of the participants had completed between high school 
to doctoral level education, and one participant (2.44%) had completed none of the above 
education levels. The survey sample’s result (see Figure 11) indicated that on average 
survey participants had either college–diploma/certificate or bachelors’ level education. 
The implication of this was that although the major of breast screening participants were 
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educated, they still have limited and/or no knowledge of overdiagnosis being an 
associated risk of breast cancer screening. The results showcased that a majority of 
survey participants still had limited and/or no knowledge of overdiagnosis in the 
screening process (see Figure 10), despite them having either college–diploma/certificate 
or bachelors level education (see Figure 11) and more than six years of knowledge of 
screening mammograms (see Figure 9).  
  
 
Figure 11. Bar chart showing the participants’ highest levels of education completed. Of 
the sample size (n = 41), 2.44% had completed education at the doctoral level, 17.07% at 
the master’s degree level, 26.83% at the bachelor’s degree, another 26.83% had a college 
diploma/certificate, and the remaining 2.44% had not completed any of the educational 
levels previously identified. 
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As outlined in Table 4, seven (13.2%) participants learned about screening 
through print media. Eight (15.1%) learned about screening via electronic media and 21 
(39.6%) using in-person contact. Finally 17 (32.1%) participants used all channels 
mentioned above as a means of learning of breast screening. These findings show that in 
51.2% of the cases participants learned about screening mammograms through in-person 
contact (via face-to-face, telephone, email with friends, family, health care professionals, 
etc.). However, 41.5% of the times a combination of print, electronic and in-person 
contact was used to learn about information related to breast cancer screening. 
Table 4 
Descriptive Statistics of the Communication Channels Participants Used to Learn About 
Breast Cancer Screening (BCS) 
Communication Channel Used to Learn About BCS 
Responses % of Cases 
n % 
Media participant 
learned about 
Breast Cancer 
Screening (BCS)
a
 
Q.6a - Participant learned about BCS 
through print media 7 13.2% 17.1% 
Q.6b - Participant learned about BCS 
through electronic media 8 15.1% 19.5% 
Q.6d - Participant learned about BCS 
through in-person contact 21 39.6% 51.2% 
Q.6e - Participant learned about BCS 
through all of the above media 17 32.1% 41.5% 
Total  53 100.0% 129.3% 
Note. a. Dichotomy group tabulated at value 1.  
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Inferential Analysis of the Survey Sample 
The consistency of the 38 question survey was assessed using a Cronbach’s alpha 
statistic. Values of Cronbach’s alpha greater than 0.7 are required for early research work 
(Black, 2012; Nunnally, 1978, p. 245). The Cronbach’s alpha for this survey was 0.79. 
This shows good consistency and as such allows the creation of summary scores. A total 
score was created as the sum of the 38 questions. To ensure that all questions were 
worded such that the highest score represents a positive response, the questions in the 
mammogram barriers section were reverse scored. Three questions in the knowledge of 
overdiagnosis section were also reversed. The total survey sum score can have a 
theoretical range of 38 (responses are all 1’s) to 190 (responses are all 5’s). One 
participant was missing two responses and for this individual their mean score on the 
section was substituted. A two sample 2-sided t test was first run to compare the total 
survey score between those who participated in BCS to those who did not participate in 
BCS. This study found that those who previously participated in breast cancer screening 
had statistically significantly higher total overall survey score (M =149.12, SD =12.07) 
compared to those who did not (M =134.88, SD =11.06), t(39) = -3.04, p = 0.004 (see 
Table 5).  
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Table 5 
Two Samples t-Test Results of Total Overall Survey Score Between Two Groups (n = 41)  
 Previous participation in BCS 
 No SD Yes SD t df 
Total Overall Survey Score 134.88 11.06 149.12 12.06 -3.04** 39 
 
Note. * = p < .05, ** = p < .01, *** = p < .001.  
 
A logistic regression analysis was conducted to predict whether patients had 
previous breast cancer screening using education level completed and total overall survey 
score as predictors. The logistic regression model was statistically significant, χ2(2) = 
11.08, p = .004. The model explained 37.8% (Nagelkerke R
2
) of the variance in previous 
breast cancer screening. The p value demonstrated that only total overall survey score 
made a significant contribution to prediction (p = .007) of past breast cancer screening 
(see Table 6). The odds ratio (OR) indicates that when total overall survey score is 
increased by one unit (i.e. becomes more positive towards screening), the patient is 1.14 
times more likely to have had previous breast cancer screening (95% confidence interval 
1.03-1.25). Education level completed was not a significant predictor (p = 0.14). 
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Table 6 
Multivariable Analysis Using Logistic Regression To Predict the Previous Breast Cancer 
Screening Based on Total Overall Survey Score and Education Level Completed (N = 41) 
Variable OR 95% CI B SE Wald df p 
Constant .00  -17.32 6.83 6.43 1 .011 
Education Level 
Completed (2 vs 1) 
4.82 0.61-38.02 1.57 1.05 2.23 1 .14 
Total Overall Survey Score 1.14 1.03-1.25 .13 .05 7.08 1 .007 
 
Note. The variable education level completed was made into a binary variable where 
participants who graduated with a bachelor’s degree or higher = 2 and college 
diploma/certificate or less = 1. 
 
The consistency of the six mammogram benefit section questions was assessed 
using a Cronbach’s alpha statistic. Values of Cronbach’s alpha greater than 0.7 are 
required for early research work (Black, 2012; Nunnally, 1978, p. 245). The Cronbach’s 
alpha was 0.74. This shows good consistency and allows the creation of summary scores. 
A total score was created as the sum of the six questions. This score can have a 
theoretical range of six (responses are all 1’s) to 30 (responses are all 5’s). A two sample 
2-sided t test was first run to compare the total mammogram benefits score between those 
who participated in BCS to those who did not participate in BCS. This study found that 
there is no statistically significant difference in total mammogram benefit scores between 
those who previously participated in breast cancer screening (M = 21.76, SD = 4.75) and 
those who did not (M = 20.25, SD = 4.46), t(39)  = - 0.72, p = 0.42 (see Table 7). 
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Table 7 
Two Samples t-Test Results of Total Mammogram Benefit Score Between Two Groups 
(n = 41)  
 Previous participation in BCS 
 No SD Yes SD t df 
Total Benefit Score 20.25 4.46 21.76 4.75 -0.82 39 
 
A logistic regression analysis was conducted to predict whether patients had 
previous breast cancer screening using education level completed and total mammogram 
benefit score as predictors. The logistic regression model was not statistically significant, 
χ2(2) = 1.482, p = .477. The model explained only 5.7% (Nagelkerke R2) of the variance 
in previous breast cancer screening. The p values demonstrated that neither total 
mammogram benefit score nor education level completed made a significant contribution 
to prediction (p = .29 and p = .38 respectively, see Table 9). This is also shown with the 
odds ratio findings for total mammogram benefit score (OR = 1.07, 95% CI = 0.92-1.34) 
and education level completed (OR = 2.19, 95% CI = 0.38-12.79) whose confidence 
intervals contain the null value of one.  
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Table 8 
Multivariable Analysis Using Logistic Regression To Predict the Previous Breast Cancer 
Screening Based on Total Mammogram Benefit Score and Education Level Completed 
(N = 41) 
Variable OR 95% CI B SE Wald df p 
Constant .371  -1.06 2.20 .23 1 .63 
Education Level 
Completed (2 vs 1) 
2.19 0.38-12.79 .78 .90 .76 1 .38 
Total Benefit Score 1.07 0.92-1.34 .10 .09 1.11 1 .29 
 
Note. The variable education level completed was made into a binary variable where 
participants who graduated with a bachelor’s degree or higher = 2 and college 
diploma/certificate or less = 1. 
 
The consistency of the 11 mammogram barriers section questions was assessed 
using a Cronbach’s alpha statistic. Values of Cronbach’s alpha greater than 0.7 are 
required for early research work (Black, 2012; Nunnally, 1978, p. 245). The Cronbach’s 
alpha was 0.81 which shows good consistency and allows the creation of summary 
scores. A total mammogram barrier score was created as the sum of the 11 questions. 
This score can have a theoretical range of 11 (responses are all 1’s) to 55 (responses are 
all 5’s). A two sample 2-sided t test was first run to compare the total mammogram 
barriers score between those who participated in BCS to those who did not participate in 
BCS. This study found that those who previously participated in breast cancer screening 
had statistically significantly higher total overall mammogram barrier score (M = 47.97, 
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SD = 5.66) compared to those who did not (M = 40.50, SD = 3.38), t(39) = -3.56, 
p = 0.001 (see Table 9).  
Table 9 
Two Samples t-Test Results of Total Mammogram Barrier Score Between Two Groups 
(n = 41) 
 Previous participation in BCS 
 No SD Yes SD t df 
Total Barrier Score 40.50 3.38 47.97 5.66 -3.56** 39 
 
Note. * = p < .05, ** = p < .01, *** = p < .001. 
 
A logistic regression analysis was conducted to predict whether patients had 
previous breast cancer screening using education level completed and total mammogram 
barrier score as predictors. The logistic regression model was statistically significant, 
χ2(2) = 11.24, p =.004. The model explained 38.2% (Nagelkerke R2) of the variance in 
previous breast cancer screening. The p values demonstrated that only total mammogram 
barrier score made a significant contribution to prediction (p = .014, see Table 10). The 
odds ratio indicates that when total mammogram barrier score is increased by one unit 
(i.e. becomes more positive), the patient is 1.31 times more likely to have had previous 
breast cancer screening. Education level completed was not a significant predictor 
(p = 0.50).  
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Table 10 
Multivariable Analysis Using Logistic Regression To Predict the Previous Breast Cancer 
Screening Based on Total Mammogram Barrier Score and Education Level Completed 
(N = 41) 
Variable OR 95% C.I. B SE Wald df p 
Constant .00  -11.01 4.89 5.06 1 .025 
Education Level 
Completed (2 vs 1) 
1.91 0.30-12.20 .64 .95 .46 1 .497 
Total Barrier Score 1.31 1.06-1.63 .27 .11 6.09 1 .014 
 
Note. The variable education level completed was made into a binary variable where 
participants who graduated with a bachelor’s degree or higher = 2 and college 
diploma/certificate or less = 1. 
 
The consistency of the eight information presentation section questions was 
assessed using a Cronbach’s alpha statistic. Values of Cronbach’s alpha greater than 0.7 
are required for early research work (Black, 2012; Nunnally, 1978, p. 245). The 
Cronbach’s alpha was 0.72. This shows good consistency and allows the creation of 
summary scores. A total information presentation score was created as the sum of the 11 
questions. This score can have a theoretical range of 8 (responses are all 1’s) to 40 
(responses are all 5’s). A two sample 2-sided t test was first run to compare the total 
information presentation score between those who participated in BCS to those who did 
not participate in BCS. This study found that there is no statistically significant difference 
in total information presentation scores between those who previously participated in 
breast cancer screening (M = 26.61, SD = 4.38) and those who did not (M = 27.00, SD = 
3.34), t(39) = 0.24, p = 0.81 (see Table 11). 
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Table 11 
Two Samples t-Test Results of Total Information Presentation Score Between Two 
Groups (n = 41) 
 Previous participation in BCS 
 No SD Yes SD t df 
Total Information Score 27.00 3.34 26.61 4.38 0.24 39 
 
A logistic regression analysis was conducted to predict whether patients had 
previous breast cancer screening using education level completed and total information 
presentation score as predictors. The logistic regression model was not statistically 
significant, χ2(2) = .327, p = .849. The model explained only 1.3% (Nagelkerke R2) of the 
variance in previous breast cancer screening. The p values demonstrated that neither total 
information presentation score nor education level completed made a significant 
contribution to prediction (p = .917 and p = .608 respectively, see Table 12). This is also 
shown with the odds ratio findings for total information presentation score (OR = 0.99, 
95% CI = 0.82-1.20) and education level completed (OR = 1.54, 95% CI = 0.30-7.89) 
whose confidence intervals contain the null value of one. 
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Table 12 
Multivariable Analysis Using Logistic Regression To Predict the Previous Breast Cancer 
Screening Based on Total Information Presentation Score and Education Level 
Completed (N = 41) 
Variable OR 95% C.I B SE Wald df p 
Constant   1.51 2.75 0.30 1 .584 
Education Level Completed 
(2 vs 1) 
1.54 0.30-7.89 0.43 0.83 0.11 1 .917 
Total Information Score 0.99 0.82-1.20 -0.01 0.10 0.01 1 .917 
 
Note. The variable education level completed was made into a binary variable where 
participants who graduated with a bachelor’s degree or higher = 2 and college 
diploma/certificate or less = 1. 
 
No further analyzes were run for the subset of health motivation questions or the 
subset of knowledge of overdiagnosis questions as they were not found to be consistent 
on their own (Cronbach’s alpha values < 0.70). This study’s lack of reliability for these 
particular scales are in part the result of the small study sample size. Note that the sample 
size limited the running of a multivariable model with more than two predictors. Greater 
numbers of respondents would allow the inclusion of the variables accessibility 
(geographic proximity/ease with which participants can access/get screening 
mammography service). The use of logistic regression analysis would also have been 
good to explore that variable.  
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Summary 
Chapter 4 served the purpose of examining and describing the data observed 
during the study survey. The study survey sought to investigate if there exists a 
relationship between knowledge of overdiagnosis and the decision to participate in breast 
cancer screening. The 41 participants in the study were women aged 50–69 years who 
currently reside in Ontario’s GTA and read and write (understand) in English. 
Knowledge of overdiagnosis among participants was measured using a 45-item closed-
ended Likert-format group administered survey instrument. Participants were asked to 
listen to a brief presentation on breast cancer screening, its limitations, benefits, and 
associated risks, after which they were instructed to complete the survey questions.  
Analysis of the study findings showed that the majority of survey participants 
(75.61%) had limited and/or no knowledge of overdiagnosis prior to the survey 
presentation. However, the acquisition of knowledge of overdiagnosis during the survey 
presentation would not negatively impact their decisions about participating in breast 
screening programs. In total 95.12% of the participants disagreed or strongly disagreed to 
question 37 that stated ‘because overdiagnosis is an associated risk of breast cancer 
screening, I will no longer/ not participate in breast cancer screening.’ The two sample 2-
sided t-test result showed that those with previous participation in BCS have significantly 
(p < 0.01) higher total survey scores than those with no previous participation in BCS. 
This meant that these individuals had more positive thoughts and attitudes towards 
overdiagnosis and the screening process. The logistic regression result showed that, after 
adjusting for educational level completed, an increasing total survey score is significantly 
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associated with increased odds of participation in BCS. The working hypothesis for the 
primary research question was therefore found to be supported by the data. Among the 
secondary analyzes, two sample 2-sided t-test results showed that those with previous 
participation in BCS have significantly (p < 0.01) higher total scores on the mammogram 
barriers subsection than those with no previous participation in BCS. This meant that 
these individuals had more positive thoughts and attitudes towards mammogram barriers. 
The logistic regression result showed that, after adjusting for educational level 
completed, an increasing total mammogram barrier score is significantly associated with 
increased odds of participation in BCS.  
Chapter 5 provides overall conclusions from the key findings of the study. It also 
offers recommendations for future research and practical applications of the information 
uncovered during this study. Connections between the theoretical framework (effective 
health communication model and schema theory) are discussed in relation to the study’s 
findings. Finally, potential positive social change implications are also detailed. 
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Chapter 5: Summary, Conclusion, and Recommendations 
Introduction 
This research was focused on determining whether or not knowledge of 
overdiagnosis correlated with decisions about screening mammography participation. 
The study’s objective was to assess if a relationship exists between these two variables. 
The study’s working hypothesis suggested that the more knowledge a woman has 
regarding the screening process, the more likely she is to participate in screening 
mammograms. The purpose of the study was accomplished by assessing 41 women aged 
50–69 years who reside in the Greater Toronto Area (GTA), Ontario, and could read and 
write in English. To answer the research question and hypotheses, a 45-item, closed-
ended Likert-format group administered survey instrument was used to measure each 
participants: knowledge of overdiagnosis; health motivations regarding screening 
mammograms; perceptions of the limitations, benefits and risks of mammography 
screening; and how each felt about the information currently presented on breast 
screening programs. 
Findings of the Study 
The results of the study revealed that 
 Thirty-three participants (80.49%) had previously participated in BCS 
programs, and eight (19.51%) had not. 
 Nineteen participants (46.34%) confirmed that they had no knowledge of 
overdiagnosis in breast screening mammograms. 
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 Twelve participants (29.27%) confirmed that they had limited knowledge of 
overdiagnosis in breast screening mammograms. 
 Twenty-eight participants (68.29%) confirmed that they learned about 
overdiagnosis in breast screening for the first time during this study’s survey 
presentation, an additional two participants (4.88%) were neutral in their 
response to that survey question. 
 Twenty-five participants (60.98%) indicated that having knowledge of 
overdiagnosis would not influence their future decision to participate in 
screening mammography, and six participants (14.63%) noted that knowing 
about overdiagnosis in screening mammograms had no impact (i.e., they 
answered neutral) in influencing their future decisions. 
 Thirty-nine participants (95.12%) indicated that they would still participate in 
breast screening programs despite the fact that overdiagnosis was an 
associated risk of the breast screening process; an additional two participants 
(4.88%) were neutral in their response to that survey question. 
 With the exception of one participant who opted not to answer, all remaining 
40 participants (100%) felt information promoting breast cancer screening 
should clearly outline both the benefits and associated risks of screening 
mammograms. 
 With the exception of one participant who opted not to answer, all remaining 
40 participants (100%) felt information promoting breast cancer screening 
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should clearly outline overdiagnosis as an associated risk of screening 
mammograms. 
 The working hypothesis for the primary research question was supported by 
the survey data. The women with more positive thoughts and attitudes towards 
overdiagnosis are more likely to undergo BCS. Consequently, the null 
hypothesis was rejected, confirming that a relationship exists between the two 
measured study variables. 
 Regarding the secondary research question about mammogram barriers, 
women with more positive thoughts and attitudes towards mammogram 
barriers are more likely to undergo BCS. 
Interpretations of the Findings 
This study examined the correlation between knowing about overdiagnosis and 
women’s decisions to get breast cancer screening. The results of this study add to the 
body of knowledge that the Province of Ontario has about breast cancer screening 
participation rates among women aged 50–69 years who live in the GTA. In the section 
immediately following, the study’s results are interpreted based on the scholarly literature 
presented in Chapter 2. To a limited extent, this study confirms and extends previous 
literature addressing overdiagnosis in screening mammography. Specifically, the study 
confirms that in Ontario overdiagnosis exists and needs to be addressed with special 
consideration for the Giordano et al.’s (2006) principles of autonomy, beneficence, 
nonmaleficence, and justice. Additionally, to a limited extent, the study confirms the 
importance of balanced information presentation. In particular, detailed attention is 
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needed for not only the quality of the information disseminated, but also the 
media/channel through which this information is transmitted. 
Relating the Study Findings to Previous Studies Discussed 
This study’s findings support the concerns expressed in studies such as Baines 
(2005), Brouwers et al. (2011), Elmore and Fletcher (2012), and Nelson and Hagedorn 
(2011) about overdiagnosis in the breast screening process. Coldman and Phillips (2013) 
estimated the rate of overdiagnosis for breast cancer in women over the age of 60 years at 
5.4% for invasive diseases and 17.3% for both invasive diseases and ductal carcinoma in 
situ (p. E492). The study results and the literature review collectively showed that even 
though the terms overdiagnosis and overdiagnosed do not appear in the information that 
Ontario women aged 50–69 years receive, this does not mean that overdiagnosis has not 
occurred. As noted by the Canadian Task Force on Preventive Health Care (CTFPHC) 
(2014), among women in this study’s target population, for every 1,000 screening, 
roughly 283 have false positive results, another 36 will get unnecessary breast biopsy 
(overdiagnosed), and overall, 5 will undergo unnecessary surgery (overdiagnosed). 
This study also support the recommendations from Bleyer and Welch (2012), de 
Gelder et al. (2011), Duffy et al. (2010b), Hellquist, Duffy, Nyström, and Jonsson (2012), 
Jørgensen and Gøtzsche (2009), Kopans, Smith, and Duffy (2011), McPherson (2010), 
and Welch et al. (2011). These previous studies each indicated the need for research that 
definitively looked at how breast screening programs were impacted by a lack of 
knowledge of overdiagnosis and mass media. Olsen et al. (2003), Welch and Black 
(2010), and Moller et al. (2010) highlighted the significance of “practitioners, policy 
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makers, and women attending or considering screening [being] aware of the potential 
extent of breast cancer overdiagnosis and consequent overtreatment” (Moller et al. 2010, 
p. 281). This study’s findings supported Moller et al.’s (2010) above statement by way of 
the data analyzed. The data illustrated that 51.2% of the participants had learned about 
screening through in-person contact and 41.5% through a combination of print, electronic 
and in-person contact communication channels (see Table 4). This illustrated result 
underscored the need for practitioners, policy makers, and women attending screenings to 
receive balanced information presentations so that issues of overdiagnosis as a risk of 
breast cancer screening can be properly discussed with potential participants. The need 
for effective communication was also reinforced by Elmore and Fletcher (2012) and 
Nelson and Hagedorn (2011) who noted it was vital that breast cancer overdiagnosis be 
carefully outlined in information related to breast screening. Each further indicated the 
need for significant assessment of how best to ensure effective communication since 
informed women deserved no less when making decisions about breast screening 
participation (Elmore & Fletcher, 2012; Nelson & Hagedorn, 2011). 
Approximately three-quarters (75.61%) of the women in the study sample had 
limited and/or no knowledge of overdiagnosis prior to the survey presentation. However, 
80.49% had previously participated in screening mammography (as shown in Figure 7 
and Tables 3), and in spite of learning about overdiagnosis being an associated risk of the 
mammography process, 95.12% agreed or strongly agreed they would still be willing to 
participate in breast screening programs. These results to a limited extent support the 
notion that potential issues of overdiagnosis (in the Province of Ontario) could be 
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reduced if current and future screening mammography participants are given an 
objective/balanced outline of the benefits and risks of the screening process. This by 
extension would enable them to make informed decisions about screening participation 
and possibly reduce currently noted levels of unnecessary breast biopsies, false positives, 
and surgery (overdiagnosis). 
For the NCI’s Mayo Lung Project (a study that used the randomized clinical trial, 
RCT, research design), this study further validated that there is a lack of knowledge in the 
target population about what constituted overdiagnosis. The applicability of this finding 
is limited by the sample size; However, the study findings clearly showed that a 
significant percentage of the survey participants had limited and/or no knowledge of 
overdiagnosis prior to the survey presentation. This lack of knowledge may have 
impacted cancer screening results and to a larger extent the noted rates of screening 
participation. The highlighted studies in Chapter 2 implemented a lead-time and/or RCT 
approach to evaluating overdiagnosis. However, because Ontario had no research (to the 
best of my knowledge) outlining an association with levels of documented screening 
participation and a knowledge of overdiagnosis, prior to examining how breast screening 
participation was impacted by other factors, including that of overdiagnosis, it was first 
necessary to determine/confirm an association between those factors (knowledge of 
overdiagnosis and decisions on whether to get screened).  
Relating the Study Findings to the Theoretical Framework 
The results of the survey instrument provide strong support for Giordano et al.’s 
(2006) effective health communication model and schema theory. Both (the effective 
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health communication model and schema theory) formed the foundation for this research 
study. As noted in the overall findings a majority of the participants (75.61%) had limited 
and/or no knowledge of overdiagnosis in the screening process. However, 80.49% would 
have still opted to participate in screening mammograms despite a knowledge of 
overdiagnosis. These results illustrated that the more positive women’s thoughts and 
attitudes were towards overdiagnosis the more likely they would undergo breast cancer 
screening. 
Relating the study findings to the effective health communication model. In 
the effective health communication model Entwistle et al. (1998) and Goyder et al. (2000, 
as cited in Giordano et al., 2006) noted that effective health communication not only 
focused on the information transmitted but needed to ensure “health 
professionals . . .provided individuals with . . .information that would allow them to 
‘knowledgeably’ decide whether or not to undergo an intervention, taking into 
consideration available alternatives, potential risks and foreseeable outcomes” (p. 382). 
To this point, the study’s findings revealed that 100% of all participants (who opted to 
answer) agreed or strongly agreed that information promoting breast cancer screening 
should clearly outline both the benefits and associated risks of screening mammograms. 
More specifically, they also agreed or strongly agreed that information promoting breast 
cancer screening should clearly outline overdiagnosis as an associated risk of 
mammograms. With these results the indication is that consumers of public health 
programs want health providers to disclose all information related to the (breast 
screening) program being offered. The indication is also that whether or not that 
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information could be perceived as negative and/or a risk of the offered health 
intervention/treatment, consumers still want to know. The overall survey scores further 
reinforced reliability of Champion’s health belief model (HBM) scale that measured 
health motivation. The survey scores illustrated that persons would still make the best 
decisions for their health despite receiving information that outlined harms/risks and/or 
limitations to the intervention/treatment options.  
Relating the study findings to schema theory. Schema theory describes the 
cognitive structure of how an individual acquires, processes, and organizes knowledge. 
At the start of this study survey I estimated that the schemata (script) currently 
established for identifying if persons would decide to participate in screening 
mammograms potentially operated on the belief that, if only the benefits of screening 
mammography were predominantly promoted, there would be higher rates of 
participation in screening programs. Conversely, the belief therefore was that if 
information on screening mammography offered a balanced (both positive and negative) 
overview of the implications of participation, this would limit participants’ willingness to 
make an informed decisions about whether they should participate in screening programs. 
However, the results of the study’s survey instrument revealed that even though 30 
participants (73.17%) agreed, strongly agreed and/or were neutral in their answer as it 
related to learning about overdiagnosis for the first time during the study’s survey 
presentation, 33 participants (80.49%) would have still decided to participate in screening 
mammograms had they known about overdiagnosis at the time of their decision to 
participate. Three participants (7.32%) were neutral in their response on whether prior 
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knowledge of overdiagnosis in breast cancer screening programs would have stopped 
their participating.  
As outlined in Table 5, seven (13.2%) participants learned about breast screening 
through print media, eight (15.1%) via electronic media, 21 (39.6%) using in-person 
contact, and finally 17 (32.1%) using all channels mentioned above. Given the respective 
percentages identified for each communication channel the implication is that electronic 
media (radio, television, cable, internet, etc.) and in-person contact (via face-to-face, 
telephone, email with friends, family, health care professionals, etc.), which garners more 
attention, should be priority channels that health care providers and policy makers spend 
time improving. So that going forward potential participants who access these channels 
for information on breast screening programs are able to receive a balanced overview of 
not only the benefits but also the limitations and associated risks of screening 
mammograms. Of all 41 survey participants, 31 (75.61%) indicated that knowing about 
overdiagnosis in breast cancer screening would not influence their future decision to 
participate. Thirty-nine participants (95.12%) also revealed they would still decide to 
participate in mammograms despite now knowing about overdiagnosis in breast cancer 
screening. Finally, 100% (40) of the participants stated that they wanted a balanced 
presentation of information (schemata) about the limitations, benefits and associated risks 
of mammograms, including the risk of overdiagnosis.  
In the context of schema theory these results support the indication that the 
current schemata being used to promote breast screening programs needs to be adjusted. 
This adjustment is necessary because a majority of the survey sample participants 
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preferred to have a balance presentation of the information so they are better able to make 
informed decisions about whether or not to participate in screening mammography. For 
schema theory this study’s findings also support the indication that if packaged 
appropriately seemingly negative information can be received in a manner that does not 
elicit a negative reaction. Answers to the secondary research question of the study—Is 
there a relationship between thoughts and attitudes on subsections of the survey (such as 
mammogram barriers) and the decision to participate in breast cancer screening among 
women aged 50–69 years?—indicated that women with more positive thoughts and 
attitudes towards mammography barriers were more likely to undergo breast cancer 
screening. 
Potential Bias and Limitations of the Study 
As part of the detailed list of limitations mentioned in Chapter 1, specific 
limitations as they related to sample size and sampling strategic were confirmed during 
the data collection and analysis. For example, the study was not able to provide 
comprehensive confirmation that all participants had potentially the same/similar level of 
access to the various communication media (channels) through which screening 
mammography is promoted and accessed. Additionally, because of the small sample size 
it limited generalizability of the findings. Note that the sample size for this study limited 
the inclusion of more than two variables in the logistic regression model. The inclusion of 
more variables could allow a model to adjust for more potential confounders. As well, it 
would have increased the accuracy of the prediction of the outcome (participation in 
breast cancer screening).  
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Additional biases and limitations of the study were related to its recruitment 
strategy. Because the study only recruited participants through Tropicana Community 
Services’ (TCS) network, this approach limited the probability of including participants 
outside that network. As such, there were concerns that the study’s sample population is 
not a true representation of the general Ontario GTA populous. With respect to this 
sampling strategy used—purposive sampling—the study’s ability to have random and 
entirely by chance inclusion of participants to the sample population was limited. This by 
extension raised questions of potential selection bias due to the selection criteria I 
outlined.  
Recommendations for Future Research 
The overall results of the survey and particularly the affirmative answers (agree 
or strongly agree) for questions 44 and 45—which asked whether information about BCS 
should include discussions of the benefits, limitations and risks—support the observation 
that women aged 50–69 years want balanced presentation of information about screening 
mammograms. Their want for this balanced information presentation was in spite of the 
noted levels of education, and family history of cancer and/or breast cancer. Based on the 
specific results as noted in Table 4 the implication is that health care providers have a 
greater responsibility to ensure they are properly informed. By extension they (health 
care providers) are then better able to provide potential breast screening participants with 
a balanced overview of the benefits and risks of the screening process—because more 
than half of the survey participants (21) look to these health care providers for 
information and guidance. Additionally, information distributed via electronic 
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channels/media also ought to be properly vetted to ensure there is consistency, accuracy, 
and balanced presentation of information. This limited scope survey data collected on 
both the in-person contact and electronic media supported Giordano et al.’s (2006) 
statements that highlighted the relevance of paying closer attention to not only what is 
said but how it is presented. The study findings also support the idea that organizations 
creating and promoting screening mammograms ought to be held more accountable by 
the Government of Ontario. An approach to increase accountability would be through the 
use of more clearly articulated public health policies that reinforce—as a basic 
requirement that—information be presented in a balanced (benefits and risks) manner 
regardless of the channel (in-person or electronic) used to disseminate that information.  
My recommendation is that this survey be conducted on a larger scale. This will 
increase the generalizability of the study findings as well as reconfirm that the noted 
results of this survey is not atypical to the target population (women aged 50–69 years). 
Another recommendation is that further research be conducted that specifically evaluates 
how each communication channel (in-person contact, electronic media, social media, and 
print media) potentially influences decision-making regarding screening mammography 
participation. Because it was observed in the data analysis that all communication 
channels (social, electronic, print, and in-person contact), especially in-person contact are 
the channels mostly used by potential breast screening participants, it would be important 
and potentially valuable to understand how each media relates to the health decision-
making process. As noted by Giordano et al. (2006) the means through which 
information is transmitted and/or received is just as relevant as the quality of that 
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information (balanced, accurate, and transparent) presented. Also according to schema 
theory, the schemata individuals use to process information varies per person, as such 
each communication channel impacts the interpretation of the information. Therefore 
close attention and additional research would have the benefit of getting a more detailed 
understanding of what methods, content presentation, and other underlining factors 
engage and/or discourage participation in breast screening programs. 
Additional recommendations are that the Government of Ontario in conjunction 
with public health policy makers, health care providers and other key contributors 
reevaluate existing and/or create guidelines/policies that require all organizations and the 
health care providers themselves (who are affiliated with breast cancer screening 
promotion and/or provision) to mandatorily outline the benefits, limitations and risks of 
any intervention proposed to potential participants. Further to the revamp and/or creation 
of these guidelines/policies the Government of Ontario should ensure there are strict 
penalties for failure to comply. Finally, because a portion of the information that is 
presented to the public on breast cancer screening is controlled and/or provided via news 
outlets and printing publications, public health care guidelines/policies should outline 
expectations of quality (balanced, accurate and transparent) information presentation. As 
well, implications/penalties should be established for any nonhealth-related entity who 
also fails to comply with the rules. 
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Implications for Social Change 
For key stakeholders to create and implement public health policies and initiatives 
that will demonstrate the four principles (autonomy, nonmaleficence, beneficence, and 
justice) of Giordano et al.’s (2006) effective health communication model, it is 
imperative that these stakeholders understand how the benefactors (the public) of these 
policies and initiatives feel. Once more thought and understanding is applied to how 
public health care policies are created and/or implemented, from a positive social change 
perspective, this potentially increases the level of participation in public health programs. 
This potential increase in participation levels would be because the end user sees that 
targeted focus has been placed on not just getting participation levels increased, but that 
any increase is based on health care provisions tailored for each user. In addition to 
increased levels of participation, the quality of the public health service being provided 
would be held to a higher standard and therefore conversely reduce the potential for 
complains due to lack of transparency and accuracy in information presentation.  
Through the identification, revision, and implementation of standards that require 
a more balanced, comprehensive, and accurate representation of breast cancer screening 
facts, this has the potential to ensure future health care media communication campaigns 
deliver more balanced information in a transparent manner. This, by extension, creates 
the potential for ensuring more accurate reporting (than currently noted) of the rates of 
success in screening programs. Additionally, the results of this study (along with any 
future larger scaled study on this topic) may better equip the Government of Ontario with 
an understanding and awareness of the concerns and barriers women aged 50–69 years 
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face in accessing a holistic view of the positive and negative potentials of participating in 
breast cancer screening programs. In turn, this may improve the current rate of success 
noted. It also may reduce the levels of and potentials for overdiagnosis, and may help the 
Ontario government develop awareness campaigns that are ultimately more successful 
because patients are better informed. 
Conclusion 
The study showed a statistically significant relationship between thoughts and 
attitudes towards overdiagnosis and participation in breast cancer screening. The logistic 
regression model showed that those with more positive thoughts and attitudes towards 
overdiagnosis are more likely to participate in BCS. This model was able to adjust for the 
completed educational level of the respondents and therefore this conclusion can be made 
after accounting for the educational background of each individual that took the survey. 
The study also found a statistically significant relationship between thoughts and attitudes 
towards mammogram barriers and participation in BCS. The logistic regression model 
showed that those with more positive thoughts and attitudes towards mammogram 
barriers are more likely to participate in BCS. This model also adjusted for the completed 
educational level of the respondents and therefore this conclusion can be made after 
accounting for the educational background of the individual taking the survey. 
With the understanding that women (people) usually make the best health 
decisions based on their respective circumstances, regardless of the perceived negative 
consequences, it is therefore imperative that those persons be equipped with accurate and 
balanced information. Specifically, accurate and balanced information that maintains a 
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high level of transparency. To this end the Government of Ontario and entities affiliated 
with breast cancer screening promotion and provision have a responsibility to potential 
participants to ensure information presented demonstrates the four principles (autonomy, 
nonmaleficence, beneficence, and justice) of Giordano et al.’s (2006) effective health 
communication model. They (the Government of Ontario and its affiliates) should also 
take into account the fact that each individual’s schemata (how they organize current 
knowledge and provide a framework for future understanding) differs (Erasmus et al., 
2002). As such, it is necessary to identify and use appropriate communication channels 
(print, electronic, social, and in-person contact) relative those individual’s schemata. 
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Scholarship Fund program, to enhance their research and analytic skills to produce well 
written and quality academic papers.  
Mediator for Roundtable discussions and workshops for the Ontario Black History 
Society International Conference. 
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RESEARCH EXPERIENCE 
 
Writing research proposals; critiquing peer and non-peer reviewed articles; primary data 
collection; analysis of secondary data; using statistical software (SPSS and NVIVO) to 
code/recode data, identify missing data, calculate statistics, and interpret and present 
findings in the form of quantitative, qualitative, and mixed methods research plans. 
 
PROFESSIONAL EXPERIENCE 
 
2013–present McCarthy Tétrault LLP 
Marketing & Communications Specialist, managing and developing 
persuasive written content for firm and lawyer brand positioning and 
promotions. Preparation (research, write and edit) of: legal directory 
submissions, awards, news announcements, presentations, internal 
communications, and other marketing materials to support the firm’s 
information distribution and business development initiatives. In 
addition, integrating social media into the firm’s public relations and 
marketing efforts. 
2012–2013 Stikeman Elliott LLP 
Marketing Content & Proposal Specialist, developed compelling 
written proposal content and legal directory submissions, presentations, 
and other marketing materials to support the firm’s marketing and 
business development initiatives. 
2011–2012 Ontario Black History Society 
Events & Project Manager and Office Manager, focused on building 
and expanding relationships with government, corporate partners and 
membership for an Ontario-based national non-profit organization. 
2008–2011 Black Business Professional Association 
Progressive roles including Project Manager (BBPA National 
Scholarship Fund and Harry Jerome Awards), Office Manager and 
Senior Office Administrator responsible for business development, 
driving relationship growth, resource development and visibility among 
sponsors, community and local media. 
2003–2009 Meuze 
Marketing Project Manager focused on business developing and 
implementing comprehensive marketing strategy for a privately-owned 
fashion design and fashion marketing/PR business. 
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PROFESSIONAL MEMBERSHIPS/AFFILIATIONS 
 
2011–present Member, Ontario Black History Society 
2011–2013 Member, Urban Financial Services Coalition 
2008–2011 Member, Black Business and Professional Association 
 
COMMUNITY INVOLVEMENT/OUTREACH 
 
2011–present Volunteer, Ontario Black History Society  
2011–2013 Volunteer, Urban Financial Services Coalition  
2010–2012 Volunteer, Reel World Film Festival 
2009–2010 Volunteer, The Applause Institute 
2008–2011 Volunteer, Black Business and Professional Association 
2008–2010 Volunteer, Caribbean Tales 
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